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Abstract: Biochemie und Molekularbiologie stehen im direkten Zusammenhang mit dem täglichen Leben:
das Wissen von biologischen Mechanismen hat eine grosse Bedeutung für die Gesundheit, die Umwelt
und die technologische Entwicklung. Die vorliegende Doktorarbeit befasst sich mit computergestützten
Beiträgen zur Molekularbiologie. Eine Vielzahl von komplexen molekularen Phänomenen wurde dank
der inhärenten Flexibilität numerischer Simulationen untersucht. Ein zentrales Problem von Simulatio-
nen der Moleküldynamik ist die Frage, wie der Konformationsraum eines komplexen Systems mit einem
genügend genauen Kraftfeld abgetastet werden soll. Das Verhältnis zwischen Genauigkeit und Effizienz
ergibt sich hierbei aus den Anforderungen des zu untersuchenden Systems. In dieser Arbeit wurden
drei Themen untersucht: Amyloid Aggregation, Stabilisierung des gefalteten Zustands eines Proteins
und Membran- Protein Interaktionen. Alle Projekte dieser Arbeit wurden mit verschiedenen comput-
ergestützten Methoden mit unterschiedlichem Grad an Vereinfachung und Genauigkeit behandelt. Die
Aggregation von Amyloid Proteinen wird mit vielen degenerativen Krankheiten wie Alzheimer, Parkinson
und Typ II Diabetes, in Verbindung gebracht. Aus diesem Grund kann das Verständnis der Vorgänge
auf molekularer Ebene dazu genutzt werden, Strategien gegen die Giftigkeit der Amyloidablagerung zu
entwickeln. Die Vorhersage der Aggregationsgeschwindigkeit von Amyloidproteinen wurde mit Hilfe einer
phänomenologischen Formel untersucht, welche Aufschluss gab über die Abhängigkeit der Bildung von
amyloiden Strukturen aufgrund der Polypeptidesequenz. Danach wurde ein grobkörniges Modell von
Amyloidpeptiden entwickelt. Die eingeführte Vereinfachung erlaubte die Erforschung von Phänomenen
wie Oligomerbildung, Keimbildung und Verlängerung von Fibrillen, die mit genauen Kraftfeldern nicht
zugänglich sind. Des Weiteren liess die Änderung eines einzigen energetischen Parameters, welcher die rel-
ative Verteilung amyloidophiler or amyloidophober Zustände des Monomers bestimmt, die Nachahmung
vieler Phänomologien zu, was Aufschluss über die Kinetik der Aggregation geben kann.Proteinfaltung
ist ein Phänomen dem die Funktionalität von molekularen Komponenten zugrundeliegt. Vorhersagen
welche Sequenzmodifikationen eine stabilere Strukur und möglicherweise ein funktionaleres Protein zur
Folge haben, haben eine enorme Auswirkung auf molekül-basierte Technologien. Eine Zusammenar-
beit mit Experimentalisten führte zur Entdeckung von Mutationen, die den gefalteten Zustand eines
Proteins, bestehend aus mehreren Armadilloeinheiten, stabilisieren, das vorgängig Charakteristika eines
geschmolzenen Kügelchens (molten globule) aufwies. Die rechenbetonten Beiträge halfen den Sequen-
zraum einzuschränken und die aussichtsreichsten Mutanten auszuwählen. Membran-Protein Interaktio-
nen bilden die Basis der Zellkommunikation und des Kerntransports. Diese Mechanismen, obwohl in einer
Vielzahl von entscheidenden Prozessen involviert, sind nach wie vor auf molekularer Ebene schlecht ver-
standen. Die Erforschung von Peptiden mittels Simulationen der Moleküldynamik, die sowohl mit Mem-
branen als auch mit Mizellen interagieren, verhalf zu neuen Einsichten dieser molekularen Mechanismen.
Im ersten System konnte die spontane Faltung von Melittin an der Lipidoberfläche einer Mizelle repro-
duziert werden, währenddem die Gleichgewichtseigenschaften des Mizellen-Melittin-Komplexes ebenfalls
erhalten blieb. In einer zweiten Arbeit wurden das in einer Membrandoppelschicht eingebettete, Lipid-
modifizierte C- terminale Heptapeptid des menschlichen N-ras Proteins untersucht. Die Ergebnisse der
Simulation bestätigten ein vorgängiges strukturelles Modell, basierend auf spektroskopischen Daten und
schlugen einen Mechanismus des Einschubs der Peptids in die Membran vor. Biochemistry and molecular
biology are directly related to everyday life: the knowledge of the biological mechanisms at the molec-
ular level has a strong impact on health, environment and technological development. In the present
thesis, the contributions of computational methods to molecular biology were investigated. Thanks to
the intrinsic flexibility of numerical simulations, a variety of complex molecular phenomena have been
addressed. One of the major issues of molecular dynamics simulations is how to efficiently sample the
conformational space of complex systems with a sufficiently accurate force field. The relationship be-
tween accuracy and efficiency must be established by the requirements of the investigated sys- tem. In
this work three subjects were treated: amyloid aggregation, stabilization of protein folded state, and
membrane-protein interactions. All the projects exposed in this thesis were approached using different
computational methods with different levels of simplification and accuracy. Amyloid protein aggregation
is related to many degenerative diseases, such as Alzheimer’s disease, Parkinson and type II Diabetes.
Therefore the understanding of this process at the molecular level can help to devise strategies against
the toxicity induced by amyloid deposits. The prediction of the aggregation rate of amyloid peptides was
addressed using a phenomenological formula that gave insights into the dependence of amyloidogenesis
on the polypeptide sequence. Thereafter a coarse-grained model of amyloid peptides was developed.
Here, the simplification introduced allowed the exploration of phenomena such as oligomer formation,
fibril nucleation and fibril elongation, which are not accessible by accurate force fields. Furthermore, the
change of a single energetic parameter, which determines the relative population of the amyloid-prone and
amyloid-protected states of the monomer, allowed to reproduce a vast phenomenology, which is useful
to shed light into the kinetics of aggregation. Protein folding is the phenomenon that lies behind the
functionality of molecular components of the cell. Predicting which sequence modifications results in a
more stable fold, and possibly more functional protein, has an enormous influence on molecular-based
technologies. Here, a collaboration with experimentalists has led to the discovery of the mutations that
stabilize the folded state of an Armadillo repeat protein, which previously displayed molten globule-like
features. The computational contribution helped to restrict the sequence space, and to select the most
promising mutants. Membrane-protein interactions are the basis for cell signalling and cellular trans-
port. These mechanisms, although involved in a number of vital processes, are still poorly understood
at the molecular level. In this work, the investigation of peptides that inter- act with both micelles
and membrane by means of molecular dynamics simulations has provided new hints on the underlying
molecular mechanisms. In the first system investigated the spontaneous folding of melittin on the lipid
micelle surface was reproduced, together with equilibrium properties of the micelle-melittin complex. In
the second work the lipid modified C-terminal heptapeptide of the human N-ras protein embedded into
a membrane bilayer was studied. The simulation results validated a previous structural model based on
spectroscopic data, and propose a mechanism for peptide insertion into the membrane
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V1 Summary
Biochemistry and molecular biology are directly related to everyday life: the knowl-
edge of the biological mechanisms at the molecular level has a strong impact on health,
environment and technological development.
In the present thesis, the contributions of computational methods to molecular biol-
ogy were investigated. Thanks to the intrinsic flexibility of numerical simulations, a va-
riety of complex molecular phenomena have been addressed. One of the major issues of
molecular dynamics simulations is how to efficiently sample the conformational space
of complex systems with a sufficiently accurate force field. The relationship between
accuracy and efficiency must be established by the requirements of the investigated sys-
tem. In this work three subjects were treated: amyloid aggregation, stabilization of
protein folded state, and membrane-protein interactions. All the projects exposed in this
thesis were approached using different computational methods with different levels of
simplification and accuracy.
Amyloid protein aggregation is related to many degenerative diseases, such as Alz-
heimer’s disease, Parkinson and type II Diabetes. Therefore the understanding of this
process at the molecular level can help to devise strategies against the toxicity induced
by amyloid deposits. The prediction of the aggregation rate of amyloid peptides was
addressed using a phenomenological formula that gave insights into the dependence of
amyloidogenesis on the polypeptide sequence. Thereafter a coarse-grained model of
amyloid peptides was developed. Here, the simplification introduced allowed the explo-
ration of phenomena such as oligomer formation, fibril nucleation and fibril elongation,
which are not accessible by accurate force fields. Furthermore, the change of a single
energetic parameter, which determines the relative population of the amyloid-prone and
amyloid-protected states of the monomer, allowed to reproduce a vast phenomenology,
which is useful to shed light into the kinetics of aggregation.
Protein folding is the phenomenon that lies behind the functionality of molecular
components of the cell. Predicting which sequence modifications results in a more sta-
ble fold, and possibly more functional protein, has an enormous influence on molecular-
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based technologies. Here, a collaboration with experimentalists has led to the discovery
of the mutations that stabilize the folded state of an Armadillo repeat protein, which pre-
viously displayed molten globule-like features. The computational contribution helped
to restrict the sequence space, and to select the most promising mutants.
Membrane-protein interactions are the basis for cell signalling and cellular transport.
These mechanisms, although involved in a number of vital processes, are still poorly
understood at the molecular level. In this work, the investigation of peptides that inter-
act with both micelles and membrane by means of molecular dynamics simulations has
provided new hints on the underlying molecular mechanisms. In the first system inves-
tigated the spontaneous folding of melittin on the lipid micelle surface was reproduced,
together with equilibrium properties of the micelle-melittin complex. In the second work
the lipid modified C-terminal heptapeptide of the human N-ras protein embedded into
a membrane bilayer was studied. The simulation results validated a previous structural
model based on spectroscopic data, and propose a mechanism for peptide insertion into
the membrane
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2 Zusammenfassung
Biochemie und Molekularbiologie stehen im direkten Zusammenhang mit dem ta¨glichen
Leben: das Wissen von biologischen Mechanismen hat eine grosse Bedeutung fu¨r die
Gesundheit, die Umwelt und die technologische Entwicklung.
Die vorliegende Doktorarbeit befasst sich mit computergestu¨tzten Beitra¨gen zur Moleku-
larbiologie. Eine Vielzahl von komplexen molekularen Pha¨nomenen wurde dank der
inha¨renten Flexibilita¨t numerischer Simulationen untersucht. Ein zentrales Problem von
Simulationen der Moleku¨ldynamik ist die Frage, wie der Konformationsraum eines kom-
plexen Systems mit einem genu¨gend genauen Kraftfeld abgetastet werden soll. Das
Verha¨ltnis zwischen Genauigkeit und Effizienz ergibt sich hierbei aus den Anforderun-
gen des zu untersuchenden Systems. In dieser Arbeit wurden drei Themen untersucht:
Amyloid Aggregation, Stabilisierung des gefalteten Zustands eines Proteins und Membran-
Protein Interaktionen. Alle Projekte dieser Arbeit wurden mit verschiedenen comput-
ergestu¨tzten Methoden mit unterschiedlichem Grad an Vereinfachung und Genauigkeit
behandelt.
Die Aggregation von Amyloid Proteinen wird mit vielen degenerativen Krankheiten
wie Alzheimer, Parkinson und Typ II Diabetes, in Verbindung gebracht. Aus diesem
Grund kann das Versta¨ndnis der Vorga¨nge auf molekularer Ebene dazu genutzt wer-
den, Strategien gegen die Giftigkeit der Amyloidablagerung zu entwickeln. Die Vorher-
sage der Aggregationsgeschwindigkeit von Amyloidproteinen wurde mit Hilfe einer
pha¨nomenologischen Formel untersucht, welche Aufschluss gab u¨ber die Abha¨ngigkeit
der Bildung von amyloiden Strukturen aufgrund der Polypeptidesequenz. Danach wurde
ein grobko¨rniges Modell von Amyloidpeptiden entwickelt. Die eingefu¨hrte Verein-
fachung erlaubte die Erforschung von Pha¨nomenen wie Oligomerbildung, Keimbildung
und Verla¨ngerung von Fibrillen, die mit genauen Kraftfeldern nicht zuga¨nglich sind. Des
Weiteren liess die ¨Anderung eines einzigen energetischen Parameters, welcher die rel-
ative Verteilung amyloidophiler or amyloidophober Zusta¨nde des Monomers bestimmt,
die Nachahmung vieler Pha¨nomologien zu, was Aufschluss u¨ber die Kinetik der Aggre-
gation geben kann.
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Proteinfaltung ist ein Pha¨nomen dem die Funktionalita¨t von molekularen Kompo-
nenten zugrundeliegt. Vorhersagen welche Sequenzmodifikationen eine stabilere Struk-
tur und mo¨glicherweise ein funktionaleres Protein zur Folge haben, haben eine enorme
Auswirkung auf moleku¨l-basierte Technologien. Eine Zusammenarbeit mit Experimen-
talisten fu¨hrte zur Entdeckung von Mutationen, die den gefalteten Zustand eines Pro-
teins, bestehend aus mehreren Armadilloeinheiten, stabilisieren, das vorga¨ngig Charak-
teristika eines geschmolzenen Ku¨gelchens (molten globule) aufwies. Die rechenbetonten
Beitra¨ge halfen den Sequenzraum einzuschra¨nken und die aussichtsreichsten Mutanten
auszuwa¨hlen.
Membran-Protein Interaktionen bilden die Basis der Zellkommunikation und des
Kerntransports. Diese Mechanismen, obwohl in einer Vielzahl von entscheidenden Prozessen
involviert, sind nach wie vor auf molekularer Ebene schlecht verstanden. Die Erforschung
von Peptiden mittels Simulationen der Moleku¨ldynamik, die sowohl mit Membranen
als auch mit Mizellen interagieren, verhalf zu neuen Einsichten dieser molekularen
Mechanismen. Im ersten System konnte die spontane Faltung von Melittin an der Lipi-
doberfla¨che einer Mizelle reproduziert werden, wa¨hrenddem die Gleichgewichtseigen-
schaften des Mizellen-Melittin-Komplexes ebenfalls erhalten blieb. In einer zweiten
Arbeit wurden das in einer Membrandoppelschicht eingebettete, Lipid-modifizierte C-
terminale Heptapeptid des menschlichen N-ras Proteins untersucht. Die Ergebnisse
der Simulation besta¨tigten ein vorga¨ngiges strukturelles Modell, basierend auf spek-
troskopischen Daten und schlugen einen Mechanismus des Einschubs der Peptids in
die Membran vor.
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3.1 Open challenges in protein structural biology
Protein Folding. Proteins are ubiquitous and highly specialized macromolecules, which
participate to nearly all metabolic process of the cell. They are polymerized by ribo-
somes in the endoplasmic reticulum as a linear chain of amino acids, whose sequence
is encoded into the DNA. Due to intrinsic flexibility of the amino acids main chain, the
”backbone”, and the side-chains, a protein can assume a huge number of isomerization
states. Nevertheless for many proteins only one specific isomerization is the functional
”native” conformation. Thus, once synthesized the protein must undergo to a complex
process of folding to attain the functional isoform. In the cell, which is a highly crowded
environment because of a concentration of 350 mg/ml [1] of macromolecules, the protein
folding is sometimes assisted by various molecular helpers.
Energy landscape. Protein folding is not merely associated to the biological environ-
ment. Mechanistic investigation of protein folding have been advanced by the ability
to observe these complex reactions also in vitro. Previously expressed and purified
polypeptides can fold under physiological thermodynamic conditions also without as-
sisting molecules: the protein folding to the native conformation is therefore a property
of the single polypeptide chain. Folding or unfolding can be detected by the acquisi-
tion or loss of an enzymatic activity (denaturation), or a structural property inherent to
the native state. Once completely denatured, a number of proteins can efficiently refold
upon dilution from denaturant (refolding). Anfinsen in the late 50s has first monitored
the activity of ribonuclease A upon denaturation [2], detecting the presence of a ther-
modynamics equilibrium between the folded and the unfolded state. Furthermore, he
established that the necessary information to proper fold is univocally contained into
the primary sequence. These earlier studies brought to the unanimously agreed picture
that the native state of a protein is a minimum into the free energy landscape, where for
landscape it is meant an abstract space consisting of all possible isomerization of the
polypeptide chain.
Folding Thermodynamics and Kinetics. The thermodynamics of folding process is
2determined by the free energy difference between the folded (F) and the unfolded (U)
states ∆G. Though the protein folding is a reaction that can involve two or more states,
in many cases it may be described by a simple two state reaction:
F
ku
⇋
kf
U (1)
where ku and kf are the rate constants of the unfolding and folding reactions respectively.
∆G is derived from the equilibrium constant K = kf/ku of the unfolding reaction:
∆G = −kBT logK (2)
being kB the Boltzmann constant and T the temperature in Kelvin. The presence of
proteins that display an equilibrium in the folding-unfolding reaction with a pure two
state kinetics, allowed the understanding of the process at a more theoretical and general
level. An interesting feature of the protein folding is that it is not a sequential sampling
of the isomerization space. In fact the estimated time to accomplish a random search is
much longer than typical time scales of biological processes, thus useless for the scope
of life [3]. Therefore, the folding process must be driven by a number of intermediates
that efficiently restraints the isomerization space in a funnel-like manner. This suggests
that not only the folding-unfolding thermodynamics, but also the kinetics is presculpted
into the sequence.
Molten globule and intrinsically disordered proteins. Not all sequences have a stable
folded structure under physiological conditions. For instance, molten globule is a par-
ticular state where a protein has a detectable secondary structure but misses of defined
tertiary contacts. Furthermore as many as 30% of eukaryotic proteins are either com-
pletely disordered or owning disordered regions [4]. These proteins, called intrinsically
disordered proteins (IDP) though not displaying any folded conformation, have indeed
important roles into the cell, and represent an extention to the concept of functional con-
formation. IDPs have been found be involved in DNA/RNA-protein interaction, function
as inhibitors or scavengers, and facilite the formation and function of multiprotein com-
3plexes [5–7]. The discussion about molten globule will be continued in section 7, where
an approach to the hydrophobic core stabilization will be presented.
Protein misfolding and aggregation. In contrast with the two state folding of model
proteins, refolding from denaturant of large proteins is generally not efficient. For such
proteins the fold is kinetically trapped in a local minima, and in this partly folded inter-
mediate, protein can associate and eventually precipitate. A certain number of human
diseases, classified as protein misfolding diseases, are due to an incorrect non-functional
protein morphology competing with the native functional form (that could be either
structured or unstructured). Recently attention has been focused on a group of mis-
folding diseases related to an abnormal deposit of polypeptide sequestered from their
soluble form, which accumulate in different tissues [8]. Remarkably the main features
of such deposits, known as amyloid deposits, are very similar among different precur-
sor proteins, suggesting a common mechanism for the polymerization and, putatively,
the toxic activity. In section 4 the phenomenology of amyloid aggregation is discussed
more in detail, and in sections 5 and 6 the results of computational modelling of amyloid
polymerization is presented.
Membrane protein. A large set of proteins belongs to the class of membrane proteins,
which are polypeptides associated or integrally anchored to the cell membranes. These
molecules play essential roles, such as signal transductions or mechanosensitive chan-
nels, and are the most important targets for drug discovery. Although it is estimated
that 25-30 % of open reading frames encode for membrane proteins, only a few of their
high-resolution structures have been resolved. And less is known about how membrane
protein folds: it has been postulated that a two or three stages [9] mechanism is nec-
essary for a complete α-helical transmembrane assembly, which might be assisted by
molecular machinery such as translocons [10]. While structural characterization of large
integral membrane molecules is still a big challenge, membrane associated polypeptides
such as amphipathic helix or lipid modified peptides are within the range of standard
structural investigation. In sections 8 and 9 molecular dynamics simulations are used to
investigate the peptide-membrane interactions.
43.2 Computational chemistry
Computational chemistry is an established branch of scientific research whose contribu-
tion is determinant for the understanding of many biomolecular process. The molecular
simulation, an applicative form of the statistical mechanics methods [11], and the con-
cept of the in silico experiment are taking part to this wide discipline. In the in silico
experiment a model of the real system is constructed, observables are measured and
compared with real experimental properties. This comparison may validate or invalidate
the model. If the model properties agree with real ones, the model can be used to make
predictions. In particular computational chemistry is useful to describe:
• The structure and stability of a molecular system
• The free energy of different states of a molecular system
• Reaction process within molecular systems
During the decades, thanks to the improvement of informatics, the research enriched
with new algorithms and new capabilities that yielded to an increase in complexity of the
investigated systems. The field of computational chemistry experienced applications that
ranged from the simple liquid phase transition to the protein folding, enzyme inhibition,
membrane channel function, extending the impact of this field of research onto everyday
life, with increasing level of reliability and prediction.
One of the most commonly used computational methods is Molecular Dynamics
(MD), which is a technique that resolves the evolution of the degrees of freedom of
molecular systems along the time. It can be roughly classified in two kinds: the ab
initio methods, which applies the principles of quantum physics, and the molecular me-
chanics, which is based on the classical mechanics [12]. The latter uses an empirical
energy potential that is called force field, and which is the set of prescriptions that de-
fine structure-energy relationship. Various force fields are currently being used, such as
CHARMM [13], AMBER [14], GROMOS [15] and OPLS [16], and the typical equation
for the potential energy is a pairwise, conservative function:
5E(r) = Ecov(r) + Enon−cov(r) (3)
being Ecov and Enon−cov the covalent and non-covalent energy terms, respectively. r is
the N × 3-dimensional array of atoms coordinates. The covalent term is the sum of
bonds b, covalent angles θ, dihedral angles φ and improper dihedral angles ω:
Ecov(r) = Eb + Eθ + Eφ + Eω =
=
∑
b
1
2
kb(b− b0)
2 +
∑
θ
1
2
kθ(θ − θ0)
2 + (4)
∑
φ
kφ[1 + cos(nφ+ ψ)] +
∑
ω
kω(ω − ω0)
2
where kb, kθ, kφ and kω are the force constants. Note that the bond, the angle and the
improper potentials are harmonic potentials that assume the minimum value at rb0 , θ0
and ω0. On the other side the torsional is a sum of periodic functions, whose indexes are
n and phases are ψ.
The non-covalent term in equation (3) is the sum of Lennard-Jones and Coulombic
potentials:
Enon−cov(rij) = ELJ(rij) + EC(rij)
=
∑
i<j
ǫij
[(
rminij
rij
)12
− 2
(
rminij
rij
)6]
+
∑
i<j
qiqj
4πǫ0rij
(5)
where qi is the partial charge of atom i, ǫ0 is vacuum permittivity, rminij is the equilibrium
separation distance of the Lennard-Jones potential and ǫij is the energy well depth, i.e.,
ELJ(r
min
ij ) = −ǫij . The Lennard-Jones potential ELJ is an effective pairwise function
that mimics the van der Waals interaction, while the Coulombic potential EC is the en-
ergy term that accounts for electrostatic attraction or repulsion between the charges. The
trajectories of the atoms belonging to the molecular system are calculated by iterative
numerical integration of the Newton equation of motion:
mi
d2
dt2
ri = mi
d
dt
vi = miai = Fi(ri) = −∇iE(ri)
6that expresses the relationship between the force field potential E(r) defined in equation
(3), and the kinematic quantities, i.e., the force F , the accelerations a, the velocities v
and the coordinates r.
3.2.1 The solvation
Water, the main component of the biological liquid in which most macromolecules op-
erate, is a complex medium, whose modellization is a particularly careful issue. A com-
mon approach is the use of explicit solvent, which consists in atomistic water molecules.
This model has the advantage of being parameterizable at the water molecule level [17],
though it has the major disadvantage to be extremely inefficient in the sampling of slow
molecular events such as protein folding or aggregation. Another possible solution is
the use of an implicit solvent, i.e., a mean field approximation of the solvent medium.
In the implicit solvent models water degrees of freedom are not included into the force
field potential but they are replaced by a potential that depends on the solute degrees of
freedoms only [18]. The hydration of a molecule can be expressed by a reversible ther-
modynamic cycle where the free energy of solvation is the sum of polar and non-polar
contributions:
Gsolv = Gnp +Gp = Gcav +GvdW +Gp
where Gcav is the solvent cavitation term, GvdW is the solute-solvent van der Waals and
Gp is the solute-solvent electrostatic polarization term. Several implicit solvent schemes
have been adopted to approximate either the non polar or the polar contributions. Con-
tinuum electrostatics approaches are the most reliable in reproducing the polar contribu-
tions, and they are based on the Poisson equation for the electrostatic potential ψ(r) [19]:
∇ · [ǫ(r)∇ψ(r)] = −4πρ(r)
where r is the vector of the solute atoms coordinates, ǫ is the position dependent dielec-
tric and ρ(r) is the fixed charge density of the solute. Numerical solution of Poisson
equations have been implemented into the force fields [20], but are still very inefficient.
7Hence, semi-analytical treatments of continuum electrostatics have been developed, in-
cluding Generalized Born approximations [21], which reduce the electrostatic solvation
energy to a pairwise potential. However the most efficient solvation schemes for molec-
ular dynamics of macromolecules are those based on the solvent accessible surface area
(SASA) [22–24] or slight variation of the same concept [25]. These models are based
on the idea that solvation energies can be decomposed into atomic contributions, which
are determined by the local solute geometry:
Gsolv =
∑
i
σiSi (6)
where i is the solute atom index, σi are surface tensions, and S(i) are the atomic solvent
accessible areas. The solute surface, which is a measure of the water accessibility in
the first shell of hydration, is responsible for the main contributions to the solvation
energies. This assumption holds for non-polar contributions, where it corresponds to the
first order approximation of the scaled particle theory of solutes [26, 27], and has been
observed in energetics of n-alkane transfer in water and amino acids [28]. The hydration
Gibbs energy of proteins can be decomposed in chemical groups contributions [29], or
atom type contributions [22]. In the latter case every atom type has its own surface
tensions σi, which are derived from gas to water transfer energies of small compounds.
Furthermore the charge screening operated by the solvent is approximated by a distant
dependent dielectric with neutralized ionic groups [25].
3.2.2 The sampling
Molecular dynamics simulations generate a set of configurations of the system that rig-
orously obeys to the thermodynamic restraints imposed on the system (the statistical
ensemble [11]). This process of coordinate exploration is called sampling and it is the
basis for calculating the average value of an observable. Constant temperature simula-
tions is a common way to perform a sampling. At fixed temperature, the probability that
a physical system adopts a particular conformation r (with r1, ..., rN coordinates of the
8atoms) is given by the Boltzmann distribution at temperature T :
p(r) = e−E(r)/kT (7)
where E(r) is the potential energy of the conformation r. The value associated to an
observable A is then obtained as the weighted average over all possible conformations:
A =
∑
r
A(r)p(r)
In a simulation, the measure of a physical quantity is simply as an average of the various
instantaneous values assumed by the quantity during the MD run:
A =
1
S
∑
s
A(s)
where S is the total number of sampled conformations, and s is the index of confor-
mation. Whether the generated set of conformations is representative for measuring ob-
servables depends on the extent to which the configuration space have been sampled, and
depends on the sampling algorithm that is applied. In fact the time required to overcome
a free energy barrier ∆G‡ is:
τ = τ0 exp(∆G
‡/kBT )
with a prefactor τ0 that has a typical value of 10−7 s. If we assume that for reactions such
as folding, binding and aggregation the estimated barrier is about 10 kT , then the event
has a single occurrence within the ms timescale [30]. These timescales are challenging
the computational efficiency of modern computers, therefore strategies that improve the
sampling have been developed.
Implicit solvent, as mentioned above, is a method that enhances the efficiency of
calculation. Furthermore it is a way to improve also the sampling. In fact the viscosity
effects due to the aqueous environment are neglected, reducing the overall frustration of
the system.
Another way that allows improvement of both efficiency and sampling is the coarse
graining [31]. Here the atomistic details are eliminated, and integrated into mesoscopic
9units which interacts through a potential of mean force. The reduction of the number
of interacting particles reflects into a dramatic gain of efficiency, but on the other side
the atomistic details are lost. Coarse grained models are particularly attractive when
the investigator is interested in studying phenomenologies at the mesoscopic scale, e.g.,
membrane-viruses interactions [32].
The reduction of the total number of the degrees of freedom of a system might help
to improve efficiency. This method is particularly useful when the investigator is in-
terested in a specific region of the molecule, e.g., the binding pocket of an enzyme or
the hydrophobic core of a protein. By restraining or constraining the coordinates of the
atoms not being part to the interested region one can substantially decrease the compu-
tation load. Furthermore some algorithms has been developed to satisfy bond geometry
constraints during molecular dynamics simulations [33]. If applied to hydrogens, they
allow a longer timestep integration.
Conformational sampling is a problem of considerable concern in the case of sys-
tems out of equilibrium,e.g., the amyloid fibril formation. In this case the state of the
system evolves irreversibly towards a steady state, and the simulation of a single replica
doesn’t sample correctly the intermediates. A simple way to overcome this problem is
to perform multiple molecular dynamics simulations [34] of the same system. Setting
different initial velocities, the replicas evolve through completely different pathways and
independently explore different intermediates. If the number of replicas is sufficiently
large, the population of intermediates converges to the expected value. This method has
been adopted by distributed computing [35] to exploit the world wide computational
power of personal computers.
Among all algorithms, replica exchange methods, REM, is a very efficient way to
simulate complex systems at low temperature. Sugita and Okamoto have extended the
original formulation into an MD based version (REMD) [36], a technique that has been
employed for studying the folding and aggregation of peptides [37–39]. The basic idea
of REMD is to simulate different replicas of the system at the same time but at different
temperature values. Each replica evolves independently by MD and periodically states
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section
of the-
sis
research project force field/ solvent
model
approximations sampling
5 Amyloid aggrega-
tion rate prediction
empirical formula based on protein
sequence
not necessary
6 Amyloid aggrega-
tion mechanisms
coarse grained po-
tential/ vacuum
monomers have 1
degree of freedom
multiple MD simu-
lations
7 de novo protein
core design
atomistic/ vacuum restrained back-
bone
random rotamer
sampling
8 Folding of helical
peptide on micelle
atomistic solute
and lipids/ implicit
solvent
aqueous solvent is
a continuum
constant tempera-
ture MD, REMD
9 Binding of lipi-
dated peptide on
membrane
atomistic solute
and lipids/ explicit
solvent
none constant tempera-
ture MD, steered
MD
Table 1: Biological problems and computational approaches.
with neighbor temperatures are swapped with a probability that is proportional to the
potential energy difference between the two states. This produces a random walk in
the space of temperature, which enables the overcome of barriers and improves low
temperature sampling.
3.2.3 Multiscale modelling
Hence, the main problem of molecular simulation is how to sample efficiently the con-
formational space of molecules with a sufficiently accurate force field and solvation
model. The relationship between accuracy and efficiency must be established by the re-
quirements of the investigated system: assumptions, approximations and simplifications
of the model must be chosen such that their contributions are comparable to the overall
inaccuracy.
In this thesis application of computational chemistry to different biochemical prob-
lems is adapted to the degree of simplification. The chapters of this thesis are organized
in increasing complexity and sophistication of the applied models. The sampling tech-
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niques mentioned above have been employed as needed, as reported in Table 1.
In sections 5 and 6 two possible approaches are adopted to investigate and predict
the kinetics of amyloid aggregation. The first method is an empirical analytical formula,
and the second is a coarse-grained model of amyloid peptide simulated with molecular
dynamics. In section 7 the optimization of the hydrophobic core of a designed protein
is discussed. Section 8 the folding simulation of melittin into micelles with an implicit
solvent model is treated. The final section concerns the explicit solvent simulation of a
lipidated peptide binding onto a membrane bilayer.
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4 Amyloid aggregation
The amyloid aggregates are fibrillar protein assemblies composed of polypeptide chains
that are arranged in a β-conformation, with their backbone perpendicular to the axis
of the fibril [40]. These aggregates, found in abnormal tissue deposits of several de-
generative diseases, are the products of a complex oligomerization and polymerization
cascade [41], and are related with the onset of cell dysfunction [8]. Amyloid accumula-
tions are found in diseased brains: the amyloid plaques in the case of Alzheimer disease,
the Lewy bodies in Parkinson disease, and the nuclear inclusions in Huntington disease.
However, although in Alzheimer disease the presence of β-amyloid plaques in the cen-
tral nervous system is associated with neurodegeneration and dementia [8], the fibrillar
deposits themselves have not been proven to be directly related to the disease pheno-
types [42]. Compelling evidences relate the toxicity of amyloid aggregation to the small
oligomers which are released during the polymerization. Mixtures of soluble globular
oligomers, which ranges from trimers to 24mers, have neurotoxic properties [43] and
lead to fibril formation. Furthermore accumulation of soluble oligomers was verified in
Alzheimer diseased frontal cortex [44] and were found to disrupt learning and interfere
with cognitive functions in rats [45].
Atomic force microscopy and electron microscopy imaging revealed that in vitro
amyloid fibrils are straight and unbranched, with a diameter which ranges between 1
and 10 nm, and they present a substructure consisting of multiple protofilaments twisted
around the fibril axis. These aggregates also display a characteristic X-ray diffraction
pattern with cross-β peaks, CD and FTIR spectra rich in β content, and a core structure
resistant to hydrogen exchange and proteinase K digestion. The ability of dyes such as
thioflavin T and Congo red to bind selectively to amyloid aggregates allows time re-
solved measurements of the fibrillization process, which helped to define the distinct
kinetic phases. Amyloid fibril formation is a nucleated polymerization process (see fig-
ure 1), strongly modulated by both external conditions and polypeptide sequence. This
process has a particularly complex phenomenology that presents a rich variety of inter-
mediates [46, 47]. Furthermore the nucleation step can be bypassed inoculating a so-
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lution of freshly dissolved monomers with seeds, which are fibrils that were previously
sonicated. Some post-nuclear oligomers display a different morphology from mature fib-
rils. These ”protofibrils” are non-spherical filamentous aggregates lacking of periodicity
that are observed to be either on or off-pathway to the formation of mature fibrils.
Experiments have shown that many proteins have amyloidogenic properties [48–50]
including a number of intrinsically unstructured proteins [7]. Natively folded proteins
can undergo to amyloid formation at low pH [51], high temperature [52, 53], moderate
alcohol concentration [48], but also upon mutation [54]. Furthermore fibril formation is
enhanced by denaturing conditions [55], suggesting that partial unfolding is a prerequi-
site for amyloid aggregation.
A number of experimental techniques have been employed to evaluate the β-aggregation
propensity of polypeptides, i.e., the relative efficiency of a given sequence to form amy-
loid aggregates under given experimental conditions. Measurements based on kinet-
ics [56] or thermodynamics [57] of the polymerization process can be used to quantify
the β-aggregation propensity of a polypeptide. Interestingly, it is likely that small re-
gions of the polypeptide sequence are responsible for the amyloidogenic behavior of
the full length protein [58, 59]. Therefore these small regions, called often susceptible
regions, or ”hot spots”, carry most of the amyloid propensity of the sequence.
Open issues regarding amyloid fibril formation include the specificity with which the
amino acid sequence determines β-aggregation propensity, the atomic details of the fibril
structure and the underlying molecular mechanisms. Investigations at the molecular level
are helpful in this regard, but few structural models are currently available because of the
difficulties encountered in X-ray crystallography and solution phase NMR spectroscopy.
Computational approaches for predicting polypeptide aggregation propensities, as for
instance the models discussed in section 5, are useful tools for determining aggregation
hot spots and predicting effects of mutagenesis on the fibril formation kinetics [60].
However, details such as oligomer formation, lag phase time, pathways and nucleus size
are not reproducible by such models. For that reason a coarse grained polypeptide under
different conditions of concentration and aggregation propensity has been simulated to
14
Figure 1: Amyloid formation displays the characteristic kinetics of a nucleated poly-
merization where the rate limiting step for fibril formation is the creation of a nucleus.
In the figure the kinetic phases of fibril formation are illustrated. Left: nucleation (or lag
phase) and elongation. In the lag phase monomeric or oligomeric soluble species are in
pre-equilibrium with nuclei, which are unstable species that can either progress to fibril
or regress to soluble species. Right: steady state equilibrium at the end of fibrillization.
investigate the effects of these agents on the nucleation velocity, the elongation and the
pathways, as described in section 6.
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5 Amyloid aggregation rate prediction
A systematic investigation of the effects over amyloid formation kinetics of 40 single
point mutations of acyphosphatase elucidated the role of certain sequence regions in the
unfolding aggregation mechanism [61], indicating that the most influential mutations (in
terms of kinetics) are those that affects the propensity to form β-sheets and the hydropho-
bicity of the protein. Analysis of 17 Aβ40 mutants at the Val18 position illustrates the
role of the mutation at the lag phase and the elongation [56]. Also in this case kinetics
is influenced by β-sheet propensity, hydrophobicity. Chiti et al. [62] first hypothesized
that kinetic data belonging to different protein mutants can be predicted by an empiri-
cal formula that involves difference in hydrophobicity ∆hydr, free energy propensities
∆∆Gcoil−α and ∆∆Gβ−coil and charge ∆Charge:
ln(νmut/νwt) = A∆hydr +B(∆∆Gcoil−α +∆∆Gβ−coil) + C∆Charge
where νmut/νwt is the ratio between the mutated and the non mutated elongation rate,
and A, B and C are coefficients to be determined.
A possible role of aromatic residues and π − π stacking has been postulated for
amyloid aggregation and inhibition [63]. More recently it has been demonstrated that
hydrophobic stretches in the sequence of Aβ 42 promote aggregation, but the presence
of aromatic sidechains can sensibly accelerate the fibril formation [64]. Given these in-
formations, and basing on physicochemical properties of amino acids, a function which
predicts the change of amyloid aggregation rates upon mutation as been proposed (see
section 5.1):
νmut/νwt = φhφβφaφc
where the factor φh includes nonpolar and polar interactions and it is proportional to
the ratio of polar, nonpolar accessible surfaces and dipole change upon mutation, φβ
accounts for the β-sheet propensity change, φa is the change of aromatic residues and φc
is the change of number of charged residues in the sequence. The novelty with respect
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to Chiti’s formula is the explicit introduction of a term depending on the quantity of
aromatic residues. The function is able to predict relative rates with a correlation of
85%, better than Chiti’s function which performs at 76%, and noticeably without any
parameter, in contrast with Chiti’s formula that contains three parameters.
The model has been further improved, with a parameterless function able to predict
absolute rate of aggregation (see section 5.2). Over a set of 90 experimental data points,
the predicted rates correlate at 95%. The advantage of having an absolute rate prediction
consists in the detection of amyloid prone segments of the amino acids sequence. In Fig.
2 the amyloid spectrum of the Abeta42 is showed. The peaks in the amyloid spectrum
can be interpreted as the aggregation susceptible regions (”hot spot”) of the sequence.
Remarkably the found aggregation spot (LVFFA) agrees with many experimental evi-
dences [58], and the second highest region (AIIGL) and (IGLMV) are consistent with
solid state NMR [65, 66]. The function can also predict the parallel or antiparallel ar-
rangement of the segment into the fibril.
Complete proteomes of nine eukariotes of different complexity were analyzed by
using the absolute rate formula (see section 5.3). Each protein was fragmented into
stretches of 5 amino acids and analyzed in term of β-aggregation propensity. Statistical
analysis of the stretch decomposition of proteomes. Form P. Tetraurelia to H. Sapiens, it
has been shown that proteomes of higher and more long-lived eukariotes contain fewer
sequences with high β-aggregation propensity. Also, compared with random proteomes,
Figure 2: β-aggregation propensity profiles of the Alzheimer amyloid peptide Aβ42
(amyloid protein precursor numbering) evaluated with three different windows.
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natural proteomes are enriched in proteins with low β-aggregation potential, as well as
proteins with high β-aggregation potential. Such polarization is a consequence of the
dual evolutive requirement of intrinsically disordered proteins with low β-aggregation
propensity, as well as proteins with stable fold, which comes at the cost of higher β-
aggregation propensity.
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5.1 The role of aromaticity, exposed surface, and dipole moment in
determining protein aggregation rates. [Protein Sci. 2004, 13, 1939]
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Abstract
The mechanisms by which peptides and proteins form ordered aggregates are not well understood. Here we
focus on the physicochemical properties of amino acids that favor ordered aggregation and suggest a
parameter-free model that is able to predict the change of aggregation rates over a large set of natural
sequences. Furthermore, the results of the parameter-free model correlate well with the aggregation pro-
pensities of a set of peptides designed by computer simulations.
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Amyloid fibrils are involved in a number of diseases, in-
cluding Alzheimer’s disease, Parkinson’s disease, Hunting-
ton’s disease, prion disease, and type II diabetes (Kelly
1998; Rochet and Lansbury Jr. 2000). Therefore, it is of
fundamental medical interest to understand the mechanisms
of fibrillogenesis with the ultimate goal of designing inhibi-
tors. The amyloid fibril formation is not a property limited
to a selected few proteins: Under certain conditions it has
been shown that any polypeptide chain can form fibrils
(Dobson 1999). Because aggregation conditions vary sen-
sibly with the composition and sequence of the polypeptide,
single amino acid substitution has been used to investigate
the fibril formation (Chiti et al. 2002). In this study we
propose a formula to predict the change of aggregation and
disaggregation rate upon mutation. The agreement between
the experimental data and our formula leads us to the con-
clusion that the formation of fibrils can be explained with a
simple model based on physicochemical properties of
amino acids. We found that the polar and the nonpolar
water-accessible surface areas, the dipole moment, and the
-stacking interaction of aromatic residues (Gazit 2002) are
essential beside the charge and the -propensity of the se-
quence (Chiti et al. 2003). To have the most possible gen-
eral model, we do not use any parameter that needs to be
experimentally estimated. Furthermore, our equation does
not present any redundancy, whereas in previous work by
others charge and hydrophobicity were considered indepen-
dent and used as two different variables in the best-fitting
(Chiti et al. 2003).
We propose the following function to predict the effect of
a mutation on aggregation rate:
mutwt = hac (1)
where wt and mut are the aggregation rates of the wild type
and mutant, respectively. The factor h captures most of the
nonpolar and polar interactions. An amino acid is called p if
its side chain carries a charge or a dipole; otherwise it is
called a.
For mutations that involve same type of amino acids
a  a or p  p
h
I
= ASAmut
a
ASAwt
a
a  a
ASAwt
p
ASAmut
p p  p
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where ASAa and ASAp are the nonpolar and polar water-
accessible surface areas of the amino acid side chains (Ma-
khatadze and Privalov 1990; Karplus 1997). Interestingly,
experimental evidence has been published recently on the
importance of nonpolar solvent-accessible surface area for
the amyloid-like properties of apomyoglobin (Chow et al.
2003).
For mutations that involve different types of amino acids
(a  p or p  a)
h
II
= 1Dmut a  pD
wt p  a
where D is the magnitude of the dipole of the amino acid
side chains. The function Ih implies that the hydrophobicity
and aggregation rate increase as the mutation results in a
larger nonpolar surface or smaller polar surface. In IIh , it
has been assumed that the nonpolar surface of p amino acids
compensates the nonpolar surfaces of a amino acids so that
the dipole of p amino acids exclusively characterizes the
mutation (see Supplementary Table 1).
The factor  is related to the ratio of -sheet propensi-
ties (Street and Mayo 1999; see Supplementary Table 1):
 =
mut
wt
Functions a and c approximate the effect of the aromatic
residues A and total charge C, respectively:
ac = e
A
e
|C|/2
The factor 1⁄2 before C has been introduced to have the same
range [−1, 1] for the arguments of the two exponential func-
tions.
In Figure 1 our model is used to predict the changes in
aggregation rates occurring in human muscle acylphospha-
tase (AcP), islet amyloid polypeptide, prion peptides,
-synuclein, amyloid -peptide, tau, leucine-rich repeat,
and some model peptides. As in Chiti et al. (2003), we
divided the data set in two parts to compare with their
equation. The correlation obtained with equation 1 is sig-
nificant (85% and 86% and P < 10−4), and slightly better
than the one obtained by Chiti et al. using three parameters
derived from best fitting (76% and 85% and P < 10−4). The
good agreement with experiments shows that our simple
equation, which does not contain any parameter, is very
general and can be used to describe the aggregation of sev-
eral and heterogeneous protein systems.
The validity of the formula is proved also by rearranging
the whole data set per a and p mutations: Slopes and cor-
relations are very close (see Supplementary Fig. 1; p  p:
slope  1.01, correlation  80%, number of points  28;
a  a: slope  0.92, correlation  82%, number of
points  15; a  p and p  a: slope  1.01, correla-
tion  89%, number of points  12).
Aggregation and disaggregation are intrinsically differ-
ent, but the role played by the hydrophobicity, -propensity,
-stacking, and charge is the same. Considering that disag-
gregation and aggregation are opposite processes, the direct
proportionality relation between mut/wt and hac that
describes the aggregation turns into a relation of inverse
proportionality for the disaggregation. Therefore, the recip-
rocal of equation 1 can be used to describe the disaggrega-
tion:
wtmut = hac (2)
To verify the validity of this assumption, we applied equa-
tion 2 to heptapeptide sequences suggested by a genetic
algorithm approach (G. Tartaglia and A. Caflisch, in prep.).
The genetic algorithm searches the space of sequences for
those that have the best match to a certain three-dimensional
target conformation (an in-register parallel aggregate of
three heptapeptides [Gsponer et al. 2003]). For each peptide
sequence, three replicas are submitted to a 330 K molecular
dynamics simulation, starting from the -parallel aggre-
gated conformation (CHARMM parameter 19 [Brooks et al.
1983] and solvent accessible surface-based solvation model
[Ferrara et al. 2002]). A temperature of 330 K is used to
obtain enough sampling in the time scale of the simulations
(Gsponer et al. 2003). Peptide sequences are ranked accord-
ing to their ability to prevent disaggregation. The disaggre-
gation rate is estimated for each sequence as the reciprocal
of the number of snapshots whose C root mean square
deviation (RMSD) from the template is lower than 1 Å. Best
Figure 1. Calculated vs. observed (Chiti et al. 2003) changes in aggrega-
tion rate upon mutation: AcP (28 triangles) and heterogeneous groups of
peptide and protein systems, including islet amyloid polypeptide, prion
peptides, -synuclein, amyloid -peptide, , leucine-rich repeat and some
model peptides (27 circles).
Tartaglia et al.
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matches, called best parents, are replicated and subjected to
mutations and crossover: 103 sequences have been studied
for a total amount of 50 sec of simulation. The genetic
algorithm predicted several sequences similar to segments
of amyloidogenic protein as well as the sequence
HFWLVFF, which presents five matches with the amyloid
-peptide fragment HQKLVFF (Tjernberg et al. 1999;
Williams et al. 2004). By considering that the genetic algo-
rithm sampled 103 sequences and a random search approxi-
mately needs 106 sequences to scan before finding five
matches, we conclude that the genetic algorithm approach
performs 103 better than random.
Disaggregation rates are analyzed with equation 2 only
for best parents (4% of data) for which false positives are
supposed to be less than the false negatives in the remaining
set. Furthermore, to have statistical significance, each dis-
aggregation rate has been averaged over a set of five mo-
lecular dynamics trajectories. Figure 2 shows that equation
2 holds and the correlation is very high (80% and P < 10−3).
In conclusion, the present results indicate that a simple
model based on physicochemical properties without param-
etrization is able to predict aggregation and disaggregation
rates.
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5.2 Prediction of aggregation rate and aggregation-prone segments
in polypeptide sequences. [Protein Sci. 2005, 14, 2723]
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Abstract
The reliable identification of b-aggregating stretches in protein sequences is essential for the develop-
ment of therapeutic agents for Alzheimer’s and Parkinson’s diseases, as well as other pathological
conditions associated with protein deposition. Here, a model based on physicochemical properties
and computational design of b-aggregating peptide sequences is shown to be able to predict the
aggregation rate over a large set of natural polypeptide sequences. Furthermore, the model identifies
aggregation-prone fragments within proteins and predicts the parallel or anti-parallel b-sheet organiza-
tion in fibrils. The model recognizes different b-aggregating segments in mammalian and nonmamma-
lian prion proteins, providing insights into the species barrier for the transmission of the prion disease.
Keywords: Alzheimer’s disease; amyloid; protein aggregation rate; prion protein; species barrier;
genetic algorithm; molecular dynamics
Amyloid fibrils are associated with a number of pathol-
ogies including Alzheimer’s, Parkinson’s, Huntington’s,
prion disease, and type II diabetes (Horwich and Weiss-
man 1997; Kelly 1998; Dobson 1999; Rochet and Lans-
bury 2000). Therefore it is of fundamental medical
interest to understand the mechanisms of fibrillogenesis,
with the ultimate goal of designing inhibitors. One
important and still unanswered question regarding amy-
loid fibril formation is the specificity with which the
amino acid sequence determines b-aggregation propen-
sity and the atomic details of the fibril structure. Because
of the difficulties in obtaining detailed structural infor-
mation by X-ray crystallography or solution phase
NMR spectroscopy, computational approaches are
needed to guide experiments, e.g., to determine short
segments of amyloid-like proteins that share the same
biophysical properties of the full-length proteins (Balbir-
nie et al. 2001) and identify those elements which are
essential for the formation of protein fibrils (Tenidis et al.
2000; von Bergen et al. 2000). As aggregation condi-
tions vary sensibly with the composition and especially
the sequence of the polypeptide, single amino acid sub-
stitutions have been used to investigate the fibril forma-
tion (Chiti et al. 1999), and complementary theoretical
studies proposed relative rate equations to predict the
change of aggregation rate upon mutation (Chiti et al.
2003; Tartaglia et al. 2004). Although the application of
relative rate equations shows high correlation with experi-
mental data, these models require the a priori knowledge
of wild-type aggregation rates.
We report here an absolute rate equation derived from
both first principles and analysis of aggregating sequences
designed by a computational approach. The latter is based
on a genetic algorithm optimization in sequence space and
molecular dynamics sampling of conformation space. The
equation does not need any information except the amino
acid sequence and two environmental factors (i.e., tempera-
ture and concentration). Our model gives both the aggre-
gation rate and the ‘‘amyloid spectrum’’ of a protein,
identifying those segments involved in b-aggregation. In
Reprint requests to: Amedeo Caflisch, Department of Biochemistry,
University of Zu¨rich, Winterthurerstrasse 190, CH-8057 Zu¨rich, Switzer-
land; e-mail: caflisch@bioc.unizh.ch; fax: +41-44-635-68-62.
Article and publication are at http://www.proteinscience.org/cgi/
doi/10.1110/ps.051471205.
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addition, the model distinguishes between the parallel and
anti-parallel b-sheet organization within the fibrils and
shows thatmammalian and nonmammalian prion proteins
have different amyloid spectra.
Results and Discussion
Absolute rate prediction
Predicted and experimentally measured rates are shown in
logarithmic scale in Figure 1. The correlation is 95% and
extends over 90 data points and about 15 natural logarith-
mic units. This is a remarkable result considering that the
rate is calculated solely from the primary structure with the
addition of two external factors, i.e., temperature and con-
centration. Interestingly, the correlation is good for differ-
ent proteins and also within mutants of the same protein.
For single-point mutants of long sequences (Acylphospha-
tase and Titin), the error is rather large because of the poor
signal-to-noise ratio due to the average over the entire
sequence. The model was subjected to statistical tests to
assess the chance correlation. In Figure 2A, the experimen-
tallymeasured rateswere randomlypermutated to generate
about 107 ‘‘scrambled’’ data sets. The calculated rates were
fitted to each scrambled set, giving an extremely small like-
lihood for high correlations. In Figure 2B, 107 data sets
were randomly generated within the range of experimental
rates. Thepredictive ability andcorrelationof themodel are
much higher than the corresponding values obtained upon
randomization of the experimental rates. These statistical
tests show that chance correlation is not present.
Prediction of b-aggregating segments
There is in vivo evidence that amyloid fibrils originate
from misfunctions of the degradation machinery and
cleavage of fragments that have high propensity for b-
aggregation (Stefani and Dobson 2003). Moreover, even
proteins not implicated in amyloid diseases were recently
found to form amyloid fibrils in vitro under denaturing
conditions, indicating that fibrillogenesis is a common
feature of proteins (Chiti et al. 1999; Dobson 1999; Ste-
fani and Dobson 2003). Our approach to estimate aggre-
gation rates can be also used to identify segments with
high aggregation propensity. The method is tested on the
following proteins: a-synuclein, apolipoprotein, amyloid
precursor protein (APP), gelsolin, islet amyloid precursor
protein (IAPP), lactadherin, prion, serum amyloid A,
transthyretin, ABri, ADan, fibrinogen, b2-microglobulin,
insulin, Sup35, and tau.The formernine proteins represent
all hits of a combined search for ‘‘amyloid’’ and ‘‘human’’
at http://www.expasy.org (Gasteiger et al. 2003) in Sep-
tember 2004; the latter seven proteins result from a litera-
ture search (references are reported in Table 1). As
indicated in Figure 3, the data set contains
 regions known to promote aggregation
 segments found to aggregate in vivo (often after degra-
dation)
 stretches extracted from the precursors and shown to
aggregate in vitro
Each sequence in the data set is scanned by shifting a
window of fixed size one residue at a time starting from the
N terminus. The extracted stretches are ranked using the
aggregation propensity p (see Materials and Methods).
The procedure is repeated for different window sizes (3–
25 amino acids), each time storing the positions of the three
stretches having the highest p. These positions are then
used to build the histogram of Figure 3. Peaks of the
histogram represent positions of stretches with the highest
b-aggregation propensity (‘‘windows’ consensus’’). All the
sequences except fibrinogen and prion showmain peaks in
segments known to promote aggregation. For prion, amy-
loidogenic areas are—up to now—not known and few
experiments have been performed and on limited portions
of the protein (Vanik et al. 2004). Following the protein-
only hypothesis (Prusiner 1988; Soto and Castilla 2004),
we suggest that the peak found at position 150 may be
determinant for prion transmissions (in the subsection
Prions, the same peak is numbered with 175 because of
the alignment with other prion sequences). For transthy-
retin, only one of the two experimentally known b-aggre-
gating fragments has been found with our analysis. We
speculate that the corresponding area promotes the aggre-
gation of the entire protein, which is consistent withNMR
data (Jaroniec et al. 2002).
Figure 1. Calculated (Equation 4; see Materials and Methods) vs.
observed aggregation rates for heterogeneous groups of peptide and
protein systems (Litvinovich et al. 1998; Konno et al. 1999; Chiti et al.
2003; Ferguson et al. 2003; DuBay et al. 2004). A t-student test on the
correlation shows the high significance in the prediction (in the present
study P<0.0001, while P^ 1 indicates no significance).
2724 Protein Science, vol. 14
Tartaglia et al.
 on June 28, 2007 www.proteinscience.orgDownloaded from 
29
To further test the sensitivity of ourmodel,we focusedon
the segments that are experimentally known to aggregate.
For this purpose, we used a window size of five consecutive
residues, as in a previous work (Fernandez Escamilla et al.
2004) (Table 1). Interestingly, several five-residue stretches
are found in segments that were shown to aggregate,
e.g., FGAIL contained in IAPP NFGAILSS, FILDL in
gelsolin’s SFNNGDCFILD, SVQFV in lacthaderin’s
NFGSVQFV, and YQQYN in Sup35’s PQGGYQQYN
(Azriel andGazit 2001). ForAPP, three stretches are found
in correspondence of the segment LVFFA, which is known
to be involved in the aggregation of Ab40 (Williams et al.
2004) (see subsection Amyloid Protein Precursor). Impor-
tantly, all the stretches are ranked among those having the
Table 1. Analysis of experimentally known b-aggregating segments
Protein 1st Stretcha Rankb 2nd Stretcha Rankb 3rd Stretcha Rankb Segment
Total
length Ref.
ABri 22{CSRTV}a 5 21{ICRST}a 8 20{LICSR}a 10 1–34 34 El-Agnaf et al. 2001
ADan 22{CFLNF}p 1 23{FNLFL}p 2 24{NLFLN}p 3 1–34 34 El-Agnaf et al. 2004
a-Synuclein 41{EQVTN}a 6 67[SIAAA]p 12 71[ATGFV]p 15 41–74 120 Ueda et al. 1993
Apolipoprotein A–I 18[YVDVL]p 1 28{DYVSQ}a 2 85[EMSKD]a 3 1–83 242 Nichols et al. 1988
APP 671{LVFFA}p 1 670{KLVFF}p 2 672{VFFAE}p 3 655–696 750 Weidemann et al. 1989
b-Microglobulin 61{SFYLL}p 1 63{TLLYY}p 2 66{YYTEF}p 3 59–79 99 Jones et al. 2003
Fibrinogen 494[FPGFF]p 7 493[TFPGF]p 13 482[AAFFD]p 32 482–504 623 Asl et al. 1997
Gelsolin 187{DCFIL}p 15 188{CFILD}p 23 189{FILDL}p 31 173–243 755 Kangas et al. 1996
IAPP 22{FGAIL}p 1 21{NFGAI}p 2 28[SNTYG]a 4 1–38 38 Westermark et al. 1987
Insulin 78{ENYCN}a 1 23{RGFFY}p 3 15{ALYLV}p 4 1–38 86 Jimenez et al. 2002
Lactadherin 260{YGNDQ}a 3 259{SYGND}a 4 289[SVQFV]p 5 245–294 364 Haggqvist et al. 1999
Prion 116{IIHFG}p 1 115{PIIHF}p 2 99[VVGGL]p 3 1–121 208 Vanik et al. 2004
Serum amyloid A 3{FFSFL}p 2 4{FSFLG}p 3 5{SFLGE}p 4 2–12 104 Westermark et al. 1992
Sup35 77[YQQYN]a 1 44[YQNYQ]a 2 67[YQQQY]a 3 1–112 683 King et al. 1997
Tau 621{SVQIV}p 23 632{SKVTS}a 24 627{KPVDL}p 25 617–636 757 Margittai and Langen 2004
Transthyretin 107[IAALL]p 1 114{YSYST}a 2 106[TIAAL]p 4 105–115 127 Jaroniec et al. 2002
aThe three five-residue stretches with the highest p, within the segments listed in the third to last column, are reported with the predicted parallel (p)
or anti-parallel (a) arrangement. The braces { } indicate stretches that are close to the peak found in the experimental regions using the windows’
consensus (Figure 3), while the brackets [ ] mark sequences that are distant from the peak. The integer before the brackets refers to the position of
the stretch in the processed protein (initial signal- and pro-peptides are omitted in the notation as in other works; see, for instance Kangas et al.
1996; Jones et al. 2003).
bThe rank of the stretches refers to the entire precursor protein and can in principle vary from 1 (i.e., the stretch has the highest p among all the
stretches in the precursor protein) to the total length of the precursor protein (i.e., the stretch has the lowest p among all the stretches in the
precursor protein).
Figure 2. Statistical tests to assess chance correlation. (A) Permutations of experimental rates: Probability distribution p of the
correlation coefficient r between rates calculated with Equation 4 (see Materials and Methods) and scrambled experimental
rates. The likelihood of obtaining high correlations (r>50%) with scrambled experimental rates is extremely small (p<1029).
(B) Randomization of experimental rates (within the same range of values): Cross-validated leave-one-out correlation coefficient
q=12PRESS/s2 (PRESS=predicted residual sum of squares, i.e., sum of squared differences between predicted and observed
values [Zoete et al. 2003]) vs. the correlation coefficient r. The predictive ability and correlation of the model (thick circle on the
top right) are significantly separated from the corresponding values obtained upon randomization of the experimental rates (thin
points). In both tests, 107 data sets were generated.
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highest p in the respective precursor proteins (see Table 1),
which suggests that a small window size is sufficient for the
identification of amyloidogenic regions. In Table 1, we also
list b-aggregating segments that have not yet been investi-
gated with experiments in vitro (e.g., YVDVL in apolipo-
protein A–I and ENYCN in insulin) and indicate the
predicted parallel or anti-parallel arrangement of the indi-
vidual segments in the fibril.
Amyloid protein precursor
Using a window size of five residues, the amyloid spectrum
of the 750-residue APP (Fig. 4) shows a predominant peak
at position 671 for the stretch LVFFA. Furthermore, the
predicted b-aggregating stretches AIIGL and IGLMV are
consistent with solid-state NMR (Antzutkin et al. 2002;
Bond et al. 2003) and scanning proline mutagenesis (Wil-
liams et al. 2004). The stretches with the highest rate for
eachwindow size in the range 3–25 are shown inTable 2 for
Ab42. Most of the high-aggregation stretches contain the
segment LVFFA and are parallel. As in experiments (Gor-
don et al. 2004), the segment KLVFFAE has a preferential
anti-parallel arrangement,whileAb42 is parallel (Antzutkin
et al. 2000; Torok et al. 2002). As shown in clinical reports
and oligomerization experiments performed with photo-
induced cross-linking of unmodified proteins (Bitan et al.
2003), we found that Ab42 has a higher aggregation pro-
pensity thanAb40 (ln pAb42=27, ln pAb40=29). Interest-
ingly, the experimental evidence indicates that the Ile41–
Ala42 extension of the 1–40 segment affects the rate of
amyloid formation rather than the fibril stability (Jarrett
et al. 1993).
Prions
To further investigate the usefulness of our model, the
amyloidogenic propensities of the prion protein from dif-
ferent organisms were evaluated using a moving window
of five residues along the entire sequence. To compare the
amyloid spectra, prion sequences have been aligned using
ClustalW (Thompson et al. 1994). It is remarkable that
prion sequences in mammals show a peak at position 175
corresponding to the segment SNQNN in human prion
(Fig. 5; Table 3; all the notations used to number stretches
refer to the major prion proteins, i.e., signal- and/or pro-
peptides are omitted). Such a peak is absent in the chicken
and the turtle. Interestingly, the peak is located in a glu-
tamine/asparagine-rich region, which shows high propen-
sity to self-propagate in amyloid fibrils (Michelitsch and
Weissman 2000). Other peaks correspond to b-strand 2
(segment NQVYY, conserved in mammals and nonmam-
mals and mutated in NRVYY in chicken) and helix 1 of
Figure 3. Windows’ consensus. Different window sizes (3–25 amino acids) are used to scan proteins. Positions of stretches with
highest aggregation propensity p are used to build the histogram. Except for fibrinogen and prion, the highest peak is located in
segments that are known to form amyloid fibrils and/or contribute to protein aggregation (gray regions). The letter ‘‘p’’ labels
regions that are known to promote fibrillogenesis (‘‘p’’ standing for ‘‘promoting’’). The letter ‘‘f ’’ indicates segments that are
found to aggregate in vivo (‘‘f ’’ standing for ‘‘fragment’’) after degradation. The letter ‘‘e’’ refers to stretches that are shown to
aggregate in vitro (‘‘e’’ standing for ‘‘extracted’’). We stress that Equation 1 (see Materials and Methods) was used to identify b-
aggregating stretches and not to predict amino acid deletions or insertions involved in amyloidosis. Positions refer to proteins
without signal- and pro-peptides. References for all the experiments are reported in Table 1.
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human prion (segment YEDRY in mammals, WNENS in
turtle, and WSENS in chicken), which are known to form
ordered aggregates in vitro (Nguyen et al. 1995; Kozin et al.
2001). Furthermore, the amyloid profiles are similar within
mammals (e.g., 97% correlation between man and cow)
and different between mammals and nonmammals
(e.g., 55% correlation between man and turtle).
To comparewith experiments in vitro (Vanik et al. 2004),
we analyzed the unstructured region of the prion protein
(residues 1–122) in human, mouse, and hamster prion pep-
tides.We found thathumanandmouse prions share similar
amyloid spectra (i.e., 98% correlation), while the hamster
prion diverges from them at position 143 (position 116 in
the nonaligned human sequence). More specifically, the
stretch 143–148 of hamster prion (position 116–121 in the
nonaligned human sequence) is found to be less amyloido-
genic than the corresponding segment inmouse and human
(ln phamster=216, ln pmouse=212, and ln phuman=212),
which is consistent with the prion 1–122 species barrier
observed in vitro (Vanik et al. 2004).
Huntingtin
The gene for Huntington’s disease consists of 67 hexons
and contains an open reading frame for a polypeptide of
>3140 residues. Using a window size of five residues,
our model identifies the N-terminal poly(Gln) repeat
and the stretch IFFFL in the middle of the sequence as
the two most prone to induce ordered aggregates. With
window sizes larger than 20, the N-terminal poly(Gln)
repeat dominates and the peak in the middle of the
sequence disappears.
Our model is not sensitive enough to discriminate
repeats of fewer than 38 glutamine residues from those
with >41 glutamine residues; the former are harmless,
whereas the latter are responsible for toxic aggregates
(Perutz et al. 1994; Perutz 1999). Alternatively, the dra-
matic difference in toxicity observed at a repeat length of
40 might require the context of a much longer poly-
peptide sequence.
Conclusions
Themodel presented herewasmotivated by the challenging
tasks of predicting aggregation propensity and identifying
b-aggregating stretches inpolypeptide sequences.Anessen-
tial element in the derivation of the equation was the anal-
ysis of a large pool of b-aggregating peptide sequences
designed by a computational approach based onmolecular
dynamics and genetic algorithm optimization in sequence
space (G.G. Tartaglia and A. Caflisch, in prep.). The very
Figure 4. Amyloid protein precursor. The aggregation propensity p is
averaged over a window of five amino acids. The entire sequence is
scanned by shifting the window by one residue at a time starting from
the N terminus (‘‘amyloid spectrum’’). The analysis shows a major
peak corresponding to the segment LVFFA at position 671. The
bottom plot focuses on the most amyloidogenic region, which is high-
lighted in gray in the top plot. Windows of different sizes (5, 7, and 10
amino acids), shifted to the central amino acid, give similar results,
indicating the robustness of the model. Furthermore, with longer win-
dow sizes, peaks in the C terminus of Ab40 become comparable to the
one at position 671 (see also Table 2). In both plots, the effective height
of the peak is compressed by the logarithm scale.
Table 2. Stretches of Ab42 with the highest rate at each
window size in the range 3–25
Sequence ln p p/a
VFF {IGL} 5.3 {22.6} p
LVFF {GAII} 2.5 {26.7} p
LVFFA {AIIGL} 0.2 {27.5} p
LVFFAE {GAIIGL} 23.9 {28.0} p
KLVFFAE {AIIGLMV} 25.9 {210.0} a
LVFFAEDV {IGLMVGGM} 27.3 {210.1} p
LVFFAEDVG {GLMVGGVVI} 27.6 {210.0} p
QKLVFFAEDV {IGLMVGGVVI} 29.3 {29.7} a
{QKLVFFAEDVG} IGLMVGGVVIA 210.1 {211.0} p
{HQKLVFFAEDVG} AIIGLMVGGVVI 210.5 {211.1} p
{FFAEDV . . . } GAIIGLMVGGVVI 210.5 {210.7} p
FFAEDVGSNKGAII 210.1 p
VFFAEDVGSNKGAII 29.3 p
VFFAEDVGSNKGAIIG 29.7 p
LVFFAEDVGSNKGAIIG 28.8 p
LVFFAEDVGSNKGAIIGL 28.2 p
KLVFFAEDVGSNKGAIIGL 29.3 p
KLVFFAEDVGSNKGAIIGLM 29.4 p
QKLVFFAEDVGSNKGAIIGLM 210.5 p
QKLVFFAEDVGSNKGAIIGLMV 210.1 p
LVFFAEDVGSNKGAIIGLMVGGV 210.7 p
LVFFAEDVGSNKGAIIGLMVGGVV 210.4 p
LVFFAEDVGSNKGAIIGLMVGGVVI 27.1 p
In braces are reported stretches that ranked after the highest rate ones
and do not overlap with them. The last column contains the preferred
b-sheet arrangement, i.e., parallel (p) or anti-parallel (a).
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good correlationbetweencalculatedand experimental rates
for a large and heterogeneous set of polypeptide chains has
allowed us to use the model to successfully identify b-
aggregating segments and predict the parallel or anti-par-
allel arrangement. Fibrils formed by short segments of a
protein might have a different molecular structure than the
fibril of the full-length protein. Yet our results, as well as
previous experimental (Chiti et al. 1999, 2003; Balbirnie et
al. 2001) and computational (Fernandez Escamilla et al.
2004) works by others, indicate that the amyloid-forming
part of a protein could be only a short segment of the entire
chain. That a function based on simple physicochemical
principles is able to predict aggregation rates and identifyb-
aggregating fragments in proteins might be a consequence
of the essential role of side-chain interactions in b-sheet
aggregates (Gazit 2002; Gsponer et al. 2003; Linding et al.
2004).
Although some of the physicochemical properties in our
model are similar to those used in previous works by others,
it is important to distinguish approaches based on param-
eter optimization for a multiterm equation (Chiti et al.
2003; DuBay et al. 2004) from first-principle models like
the one of this work and that of Tartaglia et al. (2004). On a
very similar test set of peptides and proteins, the multi-
parameter approach gives results comparable to those
obtained with our model, but it is likely to have a lower
predictive ability. As an example, positional effects are
taken into account in ourmodel, whereas they are neglected
in the multiparameter approach (DuBay et al. 2004), which
is mainly based on amino acid composition and alternation
of hydrophobic–hydrophilic residues (Broome and Hecht
2000). Recent scanning prolinemutagenesis, combinedwith
critical concentration analysis and NMR hydrogen–deu-
Figure 5. Prion proteins from turtle to human. The plot shows an evolutionary differentiation of the aggregation peaks. Prions
of cow and mouse, as well as prions of sheep and pig, show similar amyloid spectra (data not shown). The highest peak at
position 175 for mammals (segment a, i.e., SNQNN) is not present in nonmammals. Peak b (segment NQVYY, conserved in
mammals and nonmammals, and mutated to NRVYY in chicken) appears in correspondence of b-strand 2 in human prion.
Nonmammals show a peak c (segment WNENS in turtle and WSENS in chicken) in correspondence of the first helix of human
prion that is weaker in mammals (YEDRY). Sequences have been aligned using ClustalW (Thompson et al. 1994) at http://
www.expasy.org/cgi-bin/hub (Gasteiger et al. 2003). Horizontal traits in the plots represent gaps and are meant to help the eye.
For all the species, no significant peak is found in the N-terminal tandem repeats. The secondary structural elements of the
human prion are labeled with Greek letters and the stretches corresponding to the three a-helices are emphasized by shadowed
rectangles.
Table 3. Peak at position 175. Prion compatibilies of
animals with respect to human
Animal Dp/p
Turtle 9.52
Chicken 8.72
Sheep 1.66
Pig 1.13
Cow 0.76
Mouse 0.76
Hamster 0.15
The distance with respect to the human prion sequence is measured as
Dp/p ¼ (panimal – phuman)/phuman using a window size of five amino
acids for the rate calculation and summing over the segment 165–185
to better sample the variability around the peak.
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terium exchange, indicate a strong positional effect on both
the aggregation kinetics and structural properties of the
Ab40 fibril (Williams et al. 2004). Most importantly, the
multiparameter approach cannot be used to identify b-
aggregating segments as explicitly mentioned by the inves-
tigators (DuBay et al. 2004).
Recently, an approach based on secondary struc-
ture propensity and estimation of desolvation penalty
(TANGO) has been shown to accurately predict the
sequence-dependent and mutational effects on the aggre-
gation of a large data set of peptides and proteins (Fer-
nandez Escamilla et al. 2004). TANGO is based on the
assumption that the probability of finding >2 ordered
segments in the same polypeptide is negligible. The
investigators report that TANGO allows quantitative
comparison within the same polypeptide chain or
mutants. On the other hand, only qualitative compari-
son between different polypeptide chains is possible with
TANGO (Fernandez Escamilla et al. 2004), whereas our
model allows for the prediction of absolute rates (Fig. 1).
In conclusion, we have identified the physicochemical
properties of amino acids that are essential for ordered
aggregation and proposed a model that takes into account
sequence effects for aromatic and charged residues, as well
as composition. Compared with the models previously
published by others, our equation is the only one that
takes explicitly into account p-stacking. Very recent high-
resolution structural data (electron and X-ray diffraction)
have provided strong evidence for the importance of aro-
matic side chains for amyloid formation (Makin et al.
2005).
Our model derived from first principles and analysis
of in silico designed sequences is able to predict aggrega-
tion rates and identify b-aggregating segments with high
accuracy, suggesting possible biological implications as
in the prion protein case. For nonmammalian prions, the
absence of the peak at position 175 observed in mam-
mals decreases the overall aggregation propensity, in-
dicating a species-specific behavior consistent with
experiments (Marcotte and Eisenberg 1999; Matthews
and Cooke 2003) and supporting the hypothesis of a
species barrier in the transmission of the prion disease
(Hill et al. 2000).
In the accompanying article we present a bioinfor-
matics application of our model that reveals an anti-
correlation between organism complexity and proteomic
b-aggregation propensity (Tartaglia et al. 2005).
Materials and methods
Absolute rate equation
An equation based on physicochemical properties of natural
amino acids is introduced to estimate the aggregation rate of
proteins and identify b-aggregating segments. Aromaticity, b-
propensity, and formal charges play a major role in our model,
as they are known in the literature to be determinant for
fibrillization (Gazit 2002; Tjernberg et al. 2002; Chiti et al.
2003). Polar and nonpolar surfaces, as well as solubility, are
also taken into account following an analysis of sequences
designed to aggregate into b-sheets. The design of b-aggregat-
ing sequences was performed by structural sampling using
molecular dynamics and peptide sequence optimization by a
genetic algorithm (Tartaglia et al. 2004; G.G. Tartaglia and A.
Caflisch, in prep.) (see subsection Derivation of the Equation).
The aggregation propensity pil of an l-residue segment starting
at position i in the sequence is evaluated as:
il ¼ ilil ð1Þ
The factor Fil contains exponential functions and is position-
dependent
il ¼ e
AilþBilþCil ð2Þ
where Ail, Bil, and Cil are functionals related to the aromatic-
ity, b-propensity, and charge, respectively. The factor il
depends almost exclusively on the amino acid composition
il ¼
Yiþl1
j¼i
Saj
S^a
"" þ
S
p
j
S^p
"#
 
S^t
Stj
^
j
" #1=l
ð3Þ
where Sai , S
p
i , S
t
i, and si—weighted by their average over the
20 standard amino acids (hatted values)—are the side-chain
apolar, polar, total water-accessible surface area, and solubil-
ity, respectively (see subsection Parallel and Anti-Parallel
Configuration). The functionals y"" and y"# include positional
effects and reflect the parallel or anti-parallel tendency to
aggregate if the majority of residues is apolar or polar, respec-
tively. Considering the high correlation between measured and
predicted changes in aggregation rate upon single point muta-
tions (Chiti et al. 2003; DuBay et al. 2004; Tartaglia et al.
2004), it is possible to utilize the propensity pil to predict the
absolute rate nil
il ¼  c;Tð Þ il ð4Þ
where a(c,T) is introduced to take into account concentration
and temperature (see subsection Concentration and Tempera-
ture).
Parallel and anti-parallel configuration
The functional for the parallel or anti-parallel configuration
was introduced following the analysis of sequences designed by
genetic algorithm optimization (see subsection Derivation of
the Equation; Fig. 6):
 The parallel in-register b-sheet organization within fibrils is
favored by the number of side chains involved in p-stacking
(Tyr, Phe, and Trp) and apolar interactions (Ala, Gly, Ile,
Leu, Met, Pro, and Val) (McGaughey et al. 1998; Azriel and
Gazit 2001; Jenkins and Pickersgill 2001; Makin et al.
2005). The number of aromatic and apolar residues is indi-
cated with naromatic and napolar, respectively. Hydrogen bonds
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between polar residues are not considered for the parallel
aggregation because the number of polar residues decreases
significantly during the optimization of parallel aggregated
sequences (Fig. 6).
 The anti-parallel configuration is mainly determined by the
electric dipole moment of the polypeptide (Hwang et al.
2004). Sequences abounding in polar residues show a small
tendency for the parallel in-register aggregation because of
unfavorable dipole–dipole interactions between side
chains. Hence, the anti-parallel organization is promoted
by the number of polar residues (Arg, Asn, Asp, Cys, Gln,
Glu, His, Lys, Ser, and Thr), which is indicated with npolar.
In some specific positions, charged (Arg, Lys, Asp, and
Glu) and aromatic amino acids contribute to the anti-par-
allel aggregation. ‘‘Specific positions’’ means that one or
more couples of opposite charged residues or one or more
aromatic residues are symmetrically placed with respect to
the center of the sequence (Balbach et al. 2000; Hwang
et al. 2004; Makin et al. 2005). In this specific case, the
number of charged and aromatic residues is labeled as
nscharge and n
s
aromatic, respectively.
In Equation 3, a parallel configuration is preferred if
napolar+ naromatic> npolar+ n
s
charge+ n
s
aromatic. Since the
number of aromatic residues in symmetric position is always
smaller than the total amount of aromatic residues,
naromatic n
s
aromatic (e.g., in the APP stretch: LVFFA
naromatic=2, n
s
aromatic=1), we used a stricter condition for the
parallel arrangement napolar> npolar+ n
s
charge. The stricter con-
dition allows the factorization of aromatic contributions in
Equation 1. In the il factor of Equation 3, y
"" and y"# are
"" ¼
1 napolar  npolar þ n
s
charge
0 otherwise

"# ¼ 1 ""
It is useful to explain the effect of the y"" and y"# functional by
some examples. The segment LVFFA at position 671–676 of
the APP is predicted to be parallel because it satisfies the
parallel condition napolar> npolar+ n
s
charge with napolar=3 and
npolar= n
s
charge=0 (y
""=1). The segment KLVFFAE (at posi-
tion 670–677 of the APP), with two opposite charged residues,
has anti-parallel propensity because it satisfies the anti-paral-
lel condition napolar< npolar+ n
s
charge with napolar=3 and
npolar = n
s
charge=2 (y
"#=1).
The IAPP stretch FGAIL at position 22–26 is predicted to
be parallel (napolar=4 and npolar= n
s
charge=0, i.e.,y
""=1), in
agreement with experimental results (Kayed et al. 1999a;
Azriel and Gazit 2001; Gazit 2002). As in Azriel and Gazit
(2001), the following stretches are predicted to be parallel:
SVQFV at position 289–292 of lactadherin; DCFIL, CFILD,
Figure 6. Computational design: A genetic algorithm approach was developed to search the space of peptide sequences for those
with the best match to a given three-dimensional target conformation, i.e., an in-register parallel or anti-parallel aggregate of
three heptapeptides (Gsponer et al. 2003). For each peptide sequence, three replicas were submitted to a 330 K molecular
dynamics simulation, starting from the b-aggregated conformation using CHARMM parameter 19 and a solvent-accessible
surface-based solvation model (Brooks et al. 1983; Ferrara et al. 2002). The sequence optimization was performed by evolu-
tionary cycles. A total of 1728 sequences was sampled after 18 cycles. In sequences selected for the parallel aggregation, the
number of aliphatic and aromatic residues increases almost monotonically, while the number of charged and polar residues
decreases. The opposite is observed in sequences selected for the anti-parallel aggregation. In the plots, the number of aliphatic,
aromatic, charged, and polar residues is normalized by the length of the peptide and averaged over the population (48 peptides
per cycle).
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and FILDL at position 187–191, 188–192, and 189–193 of
gelsolin, respectively; FFSFL, FSFLG, and SFLGE at posi-
tion 3–7, 4–8, and 5–9 of serum amyloid, respectively.
Poly(Gln), poly(Asn), and poly(Lys) homopolymers are pre-
dicted to be in an anti-parallel arrangement, as proposed in
Perutz et al. (1994), Scherzinger et al. (1997), and Michelitsch
andWeissman (2000) and observed by Tanaka et al. (2001) and
Dzwolak et al. (2004). Moreover, it is likely that completely
aliphatic sequences result in amorphous aggregates if N and C
termini are capped, while a tendency to the anti-parallel
arrangement is expected for short stretches with charged ter-
mini (e.g., transthyretin’s stretch IAALL). Capping groups are
neglected in the present version of the model.
The fragment GNNQQNY from the Sup35 yeast prion is
predicted to be anti-parallel (napolar=1, npolar=5, and
nscharge=0, i.e.,y
"#=1), in contrast with the parallel packing
suggested on the basis of X-ray diffraction and Fourier trans-
form infrared (FTIR) data (Balbirnie et al. 2001). On one
hand, it is important to note that the experimental data sup-
porting a parallel arrangement are not conclusive, and, in
particular, FTIR can be misleading on this point. In fact, in
the unit cell of the microcrystals, the parallel b-sheets are
proposed to be in anti-parallel contact along the fibril axis.
On the other hand, a possible reason for the parallel config-
uration is that the p-interactions between the Tyr side chains
are much less favorable in the anti-parallel configuration.
Aromatic residues
Aromatic side chains contribute to the parallel aggregation
with p-interactions (McGaughey et al. 1998; Azriel and Gazit
2001; Makin et al. 2005). The density of aromatic residues
naromatic/l is used to distinguish two regimes for the aromatic
contribution Ail of Equation 2:
Ail ¼
Alowil naromatic=l  3=20
A
high
il otherwise

where 3/20 is the aromatic density averaged over the 20 stan-
dard amino acids and naromatic was defined in the previous
subsection. In the case of low aromatic density (naromatic/l3/20),
Ail
low takes into account the polar/apolar environment. Following
the results obtained by the genetic algorithm optimization of b-
aggregation-prone sequences (see Fig. 6), Ail
low has a positive
effect for mainly apolar sequences and a negative contribution
for mainly polar sequences:
Ail
low= naromatic [napolar2 (npolar+ n
s
charge)] l
21
The variables napolar, npolar, and n
s
charge are defined in the pre-
vious subsection.
As an example, the APP stretch LVFFAEDVGSNK-
GAIIGLMVGGVVI shows low aromatic density (naromatic/
l=2/25<3/20). Since i=671, l=25, napolar=17, npolar=6,
and nscharge=0, the aromatic contribution for LVFFAED-
VGSNKGAIIGLMVGGVVI is Alow671 25=2 [172 6] 25
21=
0.88.
In the case of a high aromatic density (naromatic/l>3/20), the
model takes into account the number of aromatic residues:
Ail
high = naromatic
As an example, the APP stretch LVFFA shows high aro-
matic density (naromatic/l=2/5>3/20). Since i=671 and
l=5, the aromatic contribution for LVFFA is Ahigh671 5=2.
Besides the total amount of aromatic residues and the posi-
tion dependence, which enters Equation 2 through Ail
low, the
different polar and apolar side-chain surfaces, solubility, and
b-propensity of Phe, Tyr, and Trp are taken into account in the
factor il. Hence, the mutation F22Y for the IAPP (islet b-
amyloid protein precursor) stretch NFGAILSS produces a
sensible change of rate (ln pwt=26,ln pF22Y=27), compati-
ble with experiments in vitro (Porat et al. 2003).
b-Propensity
The b-propensity is evaluated as the fraction of residues that
stabilize the b-sheet more than the a-helix:
Bil=bil l
21
2 1/2
The function bil is defined as:
il ¼
Xiþl1
j¼i
j
where
j ¼
1 j  j
0 otherwise

The variables aj and bj correspond to the a-helix and b-sheet
stabilizing effects of the amino acid at position j (Fersht 1999).
Values of aj and bj are normalized from 0 (low stabilization) to
1 (high stabilization) to have the same range of variability. In
the function Bil, the offset value of 1/2 is introduced so that
Bil>0 if at least one-half of the residues in the sequence is
more stable in a b-sheet rather than in an a-helix conformation
(i.e., bil> l
21/2).
In the case of the APP stretch LVFFA, values are i=671,
l=5, b672= b673= b674=1, and b671= b675=0. The pre-
dicted b-propensity for LVFFA is b671 5=3/52 1/2=0.1.
Charged residues
As in other models, we consider that the electrostatic repulsion
of charged sequences penalizes the aggregation (Chiti et al.
2003; Tartaglia et al. 2004). In addition, our model takes into
account the fact that side-chain pairs with opposite charges
and positioned symmetrically with respect to the center of the
segment contribute to the anti-parallel aggregation, as found in
experiments (Gordon et al. 2004). In Equation 2, the charge
contribution Cil is
Cil ¼ 
ncharge
l
j
Xiþl1
j¼i
Cj j þ
Xiþl1
j¼i
chargej
where Cj is the charge of the side chain and ncharge is the
number of charged residues. The first term of the functional
Cil takes into account the electrostatic repulsion between poly-
peptides with net charge different from zero. The second term
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counts the number of pairs of opposite charged side chains
that are symmetrically placed with respect to the central resi-
due of the sequence:
chargej ¼
1 Cj ¼ C2iþlj1 and Cj 6¼ 0
0 otherwise

In the case of the APP stretch KLVFFAE, the residues K670
and E676 have opposite charges and are symmetrically placed
with respect to the central amino acid F673. Since i=670,
l=7, C670=+1, and C1340+72 6702 1=C676=21, the net
charge for KLVFFAE is j
P
iþl1
j¼i Cj j ¼ 0 and the oppositely
charged K670 and E676 give C670 7= d670
charge+ d676
charge=2.
Surfaces and solubility
For sequences that are predominantly apolar (y""=1; see
subsection Parallel and Anti-Parallel Configuration), the apo-
lar water-accessible surface Saj measures the contribution of
hydrophobic side chains to aggregation. For mostly polar
sequences (y"#=1), the polar water-accessible surface Spj
takes into account the propensity to form hydrogen bonds
between polar residues. The total surface Stj= S
a
j + S
p
j is
used to weight polar and apolar surfaces by the total area.
Values of apolar and polar side-chain surfaces are given in
our previous work (Tartaglia et al. 2004) and span the intervals
44 –195 A˚2 and 27–107 A˚2, respectively. Averaged values are
Sˆa=108 A˚2 and Sˆp=54 A˚2. In the case of poly(Gln), values of
surfaces are Sa=53 A˚2 and Sp=91 A˚2. Since Gln is polar and
y"#=1, the surface contribution is Sp/Sˆp  Sˆt/St=(91/54)(162/
144)=1.9.
The variable sj takes into account the water solubility of the
side chain at position j. In our model, aggregation propensity
and solubility are inversely proportional to introduce a penalty
for highly soluble polypeptides. Most of the solubility values
are available at http://acrux.igh.cnrs.fr/proteomics/densities_
pi.html (Nahway 1989). The missing values (Cys, Lys, and
Thr) were taken from http://www.formedium.com/Europe/
amino_acids_and_vitamins.htm. The variable sj spans the
interval 0.04–162 g/100 g, with average sˆ=3.95 g/100 g. In
the case of poly(Gln), sˆ/s=3.95/2.5=1.5, which indicates
low solubility in agreement with experiments of b-aggregation
(Perutz et al. 1994; Perutz 1999).
Concentration and temperature
The function a(c,T ) captures the effects of concentration (c)
and temperature (T) in Equation 4:
 c;Tð Þ ¼ RT
c c 2 0; c½  mM
1 c 2 c; 1ð mM
1=c c > 1 mM
8<
:
The aggregation rate n is approximated to be proportional to
the temperature because the probability of collision and elon-
gation of peptides increases with temperature (Kusumoto et al.
1998). Although aggregation rate and temperature are not
expected to correlate above physiological values (Massi and
Straub 2001), we used a simple linear dependence, which is
preferable for the small extent of experimentally accessible
values of the temperature. In fact, the temperature ranges
from 298 K to 310 K in the data set of Figure 1.
In agreement with quasielastic light-scattering experiments
of fibrillogenesis of Ab40, the aggregation rate n is assumed to
be proportional to the concentration for c< c* mM (c*=0.1
mM) and to be independent of concentration above the critical
value c= c* (Lomakin et al. 1996, 1997) (see also subsection-
Derivation of the Equation). The hyperbolic function 1/c was
introduced to decrease the aggregation rate n for c>1 mM, as
there is experimental evidence that a very high concentration
opposes formation of ordered aggregates (Munishkina et al.
2004). The concentration ranges from 0.01 mM to 20 mM in
the data set of Figure 1.
Derivation of the equation
 Functionals for aromaticity, b-propensity, and charge were
taken from our relative rate equation (Tartaglia et al. 2004).
The aromatic term was modified according to the results
obtained by the genetic algorithm optimization of aggregating
sequences (Fig. 6) (G.G. Tartaglia and A. Caflisch, in prep.).
The functional for b-propensity, previously based on a single
scale (Tartaglia et al. 2004), now takes into account b- versus
a-propensity. Scales for b- and a-propensity are taken from
Fersht (1999) and normalized in the range 0–1. The term used
for the b-propensity was tested on 100 globular proteins: 82%
of the b-sheet content is successfully recognized (data not
shown). The functional for charged residues was modified
with the addition of a term for symmetrically placed charges
of opposite signs, which is consistent with experimental data
(Gordon et al. 2004). The function ncharge/l replaces the con-
stant factor in the relative rate (Tartaglia et al. 2004) and is
introduced to weight the overall charge by the charge density.
The three functionals for aromaticity, charge, and b-propen-
sity can be zero. Exponential functions were introduced so
that their product is different from zero.
 The product of the three functionals was plotted versus
available experimental rates (see next subsection), obtaining
a correlation of 80%, while the individual correlations for
aromaticity, charge, and b-propensity are 76%, 81%, and
70%, respectively.
 The dependence on concentration and temperature was intro-
duced toderive aggregation rates frompropensities (Lomakin et
al. 1997;Kusumoto et al. 1998;Massi andStraub2001;Munish-
kina et al. 2004). With the concentration alone, the correlation
improves to 85%. The correlation is 82% without the hyper-
bolic function for high concentrations (c>1 mM). With the
temperature function, the correlation improves to 88%.
 The factor for polar/apolar contributions fil in Equation 1
was added upon the analysis of sequences produced by
computational design (Fig. 6). The term is a linear combina-
tion of normalized surfaces and has a nonzero minimum.
The correlation improves to 92%. The solubility dependence
was added at the very end and introduces a penalty for
highly soluble sequences. The correlation improves to 95%.
Experimental data
Most of the experimental rates were kindly provided by Dr. F.
Chiti and Dr. M. Vendruscolo (Chiti et al. 2003; DuBay et al.
2004). The remainder data set was taken from previous experi-
mental studies (Litvinovich et al. 1998; Konno et al. 1999;
Ferguson et al. 2003). The absolute aggregation rates were
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determined from in vitro experiments of denaturated polypep-
tide chains without taking into account the presence of cellular
components as chaperones and proteases. Aggregation rates
were obtained from kinetic traces in different ways: thioflavin
T fluorescence, turbidity, CD, sedimentation, size exclusion
chromatography, and filtration. Lag phases were not consid-
ered in the analysis, as they were not reported or difficult to
extract from published data (DuBay et al. 2004). Since a
comprehensive understanding of lag phases in protein aggrega-
tion is lacking (Kayed et al. 1999b; Padrick and Miranker
2002) (e.g., it is not known whether fibrils form by addition
of monomers or oligomers and how growth conditions influ-
ence the amyloid formation), the aggregation kinetics was
analyzed after the lag phase. The elongation phase showing
an exponential behavior is fitted to the function z=a
(12 e2nt) where n is the rate measured in sec21.
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Abstract
We introduce a novel approach to estimate differences in the b-aggregation potential of eukaryotic
proteomes. The approach is based on a statistical analysis of the b-aggregation propensity of poly-
peptide segments, which is calculated by an equation derived from first principles using the physico-
chemical properties of the natural amino acids. Our analysis reveals a significant decreasing trend of
the overall b-aggregation tendency with increasing organism complexity and longevity. A comparison
with randomized proteomes shows that natural proteomes have a higher degree of polarization in
both low and high b-aggregation prone sequences. The former originates from the requirement of
intrinsically disordered proteins, whereas the latter originates from the necessity of proteins with a
stable folded structure.
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Even proteins not implicated in amyloid diseases have
been shown to form fibrils in vitro under denaturing con-
ditions, indicating that fibrillogenesis is a common feature
of polypeptide chains, which can form intermolecular
backbone–backbone hydrogen bonds (Chiti et al. 1999,
2003) and favorable side-chain interactions (Azriel and
Gazit 2001; Gsponer et al. 2003; Makin et al. 2005).
Although in lower eukaryotes amyloid fibrils could repre-
sent an inheritable phenotype related to specific cellular
functions (Osherovich and Weissman 2002; Osherovich et
al. 2004; Si et al. 2003b), the cytotoxicity of prefibrillar
aggregates (Bucciantini et al. 2002) and their association
with diseases such as Alzheimer’s, Parkinson’s, Hunting-
ton’s, prion disease, cystic fibrosis, and type II diabetes
(Kelly 1998; Rochet and Lansbury 2000) suggest that
amyloid aggregates are generally dangerous for higher
eukaryotes (Dobson 1999; Stefani and Dobson 2003).
We have previously developed an equation to predict
the propensity for ordered aggregation, which solely
requires the polypeptide sequence as input (Tartaglia et
al. 2004, 2005). Our model is based on the physicochem-
ical properties of the residues and takes into account
both amino acid composition and positional informa-
tion. The aggregation propensity pil of an l-residue seg-
ment starting at position i in the sequence is evaluated as
il ¼ il il ð1Þ
The factor Fil contains exponential functions and is
position-dependent
il ¼ e
AilþBilþCil ð2Þ
where Ail, Bil, and Cil are functionals related to the aro-
maticity, b-propensity, and charge, respectively. The fac-
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tor il depends almost exclusively on the amino acid com-
position
il ¼
Yiþl1
j¼i
Saj
S^a
"" þ
S
p
j
S^p
"#
 
S^t
Stj
^
j
" #1=l
ð3Þ
where Sai , S
p
i , S
t
i, and si—weighted by their average over
the 20 standard amino acids (hatted values)—are the side-
chain apolar, polar, total water-accessible surface area,
and solubility, respectively. The functionals y"" and y"#
include positional effects and reflect the parallel or anti-
parallel tendency to aggregate if the majority of residues is
apolar or polar, respectively. Details of the method are
presented in the preceding paper (Tartaglia et al. 2005).
In the present work, we analyze complete proteomes
of several eukaryotes to identify changes of b-aggrega-
tion propensity through organisms of different complex-
ity. The 32,869 entries belonging to the human proteome
database (Supplemental Material, Table 1) were decom-
posed in stretches of different sizes (5, 50, and 150 resi-
dues) to compute the b-aggregation propensity with
Equation 1 and build the normalized histogram of b-
aggregation propensity distribution, APD (Fig. 1A). For
each stretch size, the distribution is found to be nonsym-
metric with respect to the average and skewed to the left,
indicating that there are more stretches with low b-
aggregation propensity (left tail of APD) than with
high propensity (right tail). As pointed out in our pre-
vious study, short stretches are preferable to long
stretches for the analysis of b-aggregation propensity
because the latter contain folding features that deterio-
rate the signal-to-noise ratio (Tartaglia et al. 2005).
Figure 1. (A) (Inset) Distribution of the number of human polypeptide sequences as a function of b-aggregation propensity
(APD) at three different window sizes. (Main plot) APD differences with respect to H. sapiens for complete proteomes of M.
musculus, D. melanogaster, C. elegans, S. cerevisiae, and P. tetraurelia (window size of five residues). Life spans of organisms are
reported in parentheses. (B) Unrooted tree diagram derived from the APD deviation (Equation 4). The deviation is computed
from P. tetraurelia as a reference and magnified by a factor of 1000. The arrow indicates that lower eukaryotes have more high-
propensity and fewer low-propensity stretches. This diagram is built using Phylodraw with the Fitch and Margoliash (1967)
clustering algorithm. Data labeled with * belong to incomplete proteomes. (Phylodraw is available at http://pearl.cs.pusan.ac.kr/
phylodraw/.) (C) Normalized histogram of the number of proteins as a function of the content of residues enriched in low-
propensity and high-propensity stretches. Global contours are shown for all proteomes by solid lines. Isofrequency regions are
shown for the human proteome, where red color indicates the most populated area, while blue fading color indicates the least-
populated areas. (D) Same as C for shuffled proteomes.
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Hence, a window size of five residues was used to ana-
lyze complete proteomes of Homo sapiens, Mus muscu-
lus, Drosophila melanogaster, Caenorhabditis elegans,
Saccharomyces cerevisiae, and Paramecium tetraurelia
(Supplemental Material, Table 1). Nonhuman eukary-
otes show a larger amount of high-propensity stretches
and a smaller amount of low-propensity stretches com-
pared with H. sapiens (Fig. 1A). Moreover, a clear trend
is found with the increasing complexity of the organisms
and their lifetime. To quantify this trend it is useful to
introduce the APD deviation between two proteomes,
x and y
dxy ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
N
XN
i¼1
ðAPDxðiÞ  APDyðiÞÞ
2
vuut ð4Þ
where the b-aggregation propensity p is calculated by
Equation 1 (Tartaglia et al. 2005) and i runs over the
total number of bins N (N=100) in the APD histo-
gram. With the addition of the proteomes of Danio
rerio, Xenopus laevis, and Gallus gallus, the APD devia-
tion was used to build the tree diagram of Figure 1B.
Except for the inversion between the amphibious X.
laevis and the fish D. rerio (whose proteomes are not
complete), the tree of Figure 1B is similar to the phylo-
genetic tree of cytochrome c (Dayhoff et al. 1972). Thus,
the deviation calculated from P. tetraurelia, dxP, is an
observable able to rank proteomes of organisms of
increasing complexity. It is interesting to compare the
amino acid frequencies in APD tails—defined for a
subtended area of 0.05 in the histogram of Figure
1A—with amino acid frequencies in entire proteomes
(Table 1). This analysis reveals that for all proteomes
stretches with low b-aggregation propensity are rich in
A, G, H, K, P and R, whereas high-propensity stretches
in C, F, I, L, N, Q, V, and Y. Figure 1C is a two-
dimensional histogram that shows the number of pro-
teins as a function of the content of residues enriched in
low-propensity stretches and the content of residues
predominant in high-propensity stretches. By increasing
the organism complexity, the number of proteins with
low-propensity residues increases, while the number of
proteins with high-propensity residues decreases. A com-
parison with randomized proteomes is useful to further
investigate the significance of such trends. Randomized
proteomes were generated by shuffling amino acids
within complete proteomes and keeping unchanged the
global amino acid composition, number, and length of
proteins. We stress that the b-aggregation propensity of
five-residue stretches cannot differentiate natural and
shuffled proteomes, because short segments describe
mainly effects of the amino acid composition. Yet, differ-
ences between natural and shuffled proteomes are
enhanced when residues belonging to low-/high-propen-
sity stretches are used for the analysis of entire proteins.
Comparing Figure 1, C and D, it is evident that shuffled
proteomes are less spread. In other words, natural pro-
teomes reveal a sensible increase of sequences with
residues predominant in low-propensity stretches as
well as residues enriched in high-propensity stretches.
While the amino acid global composition of proteomes
is almost identical in higher eukaryotes, the content of
low-propensity stretches increases significantly, indicat-
ing a clear change of protein features from proteome to
proteome.
It has recently been shown that natively unfolded
proteins (or intrinsically disordered proteins, IDPs)
are implicated in cellular regulation, signaling, and
assembly/disassembly of macromolecular complexes
(Dunker et al. 2002; Ward et al. 2004; Oldfield et al.
2005). The absence of a fixed structure suggests func-
tional implications, which are required in complex
organisms (Koonin et al. 2002). Interestingly, a larger
diffusion of IDPs is found in higher eukaryotes than in
lower eukaryotes and prokaryotes (Dunker et al. 2002;
Liu et al. 2002; Linding et al. 2004). Using data from X-
ray crystallography, nuclear magnetic resonance, and
circular dichroism, Williams et al. (2001) found a high
percentage of P, R, K, G, A, Q, S, and E in nonfolded
segments of proteins, and F, Y, C, L, V, N, and W in
folded segments. Except for Q, S, and E, Williams’
finding is in agreement with our tail composition anal-
ysis (Table 1), indicating that residues enriched in
aggregating stretches promote both folding and b-
aggregation, whereas residues predominant in stretches
with low b-aggregation propensity are also enriched in
IDPs.
To better understand the relationship between b-
aggregation propensity and protein structure, we ana-
lyzed the APDs of polypeptide segments that assume a
regular secondary structure, as well as IDPs (Supple-
mental Material, Table 1). As shown in Figure 2A,
strands have more b-aggregation potential than helices,
Table 1. Amino acid frequencies in left or right APD tails
of H. sapiens divided by their corresponding frequency
in the whole proteome
A C D E F G H I K L
Left/total 1.1 0.2 0.4 0.5 0.4 1.3 1.6 0.5 2.1 0.5
Right/total 0.7 2.4 0.8 0.7 2.7 0.6 0.5 1.6 0.3 1.8
M N P Q R S T V W Y
Left/total 0.4 0.2 3.3 0.3 2.8 0.6 0.5 0.7 0.4 0.1
Right/total 0.8 1.5 0.2 1.2 0.2 0.7 0.8 1.2 0.8 2.7
Values exceeding 1.0 are shown in bold. Similar frequencies were found
for all the proteomes.
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and IDPs are the least prone to aggregate, in agreement
with Linding’s analysis (Linding et al. 2004). Moreover,
from lower to higher eukaryotes the APD deviation with
respect to IDP decreases, while the APD deviation from
strands increases (Fig. 2B,C). The APD deviation of
helices does not follow a monotonic trend and slowly
increases from S. cerevisiae toH. sapiens. Compared with
strands, helices display a lower amount of aggregation
stretches, but it has to be mentioned that the transition
helix-strand generates amyloidogenesis in some proteins
(Selkoe 1996; Prusiner 1997).
To quantify interspecies shifts of amino acid composi-
tions in the APD tails, we fitted the amino acid frequen-
cies as a linear function of the APD deviation from P.
tetraurelia, dxP (see Equation 4)
f ax ¼ shift
a dxP þ cst
a ð5Þ
where fax is the frequency of the amino acid a in the
proteome x, shifta is the slope of the fit, and csta is the
intercept. The sign ‘‘+’’ or ‘‘’’ of the shifta was inter-
preted as a measure for the depletion or the enrichment
of the amino acid a from P. tetraurelia to H. sapiens.
Shifts obtained from high-confidence fits (Pearson’s
correlation >0.80; Supplemental Material, Table 2)
are
 Right tails, i.e., high propensity: Decrease of Q, N, Y,
and K and increase of L, V, A, W, R, H, G, and P.
 Left tails, i.e., low propensity: Decrease of K, I, F, and
N and increase of P, A, G, R, S, and E.
Interestingly, the decrease of Q, N, and Y in the right
tails was already observed in higher eukaryote prion
homologs of the yeast Sup35 prion protein (Balbirnie
et al. 2001; Si et al. 2003a; Theis et al. 2003) and suggests
that the trend does not affect only a specific family of
proteins. In addition, we speculate that the increase of L,
V, A, and W in the right tail is a consequence of the
optimization of the ‘‘hydrophobic core’’ to stabilize the
native state (Kellis et al. 1989; Richards and Lim 1993;
Dill et al. 1995; Stefani and Dobson 2003).
The functional role of aggregation phenotypes in
multicellular eukaryotes is still a matter of debate.
Recently, it has been observed that the neuronal pro-
tein CPEB of Aplysia californica behaves like a prion
switch that regulates long-term synaptic changes asso-
Figure 2. (A) APDs of five-residue stretches belonging to intrinsically disordered proteins (IDPs) or regular secondary structure
elements within folded proteins and IDPs. (B) Deviation between the APD of entire proteomes and the APD of segments
belonging to regular secondary structure or IDPs as a function of the organism complexity. The organism complexity is
measured by the APD deviation from P. tetraurelia, dxP. Solid lines are drawn solely to guide the eye. (C) From lower to higher
eukaryotes, the decrease of b-aggregation propensity is related to the increase of intrinsically disordered proteins.
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ciated with memory storage (Si et al. 2003a,b). The switch
mechanism involves the aggregation of the CPEB
N terminus, rich in Q- and N- repeats that are missing
in mammalian isoforms of CPEB (Theis et al. 2003).
Motivated by these observations, we analyzed the data
set of proteins expressed in neurons (Supplemental Mate-
rial , Table 1). For a given proteome, the neuronal APD
perfectly overlaps with the APD of the total proteome
(data not shown), indicating that neuronal proteins are a
descriptive subset of the total proteome and do not follow
any specific trend. We thus cannot draw conclusions on
particular links between memory mechanisms and aggre-
gation phenotypes.
It has been shown that the frequency of N and Q
repeats does not represent an observable able to describe
amyloidogenic trends of proteomes (Michelitsch and
Weissman 2000; Osherovich and Weissman 2002). Our
findings indicate that to quantify aggregation trends, it
is crucial to use an observable, such as the b-aggre-
gation propensity, which accounts for the aggregation
contribution of all amino acids including positional
information.
In conclusion, we have introduced a novel approach
to compare proteomes, which is based on the statistical
analysis of ordered-aggregation propensity. From P.
tetraurelia to H. sapiens, we have shown that proteomes
of higher and more long-lived eukaryotes contain fewer
sequences with high b-aggregation propensity and are
accrued in proteins with low b-aggregation propensity.
We also observed that, compared with random pro-
teomes, natural proteomes are enriched in proteins
with low b-aggregation potential, as well as proteins
with high b-aggregation potential. Such polarization is
a consequence of the dual evolutive requirement of IDPs
with low b-aggregation propensity, as well as proteins
with a stable fold, which comes at the cost of higher b-
aggregation propensity. In the future, we plan to use
gene ontology annotations of proteins with high pre-
dicted b-aggregation propensity to obtain insights into
the specific role of some of the amyloidogenic proteins of
unknown function.
Electronic supplemental material
This section contains two tables: Table 1 contains information
for databases used in the article (origin of data sets, number of
entries of the databases, and number of stretches used in our
analysis); Table 2 contains fitting parameters for the amino
acid shifts (see Equation 5).
Acknowledgments
We thank Dr. A.G. Abebe and M. Cecchini for very interesting
discussions.Thisworkwas supportedby theSwissNational Science
Foundation and the NCCR ‘‘Neural Plasticity and Repair.’’
References
Azriel, R. and Gazit, E. 2001. Analysis of the minimal amyloid-forming frag-
ment of the islet amyloid polypeptide. J. Biol. Chem. 276: 34156–34161.
Balbirnie, M., Grothe, R., and Eisenberg, D. 2001. An amyloid-forming
peptide from the yeast prion Sup35 reveals a dehydrated b-sheet
structure for amyloid. Proc. Natl. Acad. Sci. 98: 2375–2380.
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo,
J., Taddei, N., Ramponi, G., Dobson, C.M., and Stefani, M. 2002.
Inherent toxicity of aggregates implies a common mechanism for pro-
tein misfolding diseases. Nature 416: 507–511.
Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., and Dob-
son, C.M. 1999. Studies of the aggregation of mutant proteins in vitro
provide insights into the genetics of amyloid diseases. Proc. Natl. Acad.
Sci. 99: 16419–16426.
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003.
Rationalization of the effects of mutations on peptide and protein
aggregation rates. Nature 424: 805–808.
Dayhoff, M.O., Park, C.M., and McLaughlin, P.J. 1972. Atlas of
protein sequence and structure. National Biomedical Research
Foundation, Silver Spring, MD.
Dill, K.A., Yue, K., Fiebig, K.M., Yee, D.P., Thomas, P.D., and Chan,
H.S. 1995. Principles of protein folding—A perspective from simple
exact models. Protein Sci. 4: 561–602.
Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends
Biochem. Sci. 24: 329–332.
Dunker, A.K., Brown, C.J., Lawson, J.D., Iakoucheva, L.M., and Obra-
dovic, Z. 2002. Intrinsic disorder and protein function. Biochemistry 41:
6574–6582.
Fitch, W.M. and Margoliash, E. 1967. Construction of phylogenetic tree.
Science 155: 279–284.
Gsponer, J., Habertuer, U., and Caflisch, A. 2003. The role of side-chain
interactions in the early steps of aggregation: Molecular dynamics
simulations of an amyloid-forming peptide from the yeast prion
Sup35. Proc. Natl. Acad. Sci. 100: 5154–5159.
Kellis, J.T., Nyberg, K., and Fersht, A.R. 1989. Energetics of complemen-
tary side-chain packing in a protein hydrophobic core. Biochemistry 28:
4914–4922.
Kelly, J.W. 1998. The alternative conformations of amyloidogenic proteins
and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:
101–106.
Koonin, E.V., Wolf, Y.I., and Karev, G.P. 2002. The structure of the
protein universe and genome evolution. Nature 420: 218–223.
Linding, R., Schymkowitz, J., Rousseau, J., Diella, F., and Serrano, L.
2004. A comparative study of the relationship between protein struc-
ture and b-aggregation in globular and intrinsically disordered pro-
teins. J. Mol. Biol. 342: 345–353.
Liu, J., Tau, H., and Rost, B. 2002. Loopy proteins appear conserved in
evolution. J. Mol. Biol. 322: 53–64.
Makin, O.S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L.C. 2005.
Molecular basis for amyloid fibril formation and stability. Proc. Natl.
Acad. Sci. 102: 315–320.
Michelitsch, M.D. and Weissman, J.S. 2000. A census of glutamine/aspar-
agine-rich regions: Implications for their conserved function and the
prediction of novel prions. Proc. Natl. Acad. Sci. 97: 11910–11915.
Oldfield, C.L., Cheng, Y., Cortese, M.S., Brown, C.J., Uversky, V.N., and
Dunker, A.K. 2005. Comparing and combining predictors of mostly
disordered proteins. Biochemistry 44: 1989–2000.
Osherovich, L.Z. and Weissman, J.S. 2002. The utility of prions. Dev. Cell
2: 143–151.
Osherovich, L.Z., Cox, B.S., Tuite, M.F., and Weissman, J.S. 2004. Dis-
section and design of yeast proteins. PLoS Biol. 2: 442–451.
Prusiner, S.B. 1997. Prion diseases and the BSE crisis. Science 278: 245–
251.
Richards, F.M. and Lim, W. 1993. An analysis of packing in the protein
folding problem. Q. Rev. Biophys. 26: 423–498.
Rochet, J.C. and Lansbury Jr., P.T. 2000. Amyloid fibrillogenesis: Themes
and variations. Curr. Opin. Struct. Biol. 10: 60–68.
Selkoe, D.J. 1996. Amyloid b-protein and the genetics of Alzheimer’s
disease. J. Biol. Chem. 271: 18295–18298.
Si, K., Giustetto, M., Etkin, A., Hsu, R., Janisiewicz, A.M., Miniaci, M.C.,
Kim, J.H., Zhu, H., and Kandel, E.R. 2003a. A neuronal isoform of
CPEB regulates local protein synthesis and stabilizes synapse-specific
long-term facilitation in aplysia. Cell 115: 893–904.
Si, K., Linquist, S., and Kandel, E.R. 2003b. A neuronal isoform of the
aplysia CPEB has prion-like properties. Cell 115: 879–891.
www.proteinscience.org 2739
The b-aggregation propensity of proteomes
46
Stefani, M. and Dobson, C.M. 2003. Protein aggregation and aggregate
toxicity: New insights into protein folding, misfolding diseases and
biological evolution. J. Mol. Med. 81: 678–699.
Tartaglia, G.G., Cavalli, A., Pellarin, R., and Caflisch, A. 2004. The role of
aromaticity, exposed surface, and dipole moment in determining pro-
tein aggregation rates. Protein Sci. 13: 1939–1941.
———. 2005. Prediction of aggregation rate and aggregation-prone seg-
ments in polypeptide sequences. Protein Sci. (this issue).
Theis, M., Si, K., and Kandel, E.R. 2003. Two previously undescribed
members of the mouse CPEB family of genes and their inducible
expression in the principal cell layers of the hippocampus. Proc. Natl.
Acad. Sci 100: 9602–9607.
Ward, J.J., Sodhi, J.S., McGuffin, L.J., Buxton, B.F., and Jones, D.T.
2004. Prediction and functional analysis of native disorder in proteins
from the three kingdoms of life. J. Mol. Biol. 337: 635–645.
Williams, R.M., Obradovic, Z., Mathura, V., Braun, W., Garner,
E.C., Young, J., Takayama, S., Brown, C.J., and Dunker, A.K.
2001. The protein non-folding problem: Amino acid determinans
of intrinsic order and disorder. Pac. Symp. Biocomput. 200:
89–100.
2740 Protein Science, vol. 14
Tartaglia et al.
47
6 Simplified model for simulations of amyloid aggrega-
tion
The ability of proteins to fold efficiently to their native conformation may protect them
from side-reactions such as amorphous and amyloid aggregation: evolution have shaped
the folding and the aggregation pathways in such a way that the native functional state
is in vivo a thermodynamically metastable structure [67]. One of the key questions
currently unanswered is at which point the folding and aggregation pathways meet.
A detailed picture of oligomer formation and the influence of the protein landscape
on the kinetics and the thermodynamics of the process is still under debate. The impor-
tant issues concern the understanding of the multistep process, including the early stage
of the oligomerization process and the protofibril to fibril conversion. As mentioned ear-
lier (see figure 1), amyloid fibrillization of dispersed polypeptides belongs to the more
general theory of nucleated growth polymerization. According to this mechanism the
rate limiting step for the amyloid formation is the nucleation phase, where nuclei are
generated. This phase is followed by the elongation phase, where nuclei indefinitely
grow by polypeptide addition, and they eventually assume the shape of structured fibrils.
Prior to nucleation, during the lag phase, a variety of soluble oligomers can be explored,
and depending on the system, they are observed to promote or deplete the nucleation and
the elongation phase. The nucleus is the least stable species on the aggregation pathway,
and it is in pre-equilibrium with the monomers. According to this theory the nucleus,
once formed, can either degrade to monomers and to non-amyloid oligomers, or progress
to fibril.
Interestingly, disease associated mutants of α-synuclein are related to the accelera-
tion of oligomerization rather than fibrillization [68]. Also in the case of β-amyloid pep-
tide, the ”arctic” mutation, linked to an early onset form of Alzheimer disease, has been
observed to enhance the protofibril, while keeping constant the fibril elongation kinetics
in vitro [69], but also displayed high amyloidogenicity in vivo [70]. Many recent works
have also highlighted the importance of protofibrillar assemblies, mainly addressing the
question whether protofibrils are on or off pathway intermediates. Hydrogen exchange
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measurements revealed that Abeta40 protofibrils have indeed a β-sheet rich protected
structure, revealing a possible on-pathway placement [71]. Interestingly apomyoglobin
protofibrils arise from a multi-step reaction by a random nucleation mechanism in which
the polypeptide chains sample many different aggregated conformations [72].
In section 6.1 a coarse grained model of an amphipathic polypeptide is described.
The conformational landscape of the molecule has been schematized such that only two
states are considered: the amyloid-competent (β) and the amyloid-protected (π) states
(see figure 3). The latter represents the ensemble of all polypeptide conformations that
are not compatible with the fibril arrangement. The folding reaction expressed by equa-
tion (1) can be adapted for an isolated polypeptide chain that undergoes to a reversible
isomerization from the conformation π to the conformation β:
π
kpiβ
⇋
kβpi
β (8)
The free energy difference ∆Gβpi between the two states is expressed by the equi-
librium constant Kβpi, that is the the ratio between the populations of the states π and β
Figure 3: Mapping of real polypeptides conformations onto the free energy landscape
of the coarse grained model. Top, in the yellow box, peptide conformations, bottom,
protein conformations.
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of the isolated monomer. The ∆Gβpi is thus a measure of the intrinsic accessibility of
the β state for the polypeptide in its monomeric form, and can be interpreted as a amy-
loid propensity. The variation of this observable, operated by the force field parameter
dE = Epi−Eβ, influences the kinetics and the thermodynamics of fibrillization, leading
to a wide and differentiated scenario. The range of behaviors investigated can be roughly
classified as β-stable model, which corresponds to a polypeptide with the β state that is
thermodynamically accessible, and a β-unstable model, that represents a polypeptide for
which the β state is only marginally accessible.
Depending on the parameter dE, the fibrillization occurs through alternative nucle-
ation steps. Decreasing the population of the amyloid state β, the kinetics of fibril elon-
gation and nucleation are dramatically slowed down. β-unstable models (i.e. dE <2.0)
display a lag time that is 1 or 2 orders of magnitude greater than that obtained by β-
stable model (dE=0). This can be explained by the fact that the size of the critical
nuclei is increasing together with the population of the π state. Furthermore the ki-
netic stability of oligomers that appears at the lag phase, increases with decreasing dE.
Figure 4: Observed nucleation pathways. Dark and white circles represents molecules in
the amyloid-competent (β) and amyloid protected (π) states. β-stable potentials (dE=0)
nucleate without intermediates, while β-unstable can nucleate either through micelle-
sized oligomers (dE=-2.25) or oligomers larger than micelle (dE=-2.5). A further stabi-
lization of the protected state prevent fibril formation (dE=-2.75). Legend: (M) micelle,
(N) nucleus, (T) transient oligomer, (F) fibril.
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Behaviors described in this work can help interpreting the variety of experimental ob-
servations, and derived rational models for the nucleation mechanism. Remarkably, a
predicted direct correlation between the lag time and the elongation time has been sub-
sequently confirmed by experimental measurements of the kinetics of aggregation for
different amyloid polypeptides [73], a dependence that could be explained considering
that the mechanisms behind nucleation and elongation are similar. Further details of the
coarse-grained model, such as the parameterization, the dependence of the fibril forma-
tion kinetics upon changing the barrier between the π and the β states, and the seeded
fibril growth are discussed in section 6.2.
The parameter dE also affects the pathway of fibril formation and the stability of
the intermediates (see section 6.3). The decrease of the β-aggregation propensity re-
sults in multiple elongation pathways, with intermediates consisting of protofibrils that
are smaller and less structured than the final fibril. When the β state is strongly un-
favored, the templated formation of an additional protofilament on lateral surface is a
collective transition. The simulation results of this work might help to interpret the
polymorphism in the intermediates of amyloid production [47], the dependence of the
pathways upon changing the external conditions [74], the growth of fibril assisted by
lateral scaffold [75], the production of protofibrils upon mutation [69] and the structural
models of protofibrils [71].
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6.1 Interpreting the aggregation kinetics of amyloid peptides. [J.
Mol. Biol. 2006, 360, 882]
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Amyloid fibrils are insoluble mainly β-sheet aggregates of proteins or
peptides. The multi-step process of amyloid aggregation is one of the major
research topics in structural biology and biophysics because of its relevance
in protein misfolding diseases like Alzheimer's, Parkinson's, Creutzfeld-
Jacob's, and type II diabetes. Yet, the detailed mechanism of oligomer
formation and the influence of protein stability on the aggregation kinetics
are still matters of debate. Here a coarse-grained model of an amphipathic
polypeptide, characterized by a free energy profile with distinct amyloid-
competent (i.e. β-prone) and amyloid-protected states, is used to investigate
the kinetics of aggregation and the pathways of fibril formation. The
simulation results suggest that by simply increasing the relative stability of
the β-prone state of the polypeptide, disordered aggregation changes into
fibrillogenesis with the presence of oligomeric on-pathway intermediates,
and finally without intermediates in the case of a very stable β-prone state.
The minimal-size aggregate able to form a fibril is generated by collisions of
oligomers or monomers for polypeptides with unstable or stable β-prone
state, respectively. The simulation results provide a basis for understanding
the wide range of amyloid-aggregation mechanisms observed in peptides
and proteins. Moreover, they allow us to interpret at a molecular level the
much faster kinetics of assembly of a recently discovered functional amyloid
with respect to the very slow pathological aggregation.
© 2006 Elsevier Ltd. All rights reserved.
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Introduction
Amyloid fibrils are polypeptide aggregates with a
core structure consisting of β-sheets whose strands
are perpendicular to the fibril axis, and the
backbone hydrogen bonds are parallel to it.1
Despite the medical relevance of several diseases
linked to amyloidosis, important questions about
the formation kinetics of the early ordered aggre-
gates remain unanswered. The initial phase of fibril
formation is of particular interest because experi-
mental evidence has accumulated indicating that
soluble oligomeric precursors, rather than the
fibrils, might be the toxic species.2–5 However, the
transient nature of oligomeric precursors makes it
difficult to shed light on their formation process or
structure. Additional interest in a better under-
standing of aggregation kinetics is being spurred by
the very recent discovery of functional amyloids in
mammalian cells,6which is challenging the view that
amyloid is always cytotoxic. It is likely that agg-
regation kinetics have to be very fast in functional
amyloids in contrast to the very slow progress of
pathological protein aggregation.
Theoretical models have been developed to inves-
tigate the amyloid aggregation mechanism7–9 and
predict the rates10 but important assumptions like
the irreversible association of polypeptide chains
onto the fibril7,10 are not consistent with experimen-
tal evidence.11,12 Computer simulations using low-
resolution models, which employ a simplified
representation of protein geometry and energetics,
have provided insights into the basics physical
principles underlying protein aggregation in
general13–15 and ordered amyloid aggregation.16–20
Yet, they do not explain the wide range of aggrega-
tion scenarios emerging from a variety of biophysical
measurements.21,22 Computer simulations at the
atomic level of detail23–29 have shed some light on
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oligomeric aggregates and the very early steps of
fibril formation. However, all-atom simulations of
the kinetics of fibril formation are beyond what can
be done with modern computers.
To overcome such computational limitations,
we approximate a polypeptide by a coarse-grained
model consisting of ten beads (Figure 1) and
simulate 125 monomers in a cubic box. The
monomer has internal (dihedral) flexibility and a
free energy profile with two minima at the amyloid-
competent state β and the amyloid-protected state π
(Figure 1(d)). The latter state represents the ensem-
ble of all polypeptide conformations that are not
compatible with the cross β arrangement in a fibril,
e.g. α-helical or random coil structures. An impor-
tant result obtained with the coarse-grained model
is that the kinetic phases and fibril formation
mechanism depend on the choice of a single
parameter, the relative stability of π and β states
(dE=Eπ–Eβ). Notably, very different aggregation
scenarios are observed by varying dE from the β-
unstable (dE≤−2 kcal/mol) to the β-stable
(dE≥0 kcal/mol) model. The simulation results are
used to interpret biophysical data on several
peptides and proteins.
Results
Most of the results were obtained at a temperature
of 310 K and a concentration of 8.5 mM unless
specified otherwise.
Multi-step process
The range of aggregation kinetics is shown in
Figures 2 and 3 while two illustrative snapshots from
a simulation of the β-unstable polypeptide model
(dE=−2.5 kcal/mol) are given in Figure 4. Three dif-
ferent kinetic phases are evident: lag, elongation (or
growth), and final monomer-fibril equilibrium. The
variable length of the lag phase and the higher het-
erogeneity at longer lag times are indicative of a sto-
chastic nucleation.30 Fibril formation is much slower
for the β-unstable model than the β-stable model
(dE=0 kcal/mol). The model parameter dE also af-
fects the elongation kinetics; β-unstable models dis-
play a slower elongation rate (Figure 2(b)). InterestQ
ingly, the significant anti-correlation between the
length of the lag phase and the elongation rate for
different values of dE is consistent with the kinetic
analysis of single-point mutants of Aβ40 (compare
Figure 2(a) and (b) with Figures 1 and 2 of
Christopeit et al.,31 respectively). The distribution
function p(N) of the oligomer size N evaluated at the
lag phase or the final equilibrium is depicted in Figure
3. Within a given phase the peaks of the p(N) dis-
tribution can be interpreted as stable oligomeric
species. The monomer peak ranges from N=1 to 7,
the micellar peak from N=8 to 60, and the fibril peak
fromN=61 to 125. Themicellar peak is present for the
dE=−2.5 kcal/mol model at the lag phase, but disap-
pears at the final equilibrium, where the fibril and the
monomers are the only co-existing species. The height
of the peaks depends on the relative stability of the β-
competent state as well as the total monomer
Figure 1. The model. Sticks and beads representation
of the monomer in the amyloid-protected state π (a) and
the amyloid-competent state β (b). The large spheres are
hydrophobic (black) and hydrophilic (gray). The small red
and blue spheres indicate the negative and positive partial
charges that make up the “backbone” dipoles. The circular
arrow indicates the rotatable bond ϕ. (c) Structure of a
filament embedded in a four-filament fibril. Hydrophobic
spheres are in the core of the fibril, while hydrophilic
spheres are on the outside. All monomers are in the β state.
The three other filaments are shown by gray ribbons. Each
filament is twisted and the four filaments are intertwined.
(d) The dotted line is the dihedral potential with a dE=
−2.5 kcal/mol energy difference between amyloid-pro-
tected and amyloid-competent state. The five continuous
lines represent the free energy profile of the isolated
monomer for five different dihedral potentials.
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concentration. For theβ-stable potential dE=0.0 kcal/
mol the micelle peak is not observed at any
concentration value. With increasing concentration
the monomer and micelle peak distributions are
skewed towards high N values because multi-
monomer collisions and multi-micellar collisions,
respectively, transiently generate oligomers of a larger
size.
Micellar aggregates
Micelle-like non-fibrillar aggregates are observed
only for the models with an unstable amyloid-
competent state (dE≤−2 kcal/mol). Furthermore,
the comparison between the lag times with the time
of micelle formation (gray area in Figure 2(b)) shows
that the fibril formation kinetics of the β-unstable
and β-stable models are slower and faster than
micelle formation, respectively. In fact, micelles are
intermediates consisting mainly of monomers in the
π state (Figure 4(a)) whereas the polymerization of
β-stable monomers directly yields fibrils. The
number of monomers in the micelle is 18±5 at the
concentration value of 8.5 mM and 22±8 at 62 mM,
and the critical concentration of micelle formation is
4.36 mM (see Figure 5). The micellar size, its weak
dependence on the concentration (see Figure 5), and
the on-pathway location are in good agreement with
recent fluorescence quenching data obtained for the
Alzheimer's Aβ40 peptide.32
Mechanism of nucleation
The nucleation properties of the system are
investigated by evaluating the probability of fibril
formation for β-subdomains, i.e. the clusters of inter-
acting β-monomers. The nucleus, defined as the
oligomer containing a β-subdomain with a 50%
probability to form a fibril, shows an increasing size
upon destabilization of the β-state. The number of
monomers in the nucleus is about four for the
dE=0.0 kcal/mol model, while it is 27 and 40 for the
β-unstable models dE=−2.25 kcal/mol and dE=
−2.5 kcal/mol, respectively (Figure 6(a) and (b)).
Significantly different nucleation mechanisms are
observed upon reduction of the relative stability
of the amyloid-competent state (Figure 6(c)). In the
β-stable model (dE=0 kcal/mol), the nucleus size is
sub-micellar and nucleation is simply the aggrega-
tion of monomers in the β-state. For the β-unstable
models, nucleus formation requires either spatial
proximity within a micelle of several monomers in
the β-state (dE=−2.25 kcal/mol) or collision of two
micelles with merging of their β-subdomains (dE=
−2.5 kcal/mol). The lack of lag phase in the sim-
ulation of a “seeding experiment” (with the dE=
−2.5 kcal/mol model, see Supplementary Data) is
consistent with the nucleation dependence of the
aggregation process. For the highly β-unstable
model (dE=−2.75 kcal/mol) amyloid fibril forma-
tion is inhibited by formation of non-fibrillar
aggregates having a very low density of monomers
in the amyloid-competent state (Figure 6(b) and (c)).
Figure 2. Effect of relative stability of the amyloid-
competent state on nucleation and elongation kinetics.
(a) Time series of the fraction of ordered aggregation
evaluated at four values of the protected state stability dE.
Ten independent simulations are shown for each dE value.
The degree of polymerization is normalized to the
maximum for each curve. Note that the average value at
the plateau is about 10% smaller for the dE=−2.5 kcal/mol
than the dE=0.0 kcal/mol model. It is not possible to
directly compare the slopes of the curves (i.e. elongation
rates) at different values of dE because of the logarithmic
scale of the x-axis. (b) Influence of dE on the kinetics of the
system. The time needed to reach 50% of the maximal
amplitude t50 (black circles and y-axis legend on the right)
and the elongation rate (red squares and y-axis legend on
the left) are displayed for seven dE values. Symbols
represent the average value of ten independent runs and
the error bars are the maximum andminimum values. The
broken line and the gray band indicate the average and the
max–min values for the time of micelle formation,
respectively. All simulations were performed at a temper-
ature of 310 K and a concentration of 8.5 mM.
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Concentration effects
Anothermajor difference between themodelswith
unstable and stable amyloid-competent state is the
dependence on the total monomer concentration of
the nucleation and elongation kinetics. In agreement
with the above-mentionedmechanism of nucleation,
the β-unstablemodel nucleates only at concentration
values larger than the critical concentration of
micelle formation, whereas the β-stable model
nucleates even at lower concentrations (Figure
7(a)). Furthermore, during the lag phase the micelle
concentration increases linearly with the total mono-
mer concentration for the β-unstable potential (see
Figure 5) in agreement with neutron and light
scattering data of Aβ40 during the lag phase,33
while the concentration of dispersed monomers
remains constant and equal to the critical concentra-
tion of micelle formation. Hence, the concentration
dependence of the lag phase time for the β-unstable
potential indicates that micelles promote the nucle-
ation. Interestingly, the dependence of the rate of
elongation on the concentration decreases signifi-
cantly by increasing the stability of the protected
state π (Figure 7(b)). The reduced concentration
dependence originates from competitive polymer-
izations, i.e. the elongation of the fibril and the
presence of micelles. This observation for the β-
unstable model is a consequence of the monomer–
micelle equilibrium, which maintains a nearly
constant concentration of isolated monomers.7
Final monomer–fibril equilibrium
The final part of the simulations with dE=−2.25 or
−2.5 kcal/mol is characterized by a dynamic equi-
librium between monomers and fibril11 because the
micellar aggregates disappear after the elongation
Figure 3. Oligomer size histograms of the dE=−2.5 kcal/mol potential (top) and dE=0.0 kcal/mol potential (bottom)
calculated in the lag phase (left) and the final equilibrium (right). Lag phase and equilibrium histograms evaluated at the
same value of the concentration are reported in the same row. The z-dimension represents the relative probability.
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phase (Figures 3 and 4). Fibrils consist of bundles of
four intertwined filaments (Figures 1(c) and 4(b)).
Their caps are disordered and host monomers in the
π state whose population correlates with the relative
stability of the π versus β state. The final equilibrium
observed in the coarse-grained model simulations
indicates that the assumption of irreversible associ-
ation of polypeptide chains onto the fibril10 is not
justified. Recently, a molecular recycling mechanism
has been observed by a combination of NMR spec-
troscopy andmass spectroscopy for an amyloid fibril
formed from an SH3 domain.12 To evaluate the
recycling time of the coarse-grained model, simula-
tions of mature fibrils in equilibrium with dispersed
monomers are analyzed for the β-unstable potential
(dE=−2.5 kcal/mol) at different concentration
values by monitoring the number of the unrecycled
monomers Nu(t) (Figure 8). In two of nine simula-
tions, Nu(t) goes to zero within 4 μs showing that all
monomers initially belonging to the fibril have been
recycled. The time for recycling half of themonomers
incorporated into a fibril is of the order of 2–20μs and
is independent of the total monomer concentration
(see inset of Figure 8). Such “molecular recycling”
indicates that, despite their ordered arrangement,
fibrils are dynamic assemblies.
Discussion
The detailed description of the kinetics and
thermodynamics of the coarse-grained model sug-
gests some general conclusions concerning the aggre-
gation mechanism of amyloidogenic peptides and
proteins. The striking variety of fibril formationmech-
anismsmainly depends on the relative stability of the
amyloid-competent state of the monomer. Despite
the essentially identical structure of the final fibril,
ordered aggregation of the β-stable model follows
a downhill pathway34,35 without intermediates,
Figure 4. Kinetic phases for the β-unstable model.
Snapshots from the lag phase (a) and the final monomer–
fibril equilibrium (b) for a simulation with dE=−2.5 kcal/
mol and 8.5 mM concentration. Hydrophobic and
hydrophilic spheres are black and gray, respectively.
The backbone is blue for π-state monomers and red for β-
state monomers to emphasize that micelles consist mainly
of the former (a) whereas the fibril is made up of the
latter (b). Figure 5. Lag phase of the dE=−2.5 kcal/mol poten-
tial. The micelle concentration CM (red circles, y-axis,
legend on the left) shows a linear increase when plotted as
a function of the total concentration of monomers, C. The
red continuous line is a linear fit whose parameters are
reported in the graph. The x-axis intercept of the red
continuous line is the critical concentration of micelle
formation (4.36 mM). The micelle aggregation number
(squares, y-axis, legend on the right) reaches a plateau at
monomer concentration larger than 20 mM.
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while fibrillization of the β-unstable model occurs
with the presence of on-pathway oligomers. In other
words, high and low β-prone sequences show
completely different kinetic behaviors. This simula-
tion result provides a basis to understand the more
than four orders of magnitude faster kinetic assem-
bly of a functional amyloid with respect to Aβ under
identical experimental conditions.6
An unstructured peptide with a marginally stable
β-prone state (e.g. Aβ4032,36 or the islet amyloid
polypeptide37) as well as the α/β protein acylphos-
phatase22 visit oligomeric systems in the lag phase,
and have a very weak dependence of the elonga-
tion rate on concentration due to the monomer–
micelle equilibrium. This mechanism corresponds
to the nucleated conformational conversion pro-
posed by Serio et al.38 Other examples of the β-
unstable model include phosphoglycerate kinase
(PGK), an α/β protein, which was investigated by
light scattering, circular dichroism and electron
Figure 6. (a) Probability of fibril formation as a function of the size of the β-subdomain evaluated for three different dE
values at a concentration of 8.5 mM. The integer ranges close to the dotted line are the β-subdomain sizes at probability
equal to 0.5 (see the text for nucleus definition). (b) Average number of β-state monomers as a function of the oligomer
size. The β-subdomain sizes of the left plot are reported in ordinate and the corresponding oligomer sizes are indicated by
arrows. As an example, for dE=−2.25 kcal/mol, the nucleus consists of a β-subdomain of size 9–10 incorporated in a
micelle of about 27 monomers. The broken line is the oligomer size distribution calculated at the lag phase for dE=
−2.5 kcal/mol and concentration of 8.5 mM (see Figure 3). (c) Observed nucleation scenarios. Black and white circles
represent the amyloid-competent conformer β and amyloid-protected conformer π, respectively. β-Stable monomers
nucleate without intermediates, while β-unstable monomers can nucleate either through micelle-sized oligomers (dE=
−2.25) or transient oligomers larger than micelle (dE=−2.5). A further stabilization of the protected state prevents fibril
formation (dE=−2.75). M, micelle; N, nucleus; T, transient oligomer; F, fibril.
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microscopy. The amyloid formation of PGK was
shown to be a two-stage process where critical
oligomers with low β content assembly to form
protofibril and fibrils of increasing cross-β
structure.9 A similar mechanism was proposed by
Xu et al. for the full length yeast prion-like protein
Sup35 using atomic force microscopy.39 Both afore-
mentioned mechanisms are described by the β-
unstable model, which is observed to nucleate
through an isolated micelle or transiently associated
micelles (Figure 4(c)). On the other hand, a functional
and non-pathological amyloid in mammalians6 as
well as oligopeptides with amyloid-prone sequence
(e.g. the heptapeptide GNNQQNY from the N-
terminal domain of the Sup35,40,41 or the blocked
diphenylalanine42) lack on-pathway intermediates
and correspond to the β-stable model. Most impor-
tantly, it is not necessarily the stability of the folded
structure, as suggested recently,35,43 to determine the
aggregation mechanism but rather the relative
stability of the β-prone state.44 In fact, the simulation
results can be used to interpret the different kinetic
behaviors even within proteins with stable native
fold. Transthyretin35 and β2-microglobulin21 have a
β-sheet-rich folded state and show downhill poly-
merization (depending on the solution conditions)
because of the intrinsic β-propensity of their se-
quences, as observed for the β-stable model. On the
contrary, mainly α-helical structures like myoglobin
and the prion protein require extreme environmental
conditions (high temperature for apomyoglobin)45
and show a significant lag phase as observed for the
β-unstable models. Furthermore, the importance of
the relative stability of the β-prone state is consistent
with the experimental observation that the changes
in nucleation and elongation kinetics upon single
point mutations correlate more with the β-propen-
sity and the hydrophobicity46,47 than the α-helical
stability as recently reported for Aβ40.31 However,
the possibility to change solely the intrinsic confor-
mational landscape of a monomer without affecting
the inter-monomer non-covalent interactions repre-
sent an advantage of the coarse-grained model and
simulation approach with respect to experimental
methods such as mutagenesis and solvent-induced
conformational changes, by which it is not possible
to separate the two effects. For instance, mutation of
the Aβ40 peptide, even a single point substitution,
can have an influence on both the energy landscape
Figure 7. (a) Effect of concentration on the lag phase
time t50 for β-unstable dE=−2.5 kcal/mol (black circles)
and β-stable dE=0.0 kcal/mol (green squares) models.
The symbols represent the average value calculated on 15
simulations for dE=−2.5 and ten simulations for dE=0.0.
The error bars represent the minimum and the maximum
value. (b) Effect of concentration on the elongation rate of
the fibril. Symbols and error bars are as for (a). The vertical
dotted line indicates the critical concentration of micelle
formation.
Figure 8. Number of unrecycled monomers Nu as a
function of time for nine simulations started from a
preformed equilibrated fibril. Simulations were performed
at total concentration C=16.0 mM and for the dE=
−2.5 kcal/mol model. The values of the decay time τ (i.e.
the time to reach e−1Nu(0)) at different concentrations are
reported in the inset.
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of the monomer and the intermolecular forces. In
conclusion, a slight modification of the free energy
profile is sufficient to observe a wide range of
different fibril formation mechanisms providing a
unifying description of the available experimental
results. This finding has significant implications for
the design of drugs against amyloid diseases as well
as for the production of nanofibrillar materials.48
Materials and Methods
Model
A monomer consists of ten spherical beads arranged to
have an overall amphipathic character. The relative
stability of the amyloid-competent (β) and amyloid-
protected (π) state is modulated by varying the dihedral
energy difference of the single rotatable bond of the
monomer. Interactions betweenmonomers depend on van
der Waals and electrostatic forces (Figure 1). The former
approximate both steric and hydrophobic effects while the
latter are dipole–dipole interactions responsible for the
ordered stacking of monomers incorporated in the fibril.
Details of the model are given in the Supplementary Data.
Simulation protocol
Disordered aggregation and/or fibril formation is
simulated at physiological temperature (310 K) by
following the time evolution (Langevin dynamics) of 125
monomers enclosed in a cubic box, at constant volume
conditions, and starting from a monodisperse solution.
Periodic boundary conditions are applied to avoid finite
size effects. The total monomer concentration of 8.5 mM is
about two orders of magnitude higher than the reported
experimental concentrations of 30 μM −300 μM. The very
high peptide concentration is used to increase the
probability of intermolecular interactions, making the
oligomerization process fast enough to be observed in a
simulation time scale of about 10 μs, which requires about
25 days of CPU time. All simulations were performedwith
CHARMM.49
Dihedral free energy profile
The dihedral free energy profile reported in Figure 1(d)
is evaluated for an isolated monomer as follows:
DG fð Þ ¼ kT log
nðfÞ
nðf ¼ 20-Þ
 
where n(ϕ) is the probability to assume a dihedral angle
equal to ϕ. The β-state minimum at ϕ=20° is taken as
reference.
Oligomer size distribution
A clustering algorithm is used to calculate the size of
the oligomeric species along the simulations. It is based on
the matrix of contacts Dij between labeled monomers.
Given a single frame of the simulation, Dij is equal to one
if any sphere of monomer i is closer than 6.0 Å to any
sphere of monomer j, otherwise it is zero. Dij is equivalent
to the first neighbor matrix, dij(1). The second neighbor
matrix d(2) is constructed from d (1) including the neigh-
bors of the first neighbors. The converged contact matrix
dij
(∞) is defined by the following recursive sequence:
d
ð1Þ
ij ¼ Dij
d
ðnÞ
ij ¼f 1 if d
ðn1Þ
ij ¼ 1
1 if dðn1Þik ¼ 1 and d
ðn1Þ
kj ¼ 1
0 otherwise
d
ðlÞ
ij ¼ limnYl
d
ðnÞ
ij
which yields a block matrix of ones and zeroes. Each block
represents a cluster of monomers and contains first
neighbors, second neighbors, third and so on. This proce-
dure is equivalent to a hierarchical clustering performed
with a spanning tree technique.50 With the converged
contact matrix one can identify clusters (i.e. tagging each
oligomer with an identification number), list monomers
belonging to a specific oligomer and make statistics on the
sizeofoligomers.Theabovedefinitionofoligomeric species
allows the statistical analysis of cluster size. Theprobability
that amonomer is aggregated in a cluster of sizeN is:
p Nð Þ ¼
1
NT
X
i¼1;NT
yi;t Nð Þ
* +
t
where NT is the total number of simulated monomers, δi,t
(N) is equal to 1 if the monomer i at time t is embedded
in a cluster of size N, and the angular brackets are the
time average. This function (termed oligomer size
distribution) can be evaluated for the lag phase or the
final monomer–fibril equilibrium. The elongation phase
cannot be analyzed by p(N) being an out of equilibrium
dynamic process.
Critical concentration of micelle formation
The probability distribution p(N) can be used to evaluate
the critical concentration of micelle formation CrM. The
micelle aggregation number in the lag phase is defined as:
NM ¼
X60
N¼8
NplpðNÞ
where plp is the function p(N) evaluated only in the lag
phase (where there is co-existence of micelles and mono-
mers without fibrils). The number of micelles per simula-
tion box isNTpMNM−1 ,where the total number of simulated
monomers NT is 125 and pM is the probability of a
monomer being in a micelle. The micelle concentration
CM is derived from the number of micelles in the simu-
lation volume. The micelle aggregation number NM and
concentration are plotted in Figure 5 as a function of the
total monomer concentration C for the potential dE=
−2.5 kcal/mol in the lag phase. By extrapolating a linear fit
of the concentration of micelles the critical concentration of
micelle formation CrM can be evaluated. The value is
CrM=4.36 mM.
Kinetics
The time series displayed in Figure 2(a) are evaluated by
counting the number of parallel polar contacts np, i.e. the
number of inter-monomer dipole–dipole interactions
normalized to the maximum value. This observable is
889Aggregation Kinetics of Amyloid Peptides
61
approximately zero at the lag phase and increases with the
degree of fibril polymerization after the nucleation. The
elongation rate (Figures 2(b) and 7(b)) is evaluated by
fitting the np time series with an exponential function,
whereas t50 (Figures 2(b) and 7(a)) is the time needed to
reach 50% of the maximum np amplitude. Time series of
the number of inter-monomer hydrophobic contacts nh are
used to calculate the time of micelle formation (gray band
in Figure 2(b)), which is the time needed to reach 50% of
the amplitude at the lag phase starting from initially
dissolved monomers (nh=0). See Supplementary Data for
additional information.
Probability of fibril formation
β-Subdomains, defined as clusters of interacting β-mo-
nomers, are used to evaluate the probability of fibril
formation shown in Figure 6(a). Given a β-subdomain ANβ
of size Nβ, the set of pathways Pi is defined as the set of β-
subdomain trajectories produced starting from ANβ. The
probability of fibril formation for a β-subdomain of size
Nβ is defined as:
pFf Nhð Þ ¼
1
M
X
Pi
F Pið Þ
where M is a normalization term that accounts for the
occurrence of oligomer ANβ in the simulations, and F(Pi) is
equal to 1 if the pathway produces a fiber, and otherwise it
is 0. The number of β-monomers in an oligomer of size N,
reported in Figure 6(b), is calculated from the free energy
difference between the β and π states in an oligomer of
size N, ΔGβπ(N):
Nh Nð Þ ¼
Ne
DGhkðNÞ
kT
1þ e
DGhkðNÞ
kT
See Supplementary Data for additional information.
Number of unrecycled monomers
The number of unrecycled monomersNu(t) is defined as
follows. First, all monomers belonging to the fibril at time
t=0 are labeled and counted. Then, at all times t>0 the
monomers that never detached from the fibril are counted
andtheresultingnumber isNu(t).Thenumberofunrecycled
monomersNu(t) can be fittedwith an exponential function:
NuðtÞ ¼ Nuð0Þet=H
where Nu(0). is the initial value of monomers belonging to
the fibril and τ is the decay time.
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1 Nomenclature
Energy terms
EvdW Van der Waals energy minimum for hy-
drophobic spheres
q Dipole partial charge
Eb Barrier height
Epi Potential energy at the protected state pi
Eβ Potential energy at the amyloid state β
dE Potential energy difference between the pi
and the β states
P (Eb, dE) CMAP dihedral potential
Cφ0(φ) Constraining dihedral potential
β-stable Model with dE ' 0 dihedral potential
β-unstable Model with dE / −2.0 dihedral potential
Monomer states and fibril morphology
pi Protected state
β Amyloid state
m Monomeric state
M Micellar state
f Monofilament state
F Fibril state
F (Xy) Fibril morphology symbol
System observables
np Parallel polar contacts
nh Hydrophobic contacts
Kinetic observables
tlp Lag phase time obtained by exponential
fitting
t50 Lag phase measured at 50% amplitude
(delay time)
ke Elongation rate
tM50 Time of micellization
Concentration and aggregation numbers
C Total monomer concentration
CM Micelle concentration
CrM Critical concentration of micelle formation
CrF Critical concentration of fibril formation
NT Total number of simulated monomers
Nm Number of dissociated monomers
NM Micelle aggregation number
N Oligomer size
N∗ Nucleus size
Thermodynamics
∆Gβpi(N) Free energy difference between pi and β
states in an oligomer of size N
∆Gβpi(1), ∆Gβpi Free energy difference between pi and β in
the monomeric form
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2 Supplementary description of the model
The coarse-grained model developed for studying aggregation kinetics and thermo-
dynamics is a compromise between the mesoscopic detail and the computational
efficiency, which are conflicting requirements. Each monomer has internal flexi-
bility and can interact through electrostatics and van der Waals forces with other
monomers. Some of the model parameters are chosen to enforce a certain geome-
try (such as the bonds, the spheres radii and the angles). The strength of van der
Waals and electrostatic energy terms are first varied to evaluate the effects on the
formation of aggregates. Then the dihedral potential is changed to analyze differ-
ent aggregation pathways and kinetics. The simplified model does not represent
a particular protein; it is useful to understand different aggregation scenarios as
observed for different amyloidogenic sequences and experimental conditions.
2.1 The force field
The monomer consists of 10 spherical beads, four of which represent the ”backbone”
(A2 A3 A6 A10) and six the ”sidechains” (A1 A4 A5 A7 A8 A9) (Figure 1). The
backbone consists of two identical dipoles with a partial charge q expressed in
electronic units; this part of the monomer is designed to interact specifically by
intermolecular dipole-dipole interactions. The larger beads represent the sidechains
and interact by van der Waals forces. The energy E of the system is evaluated using
the following force field formula:
E =
∑
bonds
kb(l − l0)
2 +
∑
angles
ka(θ − θ0)
2 +
∑
dihedrals
F (φ) + (1)
∑
i,j
EvdWij

(rvdWij
rij
)12
− 2
(
rvdWij
rij
)6+
∑
i,j
qiqj
4piε0εmrij
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Figure 1: Model of the monomer: light gray spheres are hydrophilic and light red
spheres are hydrophobic. The bold black bonds indicate the polar system. Here
the positive charges are blue and negative are red. The monomer in the cis state is
depicted in the left image, the +90 state in the center, the trans conformation on
the right. The spheres drawn here do not reflect the actual van der Waals radii.
Geometrical properties and force field parameters are described in the text. Labels
indicate the sphere name.
where the sums are evaluated for all bonds, angles, dihedrals and sphere pairs i, j
of the system. The variables l, θ and φ are the length of the bond, the angle and
dihedral values, respectively, while rij is the distance between the sphere pair i, j.
The values of the force constants kb, ka and the optimal distances l0 and angles θ0
are reported in Table 1. The ”molecule” can change its conformation by rotation
around the internal dihedral φ defined by the beads A6-A2-A3-A10. Depending on
the simulation purpose the dihedral potential function F (φ) is either an harmonic
function
F (φ) ≡ Cφ0(φ) = kd(φ− φ0)
2 (2)
that restrains the value of the dihedral φ around the value φ0, or a potential
F (φ) ≡ P (φ) (3)
designed using the CMAP facility [1], with a grid size of 15 degrees. Several
potentials P were investigated in the present work (see also Section 2.3).
The optimal van der Waals energy EvdW and distance rvdW as well as the partial
charges qi are listed in Table 2. The pair constants E
vdW
ij for the van der Waals
interaction in Equation 1 are evaluated using the Lorentz-Berthelot mixing rules [2].
A dielectric constant ǫm = 1 is used because the effects of the solvent are taken
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Bond energy
Bead type kb (kcal ·mol−1 · A˚−2) l0 (A˚)
A or C - B 1000.0 5.0
D - B 1000.0 2.0
Angle energy
Bead type ka (kcal ·mol−1 · rad−2) θ0 (degrees)
A or C or D - B - A or C or D 100.0 90.0
Table 1: Bonding parameter of the force field.
EvdW rvdW mass charge q
Name Bead type [ kcal/mol ] [ A˚ ] [ a.u. ] [ e.u. ]
A1 A -0.1/-1.6 (∗) 2.5 500 0.0
A2 B -0.1 2.0 500 0.29/0.52 (∗)
A3 B -0.1 2.0 500 0.29/0.52 (∗)
A4 A -0.1/-1.6 (∗) 2.5 500 0.0
A5 C -0.1 2.5 500 0.0
A6 D -0.1 2.0 500 -0.29/-0.52 (∗)
A7 C -0.1 2.5 500 0.0
A8 C -0.1 2.5 500 0.0
A9 C -0.1 2.5 500 0.0
A10 D -0.1 2.0 500 -0.29/-0.52 (∗)
Table 2: Nonbonding parameter of the force field. (∗) Variation of these parameters
is investigated in Section 2.4.
into account implicitly by the nonbonding parameters EvdW and q. Assuming
an ellipsoidal symmetry, the volume of the monomer is 941 A˚3, which roughly
corresponds to the volume occupied by a peptide of 5 to 11 residues. The mass
per bead is set to 500 a.u. This value corresponds to a mass of 4-5 residues, and is
chosen to provide stability to the molecular dynamics simulations.
Two types of sidechains are defined: A2, A3 and A5 to A10 have a van der
Waals energy minimum EvdW of −0.1 kcal/mol, while A1 and A4, the hydrophobic
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sidechains, have a much more favorable van der Waals energy minimum. These two
sidechain types generate an ”amphipathic” moment which allows the formation of
amorphous aggregates such as micelles and the assembly of fibrils. Soreghan et al.
have emphasized the surfactant properties of β-amyloid peptide and its capability
to form solvent oriented structures [3]. For many amyloid proteins, amorphous on
and off pathways intermediates have been detected [4–8]. More complex combina-
tions of ”sidechain” types could be envisaged for future investigations.
Given the geometry of the monomer (see Section 2.3) and the simplified force
field, only two nonbonding parameters are relevant. The van der Waals energy
minimum EvdW of the hydrophobic beads A1 and A4 tunes the strength of the
non-specific interaction while the partial charge q regulates the strength of the
dipole-dipole interaction (see Section 2.4).
2.2 Simulation protocol
Simulations were performed at different temperature values (300-360 K), and con-
centrations (1.52 - 106.0 mM ) using 125 monomers in a box with periodic boundary
conditions. The size of the cubic simulation box defines the value of the concentra-
tion. A few runs were performed with 1000 monomers to investigate the ”seeded”
aggregation (see Section 4.2). The simulation protocol is the same for all runs.
Monomers are initially placed in a cubic lattice. The system is then heated for 2
ps to the nominal temperature and equilibrated for 20 ps. In this first stage the
integration time step is 2 fs and there is no shake constraint. The second stage is a
more intensive equilibration; the monomer centers of mass are constrained at their
position and simulated for 50 ns. The purpose is to equilibrate the dihedral degree
of freedom. The third stage is the production, with previous constraints released.
For the second and the third stages the time step is 50 fs, all bonds are restrained
with SHAKE [9], and the leapfrog integrator is used for Langevin dynamics at a
very low viscosity (0.01 ps−1) which does not influence the thermodynamic prop-
erties. For all stages the cutoffs are set to 25 A˚ for the nonbonding list, 20.0 A˚
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and 18.0 A˚ for the nonbonding interactions cutoff and cuton, respectively, with a
switching function [10].
2.3 Probing different monomer conformations
The two dipoles are orthogonal to each other in the states π90 and π−90 corre-
sponding to φ = +90 and −90, respectively. In these conformations the monomers
cannot stack along a longitudinal axis, i.e., fibrils cannot be formed. These confor-
mations represent the amyloid-protected state. The states β0 and β180 correspond
to cis (φ = 0) and trans (φ = 180) conformation, respectively. These two states
can propagate a longitudinal stacking, namely they can form fibrils. The effects of
different dihedral conformations were investigated by 1.5µs runs (125 monomers)
with the harmonic potential C defined by the equation 2 (see Figure 2). Besides the
π90, π−90, β0 and β180 states mentioned above, conformations with a deviation of
±15 and ±30 degrees from cis or trans (noted as β±30, β±15, β±150,β±165 see Figure
2) were simulated to investigate the effect of monomer chirality on fibril structure.
All simulations were performed at aggregation-promoting conditions (see Section
3.4), i.e., concentration of 20.88 mM, 310 K, and aggregation-promoting nonbond-
ing parameters (see Section 2.4), i.e., EvdW = −1.3 kcal/mol for the hydrophobic
spheres and q = 0.34 electronic units.
For all monomeric conformations the system readily starts to form aggregates
of different kinds. As mentioned above, conformations π90 and π−90 do not produce
ordered aggregates but rather spherical micellar assemblies (see figure 4) where the
hydrophobic spheres are partitioned into the core and the hydrophilic spheres are
exposed. These micelles are in equilibrium with dissociated monomers and have
an average size of 20-23 monomers (see Section 3.4). All other conformers asso-
ciate into ordered structures, but interestingly only the chiral conformers produce
fibril-like aggregates. The simulations where the monomers are constrained to be
either in the state β0 or β180 yield an ordered oligomeric assembly that resembles
a disordered crystal lacking a precise cylindrical symmetry (see Figure 2.2) rather
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than a fibril. The remaining simulations (β±15, β±30, β±165, β±150) yield a single
cylindrical aggregate consisting of three to four filaments intertwined together, and
assembled around the hydrophobic core (see Figure 2.1-3). These ordered aggre-
gates display a twist clockwise or counter-clockwise depending on the chirality (in
Figure 2 the circular arrows indicate the helicity of the fibril). These observations
agree with a statistical mechanical model for the assembly of chiral molecules [11].
Taken together, the simulation results reveal a complex conformational scenario;
in spite of a minimal set of system degrees of freedom, by far smaller than a real
polypeptide, the morphological heterogeneity is noticeable. It is important to note
that real fibrils do not display a large morphology assortment [12, 13]. In the case
of Aβ42 only two main morphologies are observed, and probably only two monomer
conformations are favored among all possible to form fibrils [13].
Figure 2: Effects of monomer dihedral angle on aggregation behaviour. Circular
arrows indicate the helicity of the resulting fibril. The red box marks the range of
dihedral angle values focussed upon by using the CMAP potential (see Figure 3).
Fibrils resulting from the simulations of monomers in the state β165 (1), β180 (2),
and β−15 (3). Black lines connect the spheres belonging to the polar system, light
gray points are the hydrophilic spheres, and light red points are the hydrophobic
spheres.
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To prevent sampling of redundant, i.e., symmetry-related, conformations a value
of 5.0 kcal/mol for all φ values outside the interval 7.5− 97.5 degrees was imposed
by CMAP [1]. This procedure renders all conformations outside such interval
inaccessible. Therefore the accessible φ-value interval includes the state π90, which
is ordered-aggregation protected, and the states β15 and β30 that form twisted
fibrils (see Figure 2). It is now convenient to introduce a short notation for the two
conformations: the β-aggregation protected state π ≡ π90 and the β-aggregation
competent state β ≡ β15 or β30.
A dihedral potential function can be introduced in the reduced region to explore
different kinetic and thermodynamic properties of the monomer and to investigate
their influence on fibril formation. The dihedral potential is defined by two param-
eters (Figure 3): Epi is the energy of the aggregation protected conformation for φ
values ranging between 67.5 and 97.5 degrees, while Eb is the energy at the barrier,
defined for the 52.5 < φ < 67.5 interval.
By fixing the reference state at Eβ = 0 the dihedral potential is fully defined
by P (Eb; dE) where Eb is the potential value at the barrier, and dE = Epi − Eβ is
the potential difference between the states π and β. As an example P (1.0;−2.5) is
Figure 3: CMAP dihedral potential P (1.0;−2.5). Eβ is the energy for the
aggregation-competent state, Eb is the energy at the barrier, and Epi is the en-
ergy at the protected state.
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a potential with a 1.0 kcal/mol barrier for the β → π conversion, and a protected
state π stabilized by -2.5 kcal/mol.
2.4 Probing nonbonding parameters
The effects of the variation of the two nonbonding parameters, EvdW and q, are
explained in this section. For three different potentials [P (0; 0), P (1.0;−2.5) and
C+90(φ)] simulations at different values of E
vdW for the hydrophobic spheres and
q are performed (Table 3). There are different types of ordered and disordered
aggregates of increasing complexity: micelles (M), single filament (f), non-twisted
bundles of filaments (F (I)), twisted bundles of filaments (F (II)), and other ordered
aggregates (F (III)) that cannot be classified in the previous two groups (Figure
4). The bundles (fibrils) can be of different sizes ( two to four filaments, noted with
a number, see caption of Table 3), but also a single fibril can present segments with
a variable number of filaments.
All three investigated potentials show a common feature: the variation of the
two parameters defines multiple phase change. At low q and marginally favorable
EvdW the monomers are dissociated. This corresponds to the top-right corner of the
tables. An equilibrium of monomers with oligomers at the transition points is often
observed, or eventually micelles with fibrils (as in the case of potential P (1.0;−2.5),
q = 0.31 and EvdW = −1.6). At the bottom-left corner no coexistence is observed
(pure ordered aggregates).
The restrained potential. The simulations performed with the C+90(φ) po-
tential are control simulations. As mentioned above, the π state (φ = +90) cannot
form any ordered aggregate but only micelles. As it is evident from Table 3, mi-
celles formation occurs for EvdW ≤ −1.0 kcal/mol, weakly depending on the value
of the charge q.
The β-unstable potential P (1.0;−2.5). Favorable values of EvdW and high
values of q promote the ordered aggregation. F (I) fibrils are observed at high
q, together with single filaments f . The size of the bundle increases with more
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Figure 4: Different aggregation morphologies observed in simulations. The dipole
system is indicated in black, the hydrophilic spheres are indicated in transparent
gray, and the hydrophobic spheres are light red. Micelles are non-ordered spherical
or elliptical metastable aggregates. Fibrils are multi-filament assemblies. Fibrils
of ”type I” are not twisted, while fibrils of ”type II” are twisted. Fibrils of ”type
III” include everything that cannot be classified in the previous types: type III-5
is a bundle of 5 filaments, III-y is a cross of two or more fibrils, and type III-p is a
planar fibril similar to a ribbon.
favorable EvdW , i.e., by increasing the hydrophobicity. Twisted fibrils F (II) are
present at lower q, indicating that the twisting is a result of balancing of these two
parameters.
The β-stable P (0; 0) potential. The region where the fibrillation occurs is
larger than in the P (1.0;−2.5) case, which is a consequence of the larger thermo-
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Potential C+90(φ)
EvdW q=0.52 0.45 0.4 0.36 0.34 0.31 0.29
-0.1 m m m m m m m
-0.4 m m m m m m m
-0.7 m m m m m m m
-1.0 m+M m+M m m m m m
-1.3 M M m+M m+M m+M m+M m+M
-1.6 M M M M M M M
Potential P (1.0;−2.5)
EvdW q=0.52 0.45 0.4 0.36 0.34 0.31 0.29
-0.1 m+f:1 m m m m m m
-0.4 F(I2):1 m m m m m m
-0.7 F(I3):1 m m m m m m
-1.0 F(I3):2 F(II3):2 m m m m m
-1.3 F(I4):3 F(II3−4):3 F(IIIP ):3 F(II4):3 m+F(II4):3 m+M m+M
-1.6 F(IIIP ):3 F(II3−4):4 F(IIIY ):4 F(IIIP ):4 F(II3−4):4 M+F(II4):4 M
Potential P (0; 0)
EvdW q=0.52 0.45 0.4 0.36 0.34 0.31 0.29
-0.1 f:1 m+f:1 m m m m m
-0.4 F(I2−3):1 m+F(I3):1 m+f:1 m m m m
-0.7 F(I4−5):1 m+F(I3):1 m+F(I3):1 m m m m
-1.0 F(I2−4):1 F(I3):1 m+F(II3−4):1 m+F(II4):2 m+F(II4):2 m+F(II4):2 m+F(II4):2
-1.3 F(II3−4):1 F(I2−4):1 F(II4):2 F(III5):2 m+F(II4):3’ m+F(II3):3’ m+F(II3−4):3’
-1.6 F(IIIP ):2 F(IIIP ):2 F(IIIP ):2 F(II3−4):3’ F(II3−4):3’ F(II3; IIIP ):3’ F(II3−4):3’
Table 3: Effect of variation of the hydrophobic strength (EvdW is the van der Waals potential energy well of spheres A1 and A4)
and the charge q. Legend: (m) monomers, (M) micelles, (f) filaments, (F) fibrils. For the fibrils it is notated the type and the
number of filaments: e.g. F(II3−4) is a fibril of type II with 3 to 4 filaments. The number after the colon is the type of pathway
followed by the simulation (see Figure 5). The sign plus ”+” indicates coexistence of different phases. The concentration is 20.88
mM and the temperature is 310 K. The colors of the fields stand for the main aggregation morphology: green for micelles, blue
for single filaments f , pink for F (I), orange for F (II), and red for F (III).
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dynamic accessibility of the β state. It is worth noting that chemically or mutation
denaturated proteins are more susceptible to form fibrils than their standard con-
ditions or wild type counterparts, respectively [14–16].
The aggregation process can be monitored by the number of parallel polar
contacts and hydrophobic contacts along the trajectories. A parallel polar contact
is formed whenever sphere 6 and 2 or sphere 10 and 3 of different monomers are
closer than 5 A˚. This selection of contacts defines the parallel aggregation, whereas
the antiparallel is not observed because of the amphipathicity of the monomer
(see above). A hydrophobic contact is formed whenever spheres 1 or 4 of different
monomers are closer than 5 A˚. The total number of polar np and hydrophobic nh
contacts is evaluated for each frame:
np =
1
2
∑
i=A6
∑
j=A2
δ(rij ≤ 5) +
1
2
∑
i=A10
∑
j=A3
δ(rij ≤ 5) (4)
nh =
1
2
∑
i=A1,A4
∑
j=A1,A4
δ(rij ≤ 5) (5)
where, for instance, the summation index i = A1, A4 runs for all A1 and A4 spheres,
and the function δ is equal to 1 if the distance between the two spheres rij is less
than 5 A˚. These quantities are used as progress variables of the aggregation process.
A point in Figure 5 represents values of np and nh of a single snapshot. Fibril
formation corresponds to a trace of points that spans from the origin (monomeric
state) to a maximal value of both variables that is around 225 for np and 600 for nh
in the simulation with 125 monomers. Given the geometry and size of the monomer
the number of parallel polar and hydrophobic contacts per monomer incorporated
into a fibril is about 2 and 5, respectively.
The left and right plot of figure 5 display the (np, nh)-values of the snapshots
saved along the simulations with the P (0; 0) and P (1.0;−2.5) potentials respec-
tively. Different pathways of fibril formation can be identified. The meaning of the
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different pathways can be understood considering first the path number 2 which
follows a straight line for both potential models. The variables under consideration
depend linearly on each other in path 2, namely for any association event np, and
nh increase by a value that is constant along the aggregation process. The physical
meaning of this behavior is that the fibril, once it has nucleated, progressively in-
creases its size by absorbing monomers or small oligomers. During elongation the
morphology of the progressing fibril it is similar to the final fibril.
There are different considerations for path 1, path 3-3’ and path 4. Path 1 is
a double stage transition for both potentials. In the first stage monomers form
aggregates that maximize the number of polar interactions. These oligomers as-
semble by increasing hydrophobic contacts number in the second stage. They can
be identified with single filaments. Only for the P (1.0;−2.5) potential, paths of
type 3 and 4 are observed. Clouds of points in the low np and high nh can be in-
terpretated as disordered aggregates. From visual examination, these on-pathway
assemblies are micellar-like oligomers very similar to those obtained for the C+90(φ)
potential.
In the case of path 3’ of P (0; 0) potential, these on-pathway micellar aggregates
are not present: there is a faster transition from monomer state to fibril state.
Path 3’ is thus different from path 3. The pathway 4 is observed only at high
hydrophobic strength; it is similar to pathway 3, but shifted towards the high
hydrophobic contacts content. In other words it is a nucleation from a bigger
micellar aggregate. Likewise the pathway 3’ is present at high hydrophobic strength
for the P (0; 0) potential. As mentioned above the micellar state is absent for this
pathway, it is consequently equivalent to path 2, shifted towards high content of
hydrophobic contacts. Pathways 3 and 4 are therefore qualitatively the same, and
the same is valid for pathways 2 and 3’. This allows a characterization of the fibril
formation pathways in three main classes (see Figure 6).
The path numbers are reported in Table 3 for all parameters pairs. The pre-
ferred path depends on the values of q and EvdW . For potential P (1.0;−2.5) the
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Figure 5: Pathways of fibril formations. The number of parallel polar interactions
np and the number of hydrophobic interactions nh for all trajectories defined in
Table 3 for P (0; 0) and P (1.0;−2.5) potentials. The clustering of points permits
a classification of diverse aggregation pathways. Red lines are meant to guide the
eyes.
Figure 6: Pathways classification. Legend: (m) monomer, (M) micelle, (N) nucleus,
(f) filament, (F) fibril.
predominant path changes from 1 to 4 by increasing the strength of the hydrophobic
contacts. For the P (0; 0) potential the variation is influenced by both parameters.
These results allow us to describe the distinctive aggregation pathways for the
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two potential models. For the β-unstable model P (1.0;−2.5) the micellar state is
an intermediate required for nucleating the ordered aggregation. Especially when
the monomer specific affinity is low, i.e., when the charge q is small, fibril formation
occurs via micellar intermediates. The hydrophobic interactions are essential for
the fibril nucleation step. For the β-stable P (0; 0) potential the structure inter-
conversion is kinetically fast, the monomers depositing onto an ordered aggregate
promptly convert its conformation to the β state. The elongation process is driven
by polar interactions and hydrophobic interactions play a role only in the fibril
morphology, i.e., filaments assembly.
With the values of EvdW = −1.3 kcal/mol and q = 0.34 e.u. an equilib-
rium between monomers and fibrils is reached at the final stage of the β-unstable
P (1.0;−2.5) potential simulations (Table 3). This thermodynamic behavior is an
important feature of a realistic model system. For this reason these values are
adopted for all kinetic and thermodynamic analysis in the following sections and
the main text.
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3 Supplementary methods
In this section, and the main text, values of EvdW = −1.3 kcal/mol and q = 0.34
e.u. are used for the van der Waals energy minimum and the partial charge,
respectively.
3.1 Evaluation of system kinetics
The lag phase time tlp is extracted from the exponential fitting of the time series
of the number of parallel polar contacts np (defined by Equation 4). The fitting
function is
np(t) = np(0) + [np(∞)− np(0)](1− e
−ke(t−tlp))S(t, tlp) (6)
where np(0) is the initial number of polar contacts, np(∞) the equilibrium value,
and ke the elongation rate. S(t, tlp) is a switching function that is 0 for t < tlp
and 1 for t ≥ tlp and is needed to force the function np(t) to have a constant
value for t < tlp (Figure 7). The lag phase lasts during t < tlp while the final
fibril-monomer equilibrium is established at times t > 10te when the function
np(t) exceeds 90% of its maximal value np(∞), where te = 1/ke. The elongation
occurs during tlp ≤ t ≤ 10te.
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Figure 7: Example of the fitting of a time series of the number of parallel polar
contacts np (left). Time series of the number of hydrophobic contacts nh and the
time of micelle formation tM50 (right).
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For the kinetic investigations of Sections 3.7 and 3.8 it is more appropriate to use
a slightly different definition of the lag phase time, i.e., the time needed to reach
50% of the maximal amplitude t50 [17] (Figure 7). The t50 (termed delay time
henceforth) is more robust than the lag phase time tlp, especially for nucleation
events with a short lag time. The lag phase time tlp is used only for an exact
measure of the lag phase, e.g. when thermodynamic properties at the lag phase
are investigated (Sections 3.3, 3.4 and 3.5).
The number of parallel polar contacts np is not appropriate to monitor the
nucleation kinetics of disordered aggregates such as micelles. For this purpose it
is convenient to use the number of hydrophobic contacts nh (defined in Equation
5). In analogy with t50, one can define the time of micellization t
M
50 as the time
needed to reach 50% of lag phase plateau amplitude starting from t = 0 (see
Figure 7). The tM50 time can be evaluated only for β-unstable models and at low
concentration, where the lag phase is long enough to separate the micellization
from the fibril nucleation phase. The average value of tM50 is 30 ns at C=8.5 mM
(Figure 2 in the main text).
3.2 Clustering
A clustering algorithm is used to calculate the size of the oligomeric species along
the simulations. It is based on the matrix of contactsDij between labeled monomers.
Given a single frame of the simulation Dij is equal to one if any sphere of monomer
i is closer than 6.0 A˚ to any sphere of monomer j, otherwise it is zero. Dij is
equivalent to the first neighbor matrix, d
(1)
ij . The second neighbor matrix d
(2) is
constructed from d(1) including the neighbors of the first neighbors. The converged
contact matrix d
(∞)
ij is defined by the following recursive sequence
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d
(1)
ij = Dij
d
(n)
ij =


1 if d
(n−1)
ij = 1
1 if d
(n−1)
ik = 1 and d
(n−1)
kj = 1
0 otherwise
(7)
d
(∞)
ij = lim
n→∞
d
(n)
ij
which yields a block matrix of ones and zeroes. Each block represents a cluster of
monomers and contains first-neighbors, second neighbors, third and so on. This
procedure is equivalent to a hierarchical clustering performed with a spanning tree
technique [18]. With the converged contact matrix one can identify clusters (i.e.
tagging each oligomer with an identification number), list monomers belonging to
a specific oligomer and make statistics on the size of oligomers.
3.3 Cluster size histogram
The above definition of oligomeric species allows the statistical analysis of cluster
size. The probability that a monomer is aggregated in a cluster of size N is:
p(N) = 〈
1
NT
∑
i=1,NT
δi,t(N)〉t (8)
where NT is the total number of simulated monomers, δi,t(N) is equal to 1 if the
monomer i at time t is embedded in a cluster of size N , and the angular brackets are
the time average. This function (termed cluster size distribution) can be evaluated
for the lag phase or the final monomer-fibril equilibrium. The elongation phase
cannot be analyzed by p(N) being an out of equilibrium dynamic process.
The peaks of the p(N) distribution can be interpreted as stable oligomeric
species. The monomer peak ranges from N = 1 to 7, the micellar peak from
N = 8 to 60, and the fibril peak from N = 61 to 125 (Figure 8). The height of
the peaks depends on the relative stability of the β-competent state as well as the
total monomer concentration (Figure 8). For the β-stable potential P (0; 0) the
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micelle peak is not observed at any concentration value. With incresing concen-
tration the monomer and micelle peak distributions are skewed towards high N
values because multi-monomer collisions and multi-micellar collisions, respectively,
transiently generate oligomers of a larger size.
3.4 Phase diagrams and critical concentrations
Phase diagrams of temperature T and concentration C were calculated only for the
potential P (1.0;−2.5) because of their computational demand (about 2 weeks on
80 CPUs). The probability of a monomer being in the monomeric (m), micellar
(M) and fibrillar (F) states are evaluated as cumulative sum of the probability
p(N):
pm =
7∑
N=1
p(N) (9)
pM =
60∑
N=8
p(N) (10)
pF =
125∑
N=61
p(N) (11)
In the simulated system three possible phases can coexist: monomeric, micellar
(disordered oligomer), and fibril (Figure 9). The results are robust for a monomer-
micelle threshold in the range 5-10 and a micelle-fibril threshold between 50 and
70. The C, T -diagram of the lag phase is similar to the one of the final equilibrium
for large T values, where the fibrillization is inhibited. At equilibrium one has a
triphasic diagram.
The probability distribution p(N) can be used to evaluate the critical concen-
tration of micelle formation CrM . The micelle aggregation number in the lag phase
is defined as
NM =
60∑
N=8
Nplp(N) (12)
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Figure 8: Cluster size histograms of the P (1.0;−2.5) potential (top) and P (0; 0) po-
tential (bottom) calculated in the lag phase (left) and the final equilibrium (right).
Histograms belonging to the same concentration are reported in the same row. The
z-dimension represent the relative probability.
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Figure 9: Phase diagram of the lag phase (left) and final equilibrium (right) for
the potential P (1.0;−2.5). Each color of the phase diagram is obtained by mix-
ing the red, blue and green components according to the values of the calculated
probabilities, i.e., red=pF , blue=pm, green=pM (see Equations 9, 10 and 11).
where plp is the probability function evaluated only in the lag phase (where there
is coexistence of micelles and monomers without fibrils). The number of micelles
per simulation box is NTpMN
−1
M , where the total number of simulated monomers
NT is 125. The micelle concentration CM is derived from the number of micelles
in the simulation volume. The micelle aggregation number NM and concentration
are plotted in Figure 10 as a function of the total monomer concentration C for
the potential P (1;−2.5) in the lag phase. By extrapolating a linear fit of the
concentration of micelles the critical concentration of micelle formation CrM can be
evaluated. The value is CrM =4.36 mM.
Another important observable is the critical concentration of fibril formation
CrF , that is obtained from the concentration of dispersed monomers in equilibrium
with the final fibril. The number of dispersed monomers in the simulation box at
the equilibrium phase is:
Nm = NTp
eq
m = NT
7∑
N=1
peq(N) (13)
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Figure 10: Lag phase of the P(1.0;-2.5) potential. Micelle concentration CM (red
circles) and the micelle aggregation number NM (squares) as function of the total
concentration of monomers C. The straight line is a linear fit whose parameters
are reported in the graph.
Figure 11: (Left) critical concentration of fibril formation CrF as a function of the
monomeric ∆Gβpi(1). The numbers displayed near the data points are the value of
dE for the potential P (1.0; dE). The critical concentration of micelle formation is
indicated by a dashed line. (Right) Validation of the critical concentration of fibril
formation, for the potential P (1.0;−2.5). The dispersed monomer concentration
is monitored along time for the aggregation process (filled diamonds) and along a
simulation of disaggregation started from a previously formed fibril (empty circles).
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where peq is the probability function evaluated at the equilibrium (where there is
the coexistence of monomers and fibrils). The value of CrF can be evaluated by
dividing Nm by the simulation volume. In Figure 11, C
r
F is displayed for different
monomer potentials P and plotted against relative stability of the protected state
∆Gpiβ(1) (Table 4). Smaller differences in free energy result in lower critical con-
centration. In other words β-stable models are more reactive and shift the reaction
towards the fibril formation. The critical concentration of micelle formation is al-
ways higher than the critical concentration of fibril formation; for this reason the
micelles disappear at the monomer-fibril equilibrium.
The critical concentration of fibril formation is validated by additional simu-
lations (Figure 11 right plot). The dispersed monomer concentration is evaluated
dynamically for an aggregation trajectory (potential P (1.0;−2.5), C=16.0 mM).
The final concentration is equal to the predicted critical concentration of 2.5 mM
(Figure 11 left plot, dE=-2.5). The reverse reaction is also performed to test if
such CrF value is approachable also from the disaggregation direction. A fibril, pre-
viously prepared at C=16.0 mM, is simulated at the critical concentration of fibril
formation (C=CrF=2.5 mM). The fibril progressively disassembles and the dispersed
monomer concentration increases to the value of 2.5 mM. The same combination
of forward and reverse reactions were used to experimentally test the robustness of
the critical concentration of fibril formation for the β-amyloid peptide [19].
3.5 Aggregation process
Six monomeric states can be defined as a combination of β or π, and the three
oligomeric species m, M, or F: πm, βm, πM, βM, πF, βF . As an example πF is the
state for a monomer in the π conformation within a fibril. The transition matrix
Tij(∆t) is defined as
Tij(∆t) = p(i|j,∆t) (14)
where i and j are two of the six states and p(i|j,∆t) is the conditioned probability
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Figure 12: Simplified network representation of the transition matrix Tij in the lag
phase, elongation and equilibrium time regimes. The size of the nodes represents
the state self transition Tii, and the size of the links is the cross transitions Tij
with i 6= j. Assuming the initial state πm (green) and the final state βF (blue),
blue arrows indicate the pathways leading form πm to βF and green arrows from
βF to πm. Only transitions with probability greater than 0.05 are showed. The
transition matrix is evaluated on the potential P (1;−2.5) at concentration 11.8
mM and on 15 independent simulations of 12µs each.
of jumping to the j state from state i in a time ∆t. The time ∆t is chosen as
the smallest available time in the simulation (the time of coordinate saving, 0.5
ns) to resolve the fastest events. From the simplified network representation of the
transition matrix (Figure 12) it is clear that for the potential model P (1.0;−2.5)
the lag phase consists of a micellar association equilibrium πm ↔ πM as well
as intramonomer interconversions πm ↔ βm and πM ↔ βM . Furthermore, in
the lag phase the fibril state F is mainly accessible through the micellar state M .
Therefore, in this time regime the fibril state is a transient ordered oligomer in equi-
librium with micelles. At the final equilibrium micelles are very unstable and the
main pathway is βm→ πm↔ πF ↔ βF , indicating that monomers are attached
to the fibril in the protected conformation π before assuming the amyloid confor-
mation β. Furthermore, the βm state is off-pathway. This mechanism is consistent
with kinetic experiments on radiolabeled Aβ40 peptides where the transition from
soluble to amyloid-like conformation of the peptide was suggested to be mediated
by interaction with the fibril template (dock-lock mechanism) [20]. The equilib-
rium πF ↔ βF reflects coexistence of monomers π and monomers β in the fibril.
93
Pellarin and Caflisch 27
From trajectory visualization it is clear that the conformations β and π populate
different domains of the fibril; monomers β are found mainly in the central region
of the fibril, whereas monomers π populate the disordered caps. Therefore, isolated
monomers in equilibrium with the fibril are continously attaching to and detaching
from the caps of the fibril in the β-protected conformation π. The growing phase is
regulated by monomer addition, rather than oligomer addition. Collins et al. [21],
using a combination of kinetic measures, reported a monomer addition growing for
the yeast prion.
3.6 π − β free energy difference
The aggregation number N is a natural progress variable to monitor the polymer-
ization progress of an oligomer. The clustering procedure introduced in Section
3.2, can be used to calculate the free energy difference between the state π and the
state β of a monomer belonging to an oligomer of size N :
∆Gβpi(N) = Gpi(N)−Gβ(N) = −〈kT log
(
Npi(N)
Nβ(N)
)
〉N (15)
where Npi(N) and Nβ(N) are the number of π-monomers and β-monomers, respec-
tively, present in an oligomer of size N , and the angular bracket is the average over
all oligomers of size N . This function of the number of monomers does not depend
on the concentration because it is an intrinsic property of the oligomer and inde-
pendent of the surrounding environment (Figure 13.A-B). The lack of dependence
on concentration allows the evaluation of the function ∆Gβpi using simulation data
at different values of concentration (Figure 13.C).
The models with dihedral energy difference dE < −2.5 kcal/mol are not ob-
served to nucleate, even at high concentration (C=61 mM) and long simulation
times (16 µs); their aggregation number (or cluster size) N does not exceed 60−70
(empty circles in Figure 13.C). The dE = −2.5 and −2.25 kcal/mol potentials,
which are the most β-unstable potentials still capable of fibril formation, have a
∆Gβpi(N) = 0 at N ≈ 45 and 30, respectively. Interestingly, these values roughly
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Figure 13: ∆Gβpi(N) evaluated at different concentrations (different colors and
symbols) for the potential P (1;−2.5) (A) and P (0; 0) (B). (C) Variation of the
∆Gβpi(N) evaluated for different potentials. The gray area in the background is
the normalized cluster distribution during the lag phase.
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Barrier height
Potential ∆Gβpi(1) (kcal/mol)
P (4; 0) -0.165
P (3; 0) -0.0776
P (2; 0) -0.0255
P (1; 0) 0.0844
P (0; 0) 0.101
π − β Relative stability
Potential ∆Gβpi(1) (kcal/mol)
P (1;−0.5) -0.452
P (1;−1.0) -1.05
P (1;−1.5) -1.65
P (1;−1.75) -1.94
P (1;−2.0) -2.24
P (1;−2.25) -2.54
P (1;−2.5) -2.84
P (1;−2.75) -3.16
P (1;−3.0) -3.47
P (1;−3.25) -3.77
P (1;−3.5) -4.04
Table 4: Free energy difference of isolated monomers ∆Gβpi(1) for all investigated
potential models.
correspond to the estimated nucleus sizes of 40 for the dE = −2.5 model and 27
for dE = −2.25 (see Figure 6 of the main text) indicating that the oligomeric size
N0 at which ∆Gβpi(N0) = 0 identifies thermodynamically the nucleus size, in a
way which is consistent with the probabilistic definition of nucleus exposed in Sec-
tion 3.11. Comparing the ∆Gβpi(N) and the cluster size distribution at lag phase
(Figure 13.C), it is revealed that the values of N0 for nucleating models are in the
range where the cluster size distribution has a statistically significant probability.
For nucleating β-unstable models dE = −2.5 and −2.25 kcal/mol the N0 values
are located at the micelle right tail, indicating that the nucleation step is initiated
in an oligomer with a size larger than a micelle. The values of the monomeric free
energy difference ∆Gβpi(1) show a shift to more pronounced stabilization of the π
state with slightly more negative values than dE (Table 4).
3.7 Concentration influence on kinetics of fibril formation
The time series of the number of parallel polar contacts np for different potential
models and at different concentration values are shown in Figure 15. The analysis
of the concentration dependence of the delay time t50 and the elongation rate ke is
reported in Figure 14 C-D. Potentials P (1;−2.5), P (1;−2.25), P (2; 0) and P (0; 0)
were analyzed. Elongation rate ke is evaluated by fitting with the Equation 6 the
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Figure 14: (A) Influence of the micelle concentration on the delay time t50 for β-
unstable potentials P (1.0;−2.5) and P (1.0;−2.25). The power law fits are reported
as continuous lines. The isolated data point at the lowest micelle concentration
was not used for fitting for P (1.0;−2.25). The error bars represent the minimum
and the maximum value. (B) Effect on the delay time t50 (black circles) and the
elongation rate ke (red squares) of the barrier height variation for the potential
P (Eb; 0). (C) Effect of concentration on delay time t50 for four potential models:
P (1.0;−2.5) black circles, P (1.0;−2.25) blue triangles, P (2.0; 0) green diamonds,
P (0; 0) red squares. The symbols represent the average value calculated on 15
simulations of P (1.0;−2.5) and 10 simulations (all the others). The error bars
represent the minimum and the maximum value. (D) Effect of concentration on
the elongation rate ke. Symbols and error bars as in (C).
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C (mM) P(0;0) P(2;0) P(1;-2.25) P(1;-2.5)
1.52 10/10 (3.0 µs) 10/10 (3.0 µs) n.a. n.a.
2.13 10/10 (3.0 µs) 10/10 (3.0 µs) n.a. n.a.
3.01 10/10 (1.5 µs) 10/10 (1.5 µs) n.a. n.a.
4.26 10/10 (1.5 µs) 10/10 (1.5 µs) 1/10 (6.0 µs) 0/15 (3.0 µs)
6.04 10/10 (1.5 µs) 10/10 (1.5 µs) 10/10 (6.0 µs) 0/15 (6.0 µs)
8.50 10/10 (1.5 µs) 10/10 (1.5 µs) 10/10 (6.0 µs) 10/15 (12.0 µs)
11.8 10/10 (1.5 µs) 10/10 (1.5 µs) 10/10 (6.0 µs) 15/15 (12.0 µs)
16.0 10/10 (1.5 µs) 10/10 (1.5 µs) 10/10 (6.0 µs) 15/15 (12.0 µs)
20.9 n.a. n.a. 10/10 (6.0 µs) 15/15 (3.0 µs)
25.9 n.a. n.a. 10/10 (6.0 µs) 15/15 (3.0 µs)
38.7 n.a. n.a. 10/10 (6.0 µs) 15/15 (3.0 µs)
61.5 n.a. n.a. 10/10 (6.0 µs) 10/10 (3.0 µs)
Table 5: Table of all performed simulations for the concentration analysis of figure
14.C-D. The ratios indicate the number of nucleating trajectory over the number of
independent simulations. The time reported in the brackets is the simulated time.
(n.a.) the simulations were not performed at this concentration.
np time series of 15 independent simulations for the potential P (1;−2.5), and 10
simulations for each of the remaining potentials. The delay time t50 is evaluated
from the np time series as described in Section 3.1. Some of the P (1;−2.5) runs
were prolonged up to 12 µs (30 days on an Athlon 2800 GHz) to increase the
number of nucleation events (Table 5).
The concentration dependence of the delay time and the elongation rate can be
fitted by a power law t50 = A50C
γ50 and ke = AeC
γe , respectively, where C is the to-
tal monomer concentration. Results of the fit are reported in Table 6. Interestingly,
the dependence of the rate of elongation on the concentration decreases significantly
by increasing the stability of the protected state π. The reduced concentration de-
pendence originates from competitive polymerizations, i.e., the elongation of the
fibril and the presence of micelles. Furthermore, the concentration dependence of
the delay time (γ50 6= 0) for β-unstable potentials indicates that micelles promote
the nucleation.
The nucleus sizes N∗ can be extracted from the parameter γ50, being N
∗ =
−2γ50, provided that (a) the monomer concentration changes only by addition
to and subtraction from polymers longer than the seed, (b) polymer formation by
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Potential A50 γ50 Ae γe A
∗
50 γ
∗
50
P(0;0) 2.73 -2.52 2.34 1.32 - -
P(2;0) 1.75 -2.40 2.32 1.29 - -
P(1;-2.25) 1.93 -0.916 2.24 0.409 0.104 -0.680
P(1;-2.5) 225.8 -1.80 2.45 0.258 0.708 -1.02
Table 6: Resulting fit parameters of the power law regression for the concentration
dependence of kinetic observables. The delay time t50 and the elongation rate ke
were fitted for C greater that 8.5 mM for the P (1.0;−2.25) potential (see Fig-
ure 14.C-D). The values of A∗50 and γ
∗
50 were obtained by fitting to the micelle
concentration (Figure 14.A).
seed production is irreversible, and (c) the seed precursor is in pre-equilibrium with
monomers [22]. These three assumptions are valid for β-stable models where only
fibril and monomer species are produced, as demonstrated in Section 3.3. For
P (0; 0) the nucleus size N∗ is about 5, a value close to the one calculated with
the probability of fibril formation (see Section 3.11 and Figure 6 of the main text).
β-stable models, involving a small nucleus size, share the downhill polymerization
mechanism described for the partially denaturated transthyretin [17]. On the other
hand, the β-unstable models show a strong cohexistence of micellar and fibrillar
oligomers in the lag and the elongation phases (see Section 3.5), therefore the
hypothesis (a) cannot be fulfilled. Assuming that the nucleation process is first
order to the micelle concentration, one can fit the delay time with a power law
t50 = A
∗
50C
γ∗50
M , where CM is the micelle concentration (see Figure 14.A and Section
3.4 for micelle concentration evaluation). The nucleus size N∗ = −2γ∗50, expressed
in micelle units, is 1.36 for P (1.0;−2.25) and 2.04 for P (1.0;−2.5). Given the
average aggregation number per micelle of 17.5 at C = 8.5 mM (see Figure 10) a
value of 23.8 monomers and 35.7 monomers involved in the nucleation is obtained
for P (1.0;−2.25) and P (1.0;−2.5), respectively. Strikingly, very similar values are
obtained using the probability of fibril formation (see Figure 6 of the main text).
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Figure 16: Stability, i.e., π-β free energy difference (A) and barrier (B) influence
on the time series of the number of parallel polar contacts np normalized to the
maximum value which corresponds to fibril. In plot (A) each row corresponds to a
different value of dE (with constant Eb of 1.0 kcal/mol) while in plot (B) each row
corresponds to a different value of Eb with constant dE = 0 kcal/mol.
3.8 Monomer energy landscape influence on the kinetics of
fibril formation
To monitor the effects of the monomer energy surface a series of runs were per-
formed at the concentration of 8.5mM. The left plot of Figure 16 displays the
change of kinetics upon variation of the stability of the β-state without changing
the β → π barrier Eb. The resulting rates and lag phase times are reported in
Figure 2 of the main text. The right plot of Figure 16 shows the effects of variation
of the barrier, keeping constant the stability of the β-state (see also Figure 14.B).
No appreciable trend for the elongation and nucleation kinetics is observed for dif-
ferent values of Eb. These simulation results indicate that the aggregation kinetics
of the model are mainly influenced by the relative stability of the β-aggregation
prone state with negligible contribution of the β → π barrier.
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3.9 Pathways of oligomeric aggregation
Since individual oligomers change their composition of monomers (i.e., in a given
time interval an oligomer can absorb or release monomers to the solvent), it is
crucial to define criteria for identifying oligomers along the simulation. Given the
converged contact matrix at time t, d(∞)(t), all oligomers at time t can be labeled:
At1, A
t
2, ..., A
t
nt , where nt is the number of oligomers. Each oligomer A
t
k has a size
N tk and contains a list of tagged monomers m
1,t
k , m
2,t
k , ..., m
Nt
k
,t
k . The time evolution
of a single oligomer Atk at time t + τ is evaluated by comparing the monomer
composition of every single oligomer present at time t+ τ . The similarity between
two oligomers is defined as
S(Atk, A
t+τ
l ) =
∑
i=1,Nt
k
∑
j=1,Nt+τ
l
δ(mi,tk , m
j,t+τ
l ) (16)
where δ is the Kronecker function which is 1 if the compared monomers are the
same. The time evolution At+τk′ of oligomer A
t
k is defined as the oligomer with
highest similarity:
S(Atk, A
t+τ
k′ ) = max
l=1,nt+τ
(S(Atk, A
t+τ
l )) (17)
If two or more At+τk′ fulfill this equation, then the first labeled oligomer is chosen.
Atk is then forwardly linked to A
t+τ
k′ , or equivalently A
t+τ
k′ is assigned to the temporal
successor of Atk. It is worth noting that:
1) the temporal successor of an oligomer at time t is the oligomer at time t+ τ
that shares the highest number of monomers;
2) each oligomer can have a single temporal successor;
3) many oligomers can be forwardly linked to the same successor.
By iterating this procedure, one can build the pathway of individual oligomers.
Thus, the simulation trajectory is mapped to a network of temporally linked nodes
(oligomers).
One natural definition for τ is the time difference between frames of the sim-
102
Pellarin and Caflisch 36
ulation, in our case τ = 0.5ns, so that τ is smaller than the average life time of
oligomers. The life time of an oligomer is the time needed to completely recycle
monomers or to dissolve the oligomer. If this requirement for the time τ is not
fulfilled the similarity can be ill-defined. Fibrils have a life time that is by far
larger than τ being in the microsecond timescale (see Section 4.1). Metastable
oligomers such as disordered aggregates or micelles have an estimated life time in
the ten-nanoseconds scale. Unstable oligomers created by occasional collision of
monomers have a life time slightly larger than τ .
3.10 β-subdomains time evolution and nucleus definition.
An important issue is the quantitative characterization of the nucleus. In literature,
a nucleus is often defined as the smallest marginally stable structured aggregate [6].
In the framework of MD simulations a useful definition would be the oligomer that
has the same probability to either progress to a fibril or regress to the disordered
state. An analogous definition was applied to the folding transition state ensem-
ble of two-state folders [23]. Using only the aggregation number N to distinguish
the oligomers, this definition is problematic since an oligomer of given size can
have a high morphological heterogeneity. It can contain no ordered aggregates,
one subdomain ordered, two disjoint subdomains, and even more complicated fea-
tures. A β-subdomain is a portion of the oligomer made of interacting β-monomers
and the surrounding π-monomers can be considered as a local perturbation on the
β-domains. With the previous nucleus definition it is possible to follow the dy-
namic evolution of β-subdomains in the context of their constituting oligomers.
As a consequence the similarity procedure explained in Section 3.9 is applied to
β-monomers only to identify the pathways of β-subdomains.
We define as progress variable of the ordered polymerization process, the ag-
gregation number of the β-subdomain:
N(Atk) = N
t
k (18)
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where now Atk is an oligomer containing only β-monomers. A single trajectory is
a collection of many independent pathways for the labeled β-subdomains (Figure
17). The pathway (A) is an unproductive event; first a β region appears in a π-
only oligomer, it persists for a period of time, and disappears. (B) is a productive
event; the appeared β-region spreads irreversibly into a fibril. Oligomers and their
β-subdomains can interact in many different ways. Pathway (C) is a merging
event while in (D) a β-region splitting is depicted. Pathway (E) is a combination
of merging and division, while (F) is an interaction between oligomers that does
not involve their β-subdomains.
Figure 17: Classification of different pathways. The light gray regions schematize
an oligomer, while the dark gray regions are the included β-subdomains. Bold
arrows indicate the time evolution of entire oligomers, while the thin arrows are the
time evolution of β-subdomains as defined by the similarity procedure (Equations
16 and 17). In the pathway example at the bottom, the dynamic evolution of an
entire cluster (blue circles) and its β-subdomains (black dots) is depicted. Gray
shaded regions are clusters interacting with the blue one.
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3.11 Pathways analysis and probability of fibril formation
It is convenient to include an abstract state A0, whose aggregation number is zero,
to describe the beginning or the end of β-subdomain pathways. Another important
state is the fibril state AF ; it is defined as the β-subdomain with aggregation num-
ber greater than 60. Given A0 and AF , an unproductive pathway is the trajectory
of a β-subdomain that starts from A0, and returns back to A0, while a productive
pathway is the trajectory of a β-subdomain that starts from A0 and ends with the
fibril state AF . In the example of Figure 17, P1, P2 and P3 are unproductive
while P4, P5 and P6 are productive. Given a set of trajectories, one can collect
all productive and unproductive pathways Pi and define the probability of fibril
formation of a β-subdomain ANβ of size Nβ as
pFf(Nβ) =
1
M(ANβ )
∑
Pi∋ANβ
F (Pi) (19)
where M(ANβ ) is the number of times that an aggregate of size Nβ occurred in the
simulations set. The sum runs over all Pis pathways that contain an aggregate ANβ ,
and F (Pi) is equal to 1 if the pathway Pi is productive, and is 0 otherwise. In this
way the nucleus is unequivocally defined as the oligomer containing a β-subdomain
of size N∗β with a probability of fibril formation pFf(N
∗
β) equal to 0.5.
To finally characterize the nucleus it is useful to calculate its total aggregation
number N∗. The average number of β-monomers as a function of the oligomer size
N can be obtained by taking the exponential function on both side of Equation 15:
Nβ(N)
Npi(N)
= exp
[
∆Gβpi(N)
kT
]
(20)
Using the fact that Npi(N) = N −Nβ(N) one has
Nβ(N) =
N exp [kT−1∆Gβpi(N)]
1 + exp [kT−1∆Gβpi(N)]
(21)
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the average aggregation number N of an oligomer containing a β-subdomain with
size Nβ is obtained by numerical inversion of the function Nβ(N), N = N(Nβ)
(Figure 6 of the main text), and the nucleus aggregation number is N∗ = N(N∗β ).
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4 Supplementary analysis
4.1 Molecular Recycling
A molecular recycling mechanism has been observed by a combination of NMR
spectroscopy and mass spectroscopy for an amyloid fibril formed from an SH3 do-
main [24]. To evaluate the recycling time of the coarse-grained model, simulations
of mature fibrils in equilibrium with dispersed monomers are analyzed for the po-
tential P (1.0;−2.5) at all concentration values. The number of the unrecycled
monomers Nu(t) is defined as follows. First, all monomers belonging to the fibril
at time t = 0 are labeled and counted. Then, at all times t > 0 the monomers
that never detached from the fibril are counted and the resulting number is Nu(t).
In two of nine simulations, Nu(t) goes to zero within 4 µs, which shows that all
monomers initially belonging to the fibril have been recycled (Figure 18).
The number of unrecycled monomers Nu(t) can be fitted with an exponential
function:
Figure 18: Number of unrecycled monomers Nu as a function of time for nine sim-
ulations started from a preformed equilibrated fibril. Simulations were performed
at total concentration C = 16.0 mM and for the potential P (1.0;−2.5). The values
of decay time τ at different concentrations are reported in the inset.
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Nu(t) = Nu(0)e
−t/τ (22)
where Nu(0) is the initial value of monomers belonging to the fibril and τ is the
time for the decay. In the inset of Figure 18, τ values for all concentrations and
all independent simulations are reported. The decay times do not depend on the
total concentration at which the fibril was formed.
4.2 Seeding
Fibril formation generally occurs via nucleation-dependent oligomerization with a
lag time required for nucleus formation. This lag time can be abolished by using
a seed, i.e., a small preformed fibril. To further evaluate the coarse-grained model
and to validate the nucleus definition of Section 3.10, a seeding experiment is
performed in silico. For the potential P (1.0;−2.5) the smallest oligomer with high
Figure 19: Number of polar contacts np along the time for a spontaneous (red line)
and seeded trajectory both at 8.5 mM and P (1.0;−2.5) potential. The unseeded
simulation shown here is the fastest nucleation observed at this concentration while
nucleation in the other runs are about one order of magnitude slower (see Figure
16 left). The spontaneous trajectory reaches a plateau at about 225 polar contacts
because it was run with 125 monomers, whereas the seeded trajectory was run with
a total of 1000 monomers.
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probability of fibril formation is isolated from a trajectory at 38.7 mM. This post-
critical oligomer consists of 60 monomers and has a probability of fibril formation
of 98% according to the definition of Section 3.10 and to Figure 4 of the main
text. The oligomer is introduced in a box with 940 dispersed monomers at a
total concentration of 8.5 mM. This is the lowest concentration that displayed a
nucleation for this potential (see Figure 15 and Table 5). The average lag phase for
the spontaneous nucleation is around 5 µs (see Figure 14.C) and the minimal lag
phase time observed is 0.4 µs (Figure 19). Strikingly, the lag phase is completely
abolished in the seeded simulation (Figures 19 and 20).
On the other hand for the P (0; 0) potential seeding does not influence the
kinetics (data not shown), as expected for downhill polymerization [17].
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Figure 20: Six illustrative snapshots of the seeding trajectory. At the start (t = 0
ns) there are 60 monomers in the post-critical oligomer (i.e. the seed) and 940
monodispersed monomers. The total concentration is 8.5 mM. Within the first 50
ns micelles are nucleated, and progressively disappear during the fibril elongation
phase.
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7 Computer-aided stabilization of the hydrophobic core
of a consensus designed repeat protein.
Globular soluble proteins usually fold into a compact structure where hydrophobic side-
chains are partitioned in the interior and polar residue exposed on the surface of the
molecule. The force that drives a disordered polypeptide to achieve a collapsed structure
is called the hydrophobic effect [76, 77]. Crystal structures of proteins display tightly
packed side-chains in the core, an arrangement that provides a favorable van der Waals
energy. However, even a tight packing is not robust upon mutagenesis: a single mutation
in the inside of the protein can be highly destabilizing and might force the protein to
adopt many alternative conformations with similar energies. Under these conditions,
if the secondary structure of the mutated protein is preserved, then it is said that the
protein has molten globule-like features. A molten globule [78, 79] is a particular state
that characterize proteins under mildly denaturing conditions. They are characterized
by a compact state and a ”fluid” hydrophobic core, lacking specific native interactions.
Presence of secondary structure, poor signal dispersion in NMR spectra and high affinity
for hydrophobic dyes are typical molten globule features, indicating an intermediate
behavior between folded and unstructured proteins [80]. The unfolding reaction scheme
expressed by equation (1) can be generalized in presence of a on-pathway intermediate:
F ⇋ I ⇋ U (9)
Transition from a denaturated state U to a molten globule I is thought to be a contin-
uous transition, lacking of cooperativity. Conformational stability of proteins, measured
by thermal denaturation, can also be triggered by mutations of aliphatic amino acids
that are in the hydrophobic core [81]. In this work the hydrophobic optimization of a
consensus designed armadillo repeat protein (see section 7.1) that shows molten-globule
characteristics, is approached using a structure-based engineering, with the aim of pro-
ducing a modular protein with specific binding properties [82]. Consensus design is a
statistical analysis of sequence alignments of families of homologous proteins, which is
used to improve stability of proteins with respect to the natural sequences [83]. One dif-
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Figure 5: Left: employed scaffold for the computational design. The blue ribbon is the
unit repeated module. Right: thermal stability of wild type (blue) vs selected mutant
(red). CD ellipticity at 222 nm is measured at different temperatures.
ficulty in the de novo protein design is achieving the side chain packing needed to create
a stable native state. It has been reported that consensus design might seldom fail in the
engineering of hydrophobic cores [84] leading to structures that have loose activity, or
are prone to aggregate.
A number of computational techniques have been employed for protein engineer-
ing [85, 86], especially in the design of the hydrophobic core [87, 88]. The final task of
computer-aided protein design is to search, within a selected conformational space of
the protein, the global energy minimum. The efficiency of this search is limited by the
number of high energy minima, which increases exponentially with the protein size. In
the case presented in section 7.1, due to the size of the system (about 600 residues), a
number of approximations were necessary. A restricted pool of 432 hydrophobic core
mutants were selected, using the most frequent amino acid substitutions of the consen-
sus rank. The calculations have been executed on three scaffolds adapted from X-ray
structures (see figure 5), in vacuum. For each mutant a random sampling of the inner
side-chains rotamers was performed, and the force field energy was used to evaluate
and rank every single mutant. Therefore the 20 most promising mutants were employed
for further experimental investigation. One of these mutations considerably enhanced
the wild type stability, displaying a greater solubility, compactness, secondary structure,
folding cooperativity (see figure 5) and a broad NMR spectra. The overall performance
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of the computational design is very high, in fact all of the 20 highest ranked mutants
show equal or better characteristics than the wild type.
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7.1 Designed armadillo repeat proteins as general peptide-binding
scaffolds: consensus design and computational optimization of
the hydrophobic core [J. Mol. Biol. 2008, 376, 1282]
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8 A fast implicit solvent model for proteins and lipids
A class of membrane-associated peptides are observed to assume regular secondary
structure upon binding to lipid membranes. This process is the basis for all mecha-
nisms of action of toxins and microbial peptides, and it is essential for the stability of
membrane proteins [89]. Furthermore understanding the interactions that determine pep-
tide orientation and stability within membrane might help the engineering of membrane
protein [90]. Partitioning and folding of a membrane-associated peptides may be repre-
sented by a thermodynamic cycle, which generalizes the two state folding equilibrium
expressed by the kinetic scheme (1):
U ←→ F
l l
U∗ ←→ F ∗
where states F and F ∗ are the membrane unbound and membrane bound folded forms
respectively, and the states U and U∗ are the unfolded ones. The states F and U∗ are
marginally populated, therefore only the equilibrium U ←→ F ∗ is observed in experi-
ments [91]. Nevertheless, structural characterization of the intermediate states and the
interaction that drives the membrane association and folding are fundamental for the
reasons mentioned above.
The aim of the work exposed in section 8.1 is to simulate the association and the
folding of the amphipathic melittin peptide in presence of detergent micelles, in analogy
with experiments. To achieve this task a new implicit solvent , which overcome some
limitations of the models currently used, has been developed. The solvation model de-
scribed by eq. (6) has the drawback that it doesn’t include formal charges. Furthermore
surface tension parameters σi don’t have a precise physical meaning, which leads to pa-
rameterization difficulties. For these reasons a novel model based on solvent accessible
surface has been developed. Here the polar and the non polar surfaces contributions
are uncoupled, and the polar term is derived from first shell approximation of solvation
energy of a charge q, as described in section 8.1:
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Gsolv = σnp
∑
i
Si + σp
∑
i
(
q2i
Ri + rp
Si
Sfreei
)
The advantage of this form for the solvation energy is that the parameters acquires a
physical meaning: σnp is the non-polar surface tension of the molecule, and σp is the
polar surface tension.
Using this implicit model of aqueous solvent, molecular dynamics simulations of
melittin in presence of explicit dodecylphosphocholine were performed to investigate
how the micelle environment influences melittin structure. Both constant temperature
and replica exchange approaches were adopted (see section 3.2.2). In the former sim-
ulations, reversible transitions from unstructured conformations to helical fold, when
melittin is bound to the micelle, were reproduced. In the latter it was found that a spe-
cific number of lipids are needed to stabilize the helical fold. The simulation results
confirmed the proposed structural model of melittin-micelle complex, supporting a solid
microscopic view of helical formation.
Figure 6: Left: representative melittin structure in DPC micelle obtained by simula-
tion. Right: schematic of the amino acids partitioning into the micelle environments:
headgroup phosphates coordinating with melittin sidechains are represented by a yellow
circle, choline nitrogens coordinating with backbone in the kink region are represented
in blue.
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8.1 Folding of Helical Peptide at the Micelle-Water Interface. [Manuscript
in preparation].
156
157
Folding of helical peptide at the micelle-water
interface
Riccardo Pellarin and Amedeo Caflisch
Department of Biochemistry
University of Zu¨rich
Winterthurerstrasse 190
CH-8057 Zu¨rich, Switzerland
Phone: (+41 44) 635 55 21
FAX: (+41 44) 635 68 62
email: pellarin@bioc.unizh.ch
July 4, 2007
158
Abstract
Lipid micelles, as well as membranes, are known to strongly promote secondary
structure formation in a wide range of membrane active peptides. This process is
the basis for a variety of fundamental biological functions, including signal trans-
duction, toxicity and folding of membrane protein. However, little is known on
the detailed mechanisms and the driving forces underlying this process. Among
many different peptides which associate to membranes, melittin is the most inves-
tigated one. It is largely unstructured when free in solution, but clearly adopts
an amphipathic α-helical conformation when partitioned into membranes [1]. In
this work molecular dynamics simulations are used to investigate the interaction
and the folding of melittin at the dodecyl-phosphocholine (DPC) micelle surface.
An implicit solvent model with explicit lipid molecules and peptide, allows the
microsecond time scale sampling, capturing reversible folding events of the heli-
cal peptide. Both constant temperature and replica exchange simulations results
mostly agrees with present structural models of melittin-membrane interactions,
supporting a solid microscopic view of helix formation on membrane surface.
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1 Introduction
Membrane associated peptides form a wide class of molecules that includes se-
quences known to be toxic or functionally relevant for the cell. Furthermore
this class of peptides has been adopted as a model for large membrane proteins,
and their investigation contributes to the understanding of the mechanisms of
membrane-proteins interactions. Melittin, the major component of the honey bee
Apis mellifera venom, is one of the best known member of this class. It is a 26
amino acids peptide which has a potent hemolytic activity and induces membrane
leakage [2, 3]. Melittin is strongly amphipathic, a feature that characterizes many
membrane active peptides such as hormones [4, 5], antibiotics [6, 7] or designed
sequences [8]. Its sequence is:
+GIGAVLKVLT10TGLPALISWI20KRKRQQ-NH2
where the bold residue letters are the charged residues. It is a strongly basic
sequence with six positive charges; the N-terminal amino group, Lys at position 7
and four charges in the highly basic C-terminal segment.
Structural investigations of this peptide have been performed in several condi-
tions. Melittin in aqueous solution is monomeric with a 1H-NMR spectrum close to
random coil, though fragments of the polypeptide chain might adopt non-random
spatial strucure [9, 10].
The high resolution structure of melittin has been resolved by X-ray crystallog-
raphy [11, 12] starting from aqueous solution under strong ionic conditions, where
melittin adopts a homotetramer oligomeric form. In the crystal melittin is mostly
α-helical (see figure 1 left) with just the exception of proline 14, which missing the
amide that ideally interacts with Thr-10 carbonyl, breaks the α-helical structure.
Hence the helix is kinked, and the axes of the two sub-helices, defined by residues
1-10 and 16-26, intersect with an angle of about 120 degrees.
Structures of monomeric melittin in methanol and in dodecylphosphocholine
micelles have been determined using proton NMR and amide exchange analysis.
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In methanol melittin is monomeric and α-helical [3]. The kink angle in this case,
of 160 degrees, is considerably larger than the value found for the crystal [13]. In
presence of perdeuterated phosphatidylcholine micelles melittin is still α-helical,
with an estimated kink of 135 degrees [14]. Amides on the hydrophobic side of
the amphipathic helix show the largest chemical shift changes compared with the
amides of melittin in methanol, and the slowest rates, supporting a surface location
for the peptide with the non-polar side of the helix facing the micelle interior. In
magnetically oriented DMPC bilayer, the conformation orientation and dynamics
of melittin have been determinad using NMR spectroscopy [15], where the peptide
was found to adopt a transmembrane α-helical conformation, with a kink angle of
140-160 degrees. In fluorinated alcohols melittin shows a kink angle of 73 degrees
[16], while in hexafluoroacetone the structure is closest to the crystal and micellar
structure, displaying a kink of 144 degrees [17].
Pro-14, in the hinge region between the two helical segments, is believed to
have a particular structural role [18]. The proline ring produces steric hindrance to
the straight α-helical conformation as a result of not having a NH group available
for a hydrogen bond. In fact substitution of L-Pro with its diasteroisomer D-Pro
contributes to increase the misaaligniament of the hydrophobic faces of the helix,
and sensibly reduced the hemolitic activity. NMR structural analysis [19] provided
structural models for D-melittin.
The molecular mechanism of melittin-induced cell lysis is controversial, due to
instrinsic difficulties in characterizing the interactions between the peptide and the
membrane. Thanks to the atomistic details of molecular dynamics, the knowledge
in this field has been broaden. Explicit solvent molecular dynamics of membrane
proteins [20–23] and peptides [24,25] has the great advantage of having an accurate
force field. A number of fully atomistic molecular dynamics simulations of melit-
tin have been performed in different solvents [26], in bilayers [26–28] or in pore
forming oligomers [29] and evidentiate conformational changes and orientation in
membrane of the peptide. Some investigators have studied the configuration and
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Figure 1: Left: X-ray structure of melittin in tetrameric form [12]. Right: repre-
sentative melittin structure in DPC micelle from simulations. DPC molecules are
diplayed as a surface, the carbons of the tail are colored in gray, while the choline
and the phosphate are blue and red respectively.
the stability of a single membrane pore bound by four melittin molecules in a fully
hydrated membrane (Jung-Hsin and Baumgartner Biophys Journal vol 78 2000
1714). Fully atomistic simulations revealed the complexity behind polypeptide
chain and specific lipid components interactions. Yet, explicit solvent simulation
is limited in conformational sampling, especially for slow events such as peptide
binding and folding. Many theoretical works on membrane proteins propose the
implicit treatment of a membrane bilayer [30–33]. The membrane is modelled as
a region with low dielectric continuum, and the interaction with the solute are
included into the force field using a mean field approximation. These models are
very efficient in terms of calculations, but might be innaccurate, underestimating
relevant interactions between proteins and lipids. Membrane insertion of peptides
has been intesively investigated using molecular mechanics methods.
The present study was motivated by two main questions: Is it possible to sim-
ulate the spontaneous folding of melittin into a micelle environment? Can we
reproduce the structural models of melittin? We developed an efficent implicit
water model with explicit lipids that has an intermediate accuracy between the
explicit water and the totally implicit models. This solvation model, explained in
the methods part, extends the SASA models largely adopted for small peptides
folding, by including formal charges and lipid molecules. The molecular dynamics
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simulations were in the microsecond timescale, an essential time lapse to capture
the slow transitions that lead to the helical conformation. Results from constant
temperature and replica exchange simulations are in good agreement with the ex-
perimental observations.
2 Results
Constant temperature simulations. Simulations at a temperature of 330 K
have been performed with and without lipids. The simulation results in the absence
of lipids are needed to compare the structural changes induced by melittin-lipid
interactions.
Melittin in pure solvent. At 330 K, in pure solvent, melittin has a tendency
to form helical structures, but the central region (around the proline 14) is rather
unstructured, confering flexibility to the whole peptide. During the 1 µs simulation
the sampled conformations are distant from the X-ray structure, as confirmed by
rmsd analysis displayed in figure 2A. The average RMSD value is 6 A˚, and the kink
angle, measured as the instantenous angle between the axis of the helices formed
in the segment 1-14 and 15-26, highly fluctuates in the range 0-180. The helical
contacts analysis reveals a small propensity to form hydrogen bonds in the proline
region. Helical contacts between residues 11 and 15, and 12 and 16 are never
formed during the simulation. Under these conditions, melittin does not assume
any preferential structure, as shown by conformational clustering analysis using
fingerprints of contacts and kink angle, as described in the methods part. The
cluster with the highest number of visits is just marginally populated, with only
4% of the saved snapshots. The sampled conformations have a high helical kink,
mainly produced by hydrophobic collapse.
Folding of melittin in micelle. Three 0.5 µs long simulations were started
froma fully extended conformation of melittin surrounded by 40 monodispersed
DPC molecules at the temperature of 330 K. The concentration of DPC is 4·10−5
DPC/A˚3. In the early steps of the simulation the lipids aggregate, and within 10
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Figure 2: Melittin in pure solvent: (A) Time series of the Cα-RMSD with respect
to the X-ray structure of figure 1 left. The kink angle is measured as described in
the methods part. The helical contacts between residue i and i+4, described in the
methods part, are represented by a red dot. (B) Most populated cluster in pure
solvent (4%). (C) second most populated cluster in pure solvent (1%).
ns a spherical micelle is spontaneously produced. As described in the methods
part, the micelle structure consists of an hydrophobic core, that hosts the lipid
tails, and a hydrophilic surface, consisting of phosphate and choline moieties (see
figure 12). Within the first 50 ns the peptide reaches the micelle, and binds onto
the micelle surface. The time series of the Cα-RMSD with respect to the X-ray
structure, helical contacts and the kink angle is showed in figure 3A. In the time
intervals emphasized in gray in figure 3A, the Cα-RMSD with respect to the crystal
structure is less than 4.0 A˚ , and the kink angle has a well defined value of 140±20
degrees, a range that agrees with the 135 ± 15 found in micelle using 2D-NMR
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and distance geometry calculations [14]. The helical contacts analysis displayed in
figure 3 confirms that the peptide has a full helical conformation, which extends
also in the Pro-14 region. On the contrary to what happens in pure solvent, in
presence of lipids the contacts between residues 11 and 15 and residues 12 and 16
are formed. The most populated cluster, 25 %, represented in figure 3B and 3C, is
a collection of helical structures with different kink angles.
Figure 3: Melittin in DPC micelle: (A) Time series of the Cα rmsd with respect
to the X-ray structure, the kink angle value and the helical contacts. (B) Most
populated cluster (25 %), fitted at the C-terminal. (C) Most populated cluster,
fitted at the N-terminal.
Melittin in micelle: interactions with lipid moieties. The structures
belonging to the most populated cluster were analized in detail. In figure 4 the
histogram of melittin-micelle atomic interactions is reported. The solvent explosure
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is distributed inhomogeneously along the sequence. Segment from 21 to 26, and the
N terminal segment, are more exposed to the aqueous solvent than the hydrophobic
region 8-20. Among the residues belonging to this segment Val-8, Leu-9, Leu-13,
Leu-16, Ile-17, Trp-19 and Ile-20 are deeply inserted in the hydrophobic core of
the micelle, reflecting an amphipathic distribution of sidechains around the helix.
Trp-19 displays a very high propensity to interacts with the different moieties of
the DPC molecules, and in particular with the phosphate groups and the carbon
groups. Therefore, Trp-19 is partitioned at the surface-bulk phase of the micelle,
a motif common to many integral membrane proteins, and confirmed by NMR
measurements of Trp-analogues interacting with phosphatidylcholine membranes
[34]. Lysines interact preferentially with phosphates, more than arginines. In
figure 5 the cylindrical projection of selected atomic distributions around the helix
surface is reported. Here is evident that phosphates coordinates close to lysine
sidechains, while choline preferentially coordinates with peptide moieties at the
Pro-14 region.
Melittin in micelle: peptide orientation. Amide exchange analysis [35] of
melittin in fully hydrated phospholipid bilayers reveals that the helix is oriented
with the hydrophobic face directed toward the interior of the membrane. More
recently vibrational spectroscopy studies [36] evidenciated that melittin might have
both transbilayer and parallel orientation, with a preference for the parallel one.
In DPC micelle, using spin labeling and 1H NMR [37], melittin is located at the
surface.
Lysines are exposed to the solvent and interact with phosphate groups, while
the hydrophobic sidechains contact with the lipid carbon tails. N terminal amino
group is completely exposed. These results enforce the view that folded melittin
is located at the surface of the micelle, i.e., micelle/water interface (as depicted in
figure 1 right).
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Figure 4: Histograms of melittin-micelle interactions calculated on the most popu-
lated cluster of structures. The X-axis is the atom number. Residues are labelled
from the N terminal to the C terminal.
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Figure 5: Cylindrical projection of the atomic distribution probabilities around the
folded helical conformation. Y-axis is the position along the helical axis, X-axis
is the angular position. The blue dotted lines are drawn to help the eye. The
red circles represent the average positions of charged moities of the Arg and Lys
sidechains (guanidinium and ammonium for Arg and Lys respectively). Darker
colors are higher probabilities. Left: distribution of Cα atoms, residues are labeled
here and in the other two projections. Center: choline distributions, in red the
positions of the positively charged sidechains. Right: phosphate distributions.
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Replica exchange simulations. 0.5 µs replica exchange simulation at three
different melittin/DPC concentration ratios 1/30, 1/40 and 1/50 were performed,
keeping the same lipid concentration of 4 · 10−5 DPC/A˚3 for all simulations. Four-
teen replicas were used (290 K to 390 K). The α-helical content increases with the
size of the micelle to which is bound (figure 8). The native content (α-Helix+Kink)
has a maximum at 30-40 DPCs (figure 7). The unbound peptide is fairly random
coil (loop+turn+coil), in agreement with the experimental observations [1]. A
native-like conformation prefers a size of 30-40 lipids. There is a deep minimum at
the folded conformation only with a bound micelle of 30-40 lipids. This is consistent
with NMR measurements [38].
The micelle environment influences the helical fold and viceversa.
Stuctural features of micelle-bound melittin have been investigated using 1H NMR,
ultracentrifugation, and circular dichroism [38]. It was reported that stoichiometry
of the melittin-DPC complex is about 1 peptide and 32±10 detergent molecules.
Being the kink angle similar for crystalline state, methanolic solution and micelles,
it was proposed that micelles conform to melittin structure, rather than the melittin
conform to the curvature of the micelle [39].
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Figure 6: Histograms of the native helical contacts calculated at different micelle
size and temperature. Three representative temperatures, i.e., 290, 341 and 390,
are shown as red lines.
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Figure 7: Contour plots of the populations of conformers with given kink angle
(Y=axis) and α-helical percentage (X-axis) at three different aggregation size of
the associated micelle.
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Figure 8: Secondary structure of melittin at 311 K, as a function of the number of
associated lipids
3 Conclusions
Molecular dynamics simulations of the melittin peptide in presence of explicit DPC
and an implicit model of aqueous solvent were carried out to investigate how micelle
environment influences the structure of melittin. Constant temperature molecu-
lar dynamics reproduce a reversible transition from unstructured conformations to
stable helical fold when melittin is bound to the micelle. Replica exchange sim-
ulations revealed that the the micelle aggregation number needed to stabilize the
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helix conformation is between 30 to 40 lipids, a number that provides a perfect
match between the hydrophobic portion of the helix and the hydrophobic core of
the micelle.
The structural model of melittin that emerges from these simulations agrees
with experimental data. The triptophan residue partitioning has been intesively
investigated for many sequences. It is postulated that tryptophan-phosphocholine
interaction may mediate important peptide conformational changes [40]. Model
system consisting of phosphocholine lipids and α-helical peptides were employed to
investigate the partitioning of Trp residues and Lys using a full range of biophysical
experiments [41]. A functional role of Trp residues has been postulated [42], where
these residues are involved in the translocation of protein through the membrane
and that following translocation, Trp residues serve as anchors on the periplasmic
side of the membrane.
Trp residues displace at the lipid carbonyl region, while Lys prefer to be lo-
cated closer to the aqueous phase, near the lipid phosphate group. Interactions
between positively charged amino-acids and phosphate group of phospholipid has
been observed in a multinanosecond simulation of the N-terminal region of human
pulmunary surfactant protein-B in DPPC monolayers ( [43] and in Palmitic acid
monolayer [44]. Spin labeling experiments at lysine positions 7, 21 and 23 assign
an apparent order of accessibility to these residues, which ranks 23 < N < 21 <
7 [45].
In this work, an efficient model was developed for use with explicit lipid molecules.
It has allowed the exploration in the microsecond timescale. Explicit treatment of
lipids is important for correct peptide behaviour. Possible applications are the ag-
gregation and equilibration of lipids or surfactants on membrane proteins, and the
association of TM helices.
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to mellittin in the three REM simulations.
4 Methods
Simulation protocols. All simulations presented in this work were done with the
CHARMM program [46]. Constant temperature molecular dynamics have been
performed using Langevin integrator with a friction of 0.15 ps−1 with periodic
boundary conditions. Replica exchange simulations were set up according to the
protocols described by Rao et al. [47]. In all simulations the starting conformation
of melittin was completely extended, and lipids were monodispersed. The peptide
was modeled by explicitly considering all heavy atoms and the hydrogen atoms
bound to nitrogen or oxygen atoms (PARAM19 force field [46]. The CHARMM
PARAM19 default cutoffs for long range interactions were used, i.e., a shift function
[46] was employed with a cutoff at 7.5 A˚ for both the electrostatic and van der Waals
terms. This cutoff length was chosen to be consistent with the parameterization of
the force-field and implicit solvation model.
For both REMD and constant temperature MD, the SHAKE algorithm was
used to fix the length of the covalent bonds involving hydrogen atoms, which allows
an integration time step of 2 fs. Furthermore, the nonbonded interactions were
updated every 10 dynamics steps and coordinate frames were saved every 20 ps for
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a total of 5 · 104 conformations/µs. A 1 µs run requires approximately 4 weeks on
a 2.0 GHz Athlon processor.
Dihedral Potential for DPC alkane chain. As an united atom force field
has not been developed for lipids in CHARMM, it has been necessary to include
it into the standard PARAM19. United atom dihedral potential V ′φ for the alkane
(CH2)4 chains, i.e. the dihedral potential that accounts for hydrogen presence,
was derived from the all-atoms atoms CHARMM force field PARAM27 [48] using
a coarse graining procedure:
V ′φ(R) + V
′eff
vdw (R) = Vφ(R, r) + V
eff
vdw (R, r) + V
eff
elec (R, r)
V
′eff
φ = V
eff
φ
where R are the the carbons coordinates, r are the hydrogens coordinates, V ′
are the coarse grained potentials, and V are the extended atoms potentials. The
effective potentials are measured thruogh:
V eff =
1
2
〈V13〉+
1
2
〈V24〉+ 〈V14〉+ 〈V23〉
where 1,2,3,4 are the indicate the first, second, third and fourth CH2 group in the
dihedral chain. The average 〈·〉 is a (480K) high temperature average, performed
on a simulation of a single DPC molecule simulation. Angles, bond and van der
Waals parameters were assigned as standard values for the extended CH2 carbon of
PARAM19. The all-atoms atoms affective potential V effφ is represented in figure 12.
Fourier transform of V effφ yelds to the parameters for the coarse grained potential,
whose first three harmonics are reported in table 1.
The dihedral populations of a simulation of the DPC molecule with the coarse
grained potential V ′φ(R), reported in figure 10, agrees with the original potential,
validating thus the whole procedure.
Solvent Model The solvation energy Esolv is expressed as an additive expres-
sion of the atomic solvent accessible surface (SASA):
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Bond Energy
Atom types kb (kcal ·mol
−1
· A˚−2) l0 (A˚)
NTL CTL5 215.00 1.47 (a)
NTL CTL4 215.00 1.47 (a)
CTL4 CTL4 222.5 1.53 (a)
CTL4 OSL 340.0 1.43 (a)
OSL PL 270.0 1.61 (a)
O2L PL 580 1.48 (a)
OSL CTL2 340 1.43 (a)
CTL2 CTL2 222.5 1.53 (a)
CTL2 CTL3 222.5 1.52 (a)
Angle Energy
Atom types ka (kcal ·mol
−1
· rad−2) θ0 (degrees)
CTL5 NTL CTL5 60.0 109.5 (a)
CTL5 NTL CTL5 60.0 109.5 (a)
NTL CTL4 CTL4 67.7 115.0 (a)
CTL4 CTL4 OSL 75.7 110.10 (a)
CTL2 CTL2 OSL 75.7 110.10 (a)
PL OSL CTL4 20 120 (a)
OSL PL O2L 98.9 111.6 (a)
OSL PL OSL 80 104.3 (a)
O2L PL O2L 120 120 (a)
CTL2 CTL2 CTL2 58.35 113.6 (a)
CTL2 CTL2 CTL3 58.35 113.6 (a)
Dihedral Energy
Atom types kφ (kcal ·mol
−1) n ψn (degrees)
CTL5 NTL CTL4 CTL4 0.90 3 0.00 (b)
NTL CTL4 CTL4 OSL 1.40 3 0.00 (b)
CTL4 CTL4 OSL PL 0.9 3 0.00 (b)
CTL2 CTL2 OSL PL 0.9 3 0.00 (b)
CTL4 OSL PL OSL 0.25 3 0.00 (b)
CTL4 OSL PL OSL 0.75 2 0.00 (b)
CTL2 OSL PL OSL 0.25 3 0.00 (b)
CTL2 OSL PL OSL 0.75 2 0.00 (b)
OSL CTL2 CTL2 CTL2 1.40 3 0.00 (c)
OSL CTL2 CTL2 CTL2 0.10 2 0.00 (c)
CTL2 CTL2 CTL2 CTL2 0.52 1 0.00 (c)
CTL2 CTL2 CTL2 CTL2 1.50 3 0.00 (c)
CTL2 CTL2 CTL2 CTL2 0.13 4 0.00 (c)
CTL2 CTL2 CTL2 CTL3 0.52 1 0.00 (c)
CTL2 CTL2 CTL2 CTL3 1.50 3 0.00 (c)
CTL2 CTL2 CTL2 CTL3 0.13 4 0.00 (c)
van der Waals Energy
Atom types EvdW (kcal ·mol−1) rvdW (A˚)
CTL2 -0.1142 2.235 (d)
CTL3 -0.1811 2.165 (d)
CTL4 -0.1142 2.235 (d)
CTL5 -0.1811 2.165 (d)
O2L -0.12 1.70 (a)
OSL -0.1521 1.77 (a)
NTL -0.20 1.85 (a)
PL -0.585 2.15 (a)
Table 1: DPC force field parameters. (a) from [48], (b) from [49] (c) from dihedral
reparametrization, (d) from [46].
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Esolv = Enp + Ep =
= σnp
∑
i
Si + σp
∑
i
q2i
Ri + rp
Si
Sfreei
(1)
where i is the atom index, Si is the atomic surface, σp and σnp are the polar and
non-polar surface tensions respectively, qi is the partial charge of atom i, Ri is the
van der Waals radius, rp = 1.4A˚ is the water probe radius and S
free
i is the surface
of the free atom:
-200 -100 0 100 200
angle
-2
-1
0
1
2
3
4
All-H effective potential
armonical approximation
Dihedral potetial for a coarse grained model
application to the (CH2)4 for DMPC
-200 -100 0 100 200
0
0.005
0.01
0.015
0.02
All H Dihedral distribution
Dihedral distribution  using the coarse grained potential
Figure 10: Top: topology of DPC molecule. Bottom: parametrization of the
dihedral potential for the united atom model of lipid.
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Sfreei = 4π(Ri + rp)
2
The atomic solvent exposed surface Si is evaluated with the Still’s formula.
Polar term The polar surface tension σp is extracted by linear fit of computed
solvation energies using formula 1 with respect to finite different Poisson electro-
static solvation energies of neutral compounds. The compounds that have been
used are Acetyl-X-N-methyl, where X is a non-charged residue, and zwitterionic
Phosphatidylcholine (PC). 50 conformations extracted from a simulation of 500 ns
at 330 K in vacuum with ǫ = 2r distance dependent dielectric constant are used
for each compound. The value of σp obtained from the linear fit (see figure 11) is
−96.0.
It is important to note that the polar part of equation 1 is a generalization of
the Born formula for the solvation of unbound ions:
Eion =
q2
RB
(2)
In fact in the ideal case that atom i is completely exposed to the solvent, then
Si = S
free
i , and Ep = Eion with qi = q and the Born radius is RBorn = (Ri +
rp). In the case that atom i is completely buried, Ep = 0. The polar part of
equation (1) might be interpreted as the first order approximation of the dielectric
descreening spherical integral [50], which after performing the angular integration
may be written as [51]:
Ep = −
1
2
(1−
1
ǫ
)
∑
i
q2i
∫ ∞
ρi
dρ
ρ2
Si(ρ)
4πρ2
(3)
where the ρi are tha atoms intrinsic radii. The integral can be written as
G(∞)−G(x) =
∫ ∞
x
dρ
ρ2
Si(ρ)
4πρ2
=
∫ ∞
x
F (ρ)dρ
since G(∞) = 0 one obtains that G′(x) = −F (x) and developing G(x) as Maclaurin
series around x = ri = Ri + rp to the first order:
175
Pellarin Riccardo 17
G(x) = G(ri) + (x− ri)G
′(ri) = G(ri) + (ri − x)F (ri)
which, imposing x = 2ri, reads:
G(2ri)−G(ri) = −riF (ri)
Since G(2ri) can be neglected with respect to G(ri) if the charges are small, this
brings to the short distance approximation:
G(ri) = riF (ri) (4)
that together with the equation (3), the polar term of equation (1) is obtained.
Electrostatic interaction. The electrostatic interaction screening is expressend
by the distant dependent approximation ǫ(r) = 2r.
Non-polar term The non-polar term has been obtained using an empirical
approach, and two indipendent procedures has been employed for lipids and pro-
teins. A spontaneous aggregation of DPC molecules, and structural investiga-
tion of obtained micelle has been adopted as a criterium for choosing the σnp for
lipids. 56 initially homogenously dispersed lipids are simulated at 300 K with the
Langevin dynamics in a cubic box of 90 A˚. Ten simulation are run in the interval
σnp = 0.010 − 0.080kcal/mol · A˚−2. At each value of the non-polar surface ten-
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sion, the radial distribution of heavy atoms with respect to the centre of the self
aggregated micelle and the order parameter tensor:
Sij =
1
2
〈3 cos θi cos θj〉 − δij ; i, j ∈ x, y, z
as well as the area per lipid, were evaluated as described in [52]. The σnp value
that best approaches the explicit water simulations [52] is 0.043 kcal/mol · A˚−2.
Using experimental solvation data of non-polar compounds sigma is 0.025.
Polar solvation for charged groups. A major drawback of using 1 is that the
solvation energy of charged residues is underestimated. As an example the direct
solvation energy of glutamine is lower than that of glutammate, in contranst with
solvation scales (cite some scales). The partial charge sum expressed by formula
(1) works correctly for polar groups with neutral charge where the short distance
approximation of equation (4) holds, but not for charged chemical moieties. To
correct these discrepancies further adjustable parameters are introduced, which
are the effective partial charge q∗X of a residue, where X =LYS, ASP, GLU, ARG
and protonated HIS. The different partial charges of atoms belonging to charged
chemical groups (such as carboxy for ASP and GLU, guanidinium for ARG and
ammonium for LYS) are substituited by the same value q∗X . To understand the
physical meanining of this parameter, let us consider a molecular ion completely
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Figure 12: Micelle structure. Left: DPC micelle atomic distribution densities.
Right: deuterium order parameter of DPC in micellar aggregates.
177
Pellarin Riccardo 19
exposed to solvent. Using the Born’s formula (2) for a molecular system with
unitary charge, exploiting the fact that the exposed molecular surface S is equal
to the free molecular surface Sfree:
Ep =
1
RB
=
1
RB
S
Sfree
(5)
In the spherical approximation, the molecular surface can be expressed in term
of the Born radius Sfree = 4/3πR3B. The molecular volume is thus defined as
3VM = Rb ·Sfree. If 〈V 〉 = VMN−1 is the average atomic partial volume, and using
the fact that the sum of surface atomic contribution is the total molecular surface
S =
∑
Si, then one obtains
1
RB
=
1
3N〈V 〉
·
∑
i
Si
One can express the average free volume of one atom 〈V free〉 in term of the average
atomic partial volume, by introducing a factor 0 < λ < 1 that expresses the average
atomic volume reduction for being buried in a covalent molecular structure:
〈V free〉 =
4π
3N
∑
i
(Ri + rp)
3 = λ〈V 〉 (6)
Using equation (5) and equation (6) the solvation energy of a molecular ion is thus:
Ep =
1
RB
=
∑
i
q∗2
ri +RP
·
Si
Sfreei
where the square of the effective partial charge q∗2 is the factor λ: q∗2 = λ. Note
that the partial charge is the same for all atoms belonging to the same ion. The
polar term for charged sidechains has been parametrized using Potential of Mean
force of ionic sidechains analogues [53], see figure 11. We introduce an effective
group charge, different from the interaction charge, that appears only in solvation
energy.
Transferability of the model The model is not biased toward any particular
secondary structure type. In fact, exactly the same force field and implicit solvent
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σnp ARG LYS GLU/ASP Hbond
0.025 0.70 0.90 0.70 -3.36
0.030 0.71 0.91 0.71 -4.09
0.035 0.725 0.925 0.725 -4.85
0.043 0.75 0.95 0.75 -5.99
Table 2: Table of ionic effective charges
model have been used in MD simulations of folding of structured peptides (α-helices
and β-sheets) and a number of small proteins.
Kink Angle The kink angle is evaluated whenever helical contacts are formed
both in the 1-14 segment and the 15-26 segment. An helix is considered formed
when at least two helical turns are present. Given the axis versors v1 and v2 the
kink angle is arccos(v1 · v2).
Helical contacts An helical contact is defined whenever the backbone amide
nitrogen of residue i is close less than 4A˚ from carbonyl carbon of residue i+4.
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9 Explicit solvent simulation of a lipidated peptide
Among all the membrane associated peptides, lipid-modified proteins binds to the mem-
brane by inserting their lipid chain into the hydrophobic core. These proteins plays
important roles in the events of signal transduction of the cell. A particular notice-
able example is the GTPase ras, which is involved in cell proliferation [92]. A detailed
knowledge of the ras signal transmission is fundamental, since about one-third of human
cancers present a mutated form of ras proteins. The C-terminal segment GTPase ras
contains two lipidated cysteines: since downstream effectors occur at the membrane sur-
face, post-translational lipidation of these two residues regulates the protein function by
partitioning the C-terminal portion at the membrane surface. Spectroscopic techniques
were used to investigate the membrane localization of the heptapeptide 180-186 [93].
The authors gave evidence that lipid chains were deeply inserted into the membrane,
that hydrophobic amino acid side chains were partitioned at the membrane interior, and
the peptide backbone is disordered and preferentially resides at the membrane-water
interface. In this work (see section 9.1) several explicit water MD simulations have
been performed, to investigate the stability, the conformations and the interaction of the
membrane-peptide system (see figure 7). The position and orientation of the ras pep-
tide and its components obtained by MD simulations are consistent with spectroscopic
data [93], and a mechanism of insertion is proposed.
Figure 7: Schematic representation of ras peptide partitioning at the different membrane
environments, as resulted from simulation analysis presented in section 9.1.
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9.1 Membrane localization and flexibility of a lipidated ras peptide
studied by molecular dynamics simulations.[J. Am. Chem. Soc.
2004, 126, 15277]
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Abstract: Lipid-modified membrane-binding proteins are essential in signal transduction events of the cell,
a typical example being the GTPase ras. Recently, membrane binding of a doubly lipid-modified heptapeptide
from the C-terminus of the human N-ras protein was studied by spectroscopic techniques.14 It was found
that membrane binding is mainly due to lipid chain insertion, but it is also favored by interactions between
apolar side chains and the hydrophobic region of the membrane. Here, 10 explicit solvent molecular
dynamics simulations for a total time of about 150 ns are used to investigate the atomic details of the
peptide-membrane association. The 16:0 peptide lipid chains are more mobile than the 14:0 phospholipid
chains, which is in agreement with 2H NMR experiments. Peptide-lipid and peptide-solvent interactions,
backbone and side-chain distributions, as well as the effects of lipidated peptide insertion onto the structure,
and dynamics of a 1,2-dimyristoylglycero-3-phosphocholine bilayer are described. The simulation results
validate the structural model proposed by the analysis of spectroscopic data and highlight the main aspects
of the insertion mechanism. The peptide in the membrane is rather rigid over the simulation time scale of
about 10 ns, but different partially extended conformations devoid of backbone hydrogen bonds are observed
in different trajectories.
Introduction
The regulation of cellular functions is coordinated by signal
molecules. External signals transmitted across membranes and
received by cellular receptors are relayed to their target by
intracellular signal cascades. Posttranslational lipid-modified
proteins1,2 are commonly involved in regulation of the signal
transmission processes.3-5 Typical among fatty-acid-modified
proteins is the GTPase ras. The ras signal transduction cascade
is central in cell proliferation and differentiation events, in which
ras proteins, by activating downstream effectors,6,7 mediate the
signal flow from receptor tyrosine kinase to the cell nucleus.
Malfunction in the regulatory action (the switching function)
of ras proteins leads to uncontrolled cell growth, or cancer,
manifested by the fact that about one-third of all human cancers
carry a mutated form of ras proteins. Detailed characterization
of the molecular interactions playing a role in the ras signal
transmission pathways is therefore of great importance.
The specific attachment of lipids to proteins that contain the
C-terminal motif, CAAX, by cleavage and addition to the SH
group of Cys, is a common structural feature in membrane
proteins involved in signal transduction events. Lipidated
proteins (and their analogue peptides) achieve strong binding
by inserting their lipid chains into the hydrophobic core of the
membrane. Thus, the major membrane-binding energy contribu-
tion comes from the hydrophobic interaction between the
hydrocarbon tails of the protein and the membrane. For a
maximum binding potential, ras proteins can acquire two
different types of lipid modification, single or double lipid
modification. Typically, ras proteins with single lipid modifica-
tion also contain cluster(s) of basic amino acids and bind to
negatively charged plasma membranes. The interaction between
the phospholipid headgroups (of the negatively charged mem-
branes) and the positive peptide charges provides additional
attractive electrostatic energy for a stable membrane association
(e.g., the K-ras protein8). H- and N-ras proteins require double
modifications.9 Farnesylated, but nonpalmitoylated, H- and N-ras
proteins mislocate to the cytosol and break the signal cascade.10-12
The human N-ras protein, the focus of this paper, undergoes
farnesylation at the C-terminal recognition region (Cys186)
followed by palmitoylation at Cys181. Single lipid modification
of N-ras provides insufficient hydrophobic binding energy for
it to permanently anchor to plasma membranes. As a result, a
fast equilibrium between adsorbed and desorbed states is
observed.(1) Hancock, J. F.; Cadwallader, K.; Paterson, H.; Marshall, C. J. EMBO J.
1991, 10, 4033-4039.
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(8) Ghomashchi, F.; Zhang, X.; Liu, L.; Gelb, M. H. Biochemistry 1995, 34,
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(9) Silvius, J. R. Lipidated Peptides as Tools for Understanding the Membrane
Interactions of Lipid-Modified Proteins. In Peptide Lipid; Simon, S. A.,
McIntosh, T. J., Eds.; Elsevier: New York, 2002; pp 371-395.
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Unlike integral proteins that are permanently anchored to
membranes, the association of ras proteins to plasma membranes
is an equilibrium process.13 Because interactions with other
downstream effectors occur at the membrane surface, ras
proteins are functional only in the membrane-associated state
and are inactive desorbed into the cytosol. Experimental studies
on membrane interactions of lipid-modified proteins, mainly
using lipidated peptides and artificial membranes,9,13 have shed
light on how their distribution is regulated between the active
(membrane-bound) and inactive (unbound) states, as well as
on the energetics and thermodynamics of the interaction.
Using a combination of Fourier transform infrared, solid-state
NMR, and neutron diffraction spectroscopy, Huster et al.
recently studied membrane insertion and localization of a
heptapeptide representing the carboxy terminus (residues 180-
186) of the human N-ras protein.14 The plasma membrane was
modeled by 1,2-dimyristoylglycero-3-phosphocholine (DMPC).
This study highlighted the key structural features that accompany
membrane insertion of ras proteins. The peptide inserts its two
lipid chains deep into the membrane interior, such that stabilizing
hydrophobic contacts between the DMPC and peptide lipid
chains are possible. Binding is further assisted by the insertion
of two hydrophobic amino acid side chains (Leu and Met) into
the hydrophobic section of the membrane. The backbone adopts
a disordered conformation and is preferentially localized in the
lipid-water interface. These observations led to a plausible
structural model for membrane binding of N-ras proteins.
It is worth noting that while the structure of the soluble part
of ras proteins (residues 1-166) has been solved by both X-ray
diffraction15-18 and solution NMR spectroscopy,19 there are no
structural data for the C-terminal membrane binding region
(residues 180-186). The biophysically derived structural model
of Huster et al. for a doubly lipid-modified synthetic heptapep-
tide bound to a DMPC bilayer mimics the binding mode of the
human N-ras protein. It is therefore of general significance.
However, not all of the details of association can be observed
spectroscopically; atomic level analysis of peptide-lipid and
peptide-solvent interactions, backbone and side-chain distribu-
tions, as well as the effect of lipidated-peptide insertion onto
the structure, and dynamics of a DMPC bilayer are required
for a molecular-level interpretation and full description of the
association process. A more-direct approach to investigate these
and related issues is provided by computational methods. Due
to the level of details that they can provide, molecular dynamics
(MD) simulations of the lipidated peptide and DMPC bilayer
are uniquely suited to address these questions at the atomic level.
Several explicit water MD studies of membrane-protein
systems have been conducted (see, for example, review
articles20-22 and recent reports23-25). The majority of these
simulations targeted the stability, dynamics, and functional
aspects of integral proteins in a variety of membranes,26-32 pure
membranes and their environments,33-35 and peptide-bilayer
systems.36-40 So far, however, only few attempts have been
made to simulate membrane localization, and the accompanying
mechanisms of insertion of peptides/proteins whose initial
positions, with respect to the phospholipids, are not clearly
known a priori.41-43 Kaznessis et al. investigated the interaction
between the N-terminal region of the human surfactant protein-B
in dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphos-
phatidylglycerol (DPPG) monolayers.41 Their simulations re-
vealed that the peptide fragment of protein-B adopts different
modes and energetics of interactions with the different phos-
pholipid monolayers, with preferential affinity for anionic
phospholipids. Knecht and Grubmu¨ller used MD and annealing
simulations to study mechanical coupling by the membrane
fusion SNARE protein syntaxin 1A.42 Their simulation results
indicate that partially unstructured linkers provide significant
mechanical coupling. Sankararamakrishnan and Weinstein
simulated the helical region of dynorphin in a DMPC bilayer.43
They showed that in the complex, the tilt angle of the dynorphin
helix from the bilayer normal is stabilized at ∼50° for different
initial orientations of the dynorphin.43 In a recent study on the
insertion of antimicrobial peptides into a zwitterionic lipid
bilayer in which the peptides were directed toward the interface
either on their hydrophobic or positively charged face, it was
found that the former bind to the interface and subsequently
penetrate the bilayer while the latter displayed only partial
surface binding.44
In the present study, MD simulations are used to investigate
the position, orientation, and flexibility of a lipidated ras peptide
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in a DMPC bilayer. The simulation results are first validated
by comparison with NMR, Fourier transform infrared, and
neutron diffraction spectroscopy experiments.14 The good agree-
ment between simulation and experimental results allows the
use of the former to extract a clear and detailed picture of
membrane insertion of the lipidated ras peptide.
Methods
It was shown experimentally that equilibrium membrane adsorption
of doubly lipid-modified ras peptides have average half-life times in
the order of hours to days.45,46 Although it would be interesting to
simulate the system long enough for the peptide to insert spontaneously,
this is impossible to achieve within the current accessible time scales
of MD simulations. A procedure to speed up the insertion is therefore
necessary. The initial position and orientation of the peptide with respect
to the bilayer were chosen such that insertion could be observed within
a reasonable simulation time. Furthermore, to maximize sampling, two
peptides (i.e., one peptide per leaflet) were simulated in each MD run.
This is partly justified by the fact that the lipid bilayers are symmetrical
in a simulation box and also because, in the in vitro experiments, the
two leaflets were both populated.
Peptide Structure. The peptide sequence used in the simulations
consisted of residues (X)Gly-Cys(R1)-Met-Gly-Leu-Pro-Cys(R2)-OMe,
where R1 and R2 represent the lipid modifications (i.e., palmitic and
hexadecyl thioether tail, respectively).14 The latter was preferred to the
natural occurring farnesyl to directly compare with the experimental
data.14 The X represents a hydrogen atom in the case of a charged
N-terminus and an acetyl (CH3OC-) in the neutral form of the peptide.
Since the peptide sequence corresponds to the C-terminal end of the
N-ras protein, the neutral form is closer to the natural protein, while
the charged form corresponds to the one used in the experiments.14
Parameters for the lipid modifications were derived from the
CHARMM27 force field.47,48 A model for the structure of the peptide
was then built manually and minimized by 1000 steps SD and 1000
steps conjugate gradient to remove bad atomic contacts, leading to the
structure shown in Figure 1A.
Initial Peptide Positions and Orientations. Figure 1B and Table
1 schematically show the strategy used to obtain starting structures.
First, the peptides were placed in the middle of each water slab and
relaxed for 0.25 ns. Then, one trajectory was continued without any
bias (A0), and another trajectory was continued with distance constraints.
In the latter, the distances along the z-axis between corresponding C16
atoms of peptide 1 (P1) and peptide 2 (P2), i.e., R1(P1)-R1(P2) and
R2(P1)-R2(P2), were slowly decreased by applying a harmonic force
constant (see legend of Figure 1B for details). By removing the
(45) Shahinian, S.; Silvius, J. R. Biochemistry 1995, 34, 3813-3822.
(46) Schroeder, H.; Leventis, R.; Rex, S.; Schelhaas, M.; Nagele, E.; Waldmann,
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1997, 73, 2269-2279.
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J. D.; Field, M. J.; Fischer, S.; Gao, J.; Kuchnir, L.; Guo, L.; Guo, H.;
Kuczera, K.; Lau, F. T. K.; Mattos, C.; Joseph-McCarthy, D.; Michnick,
S.; Ngo, T.; Nguyen, D. T.; Prodhom, B.; Reiher, W. E., III.; Roux, B.;
Schlenkrich, M.; Smith, J. C.; Stone, R.; Straub, J.; Watanabe, M.;
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3616.
Figure 1. (A) Sequence and starting structure of the acetylated form of the N-ras peptide used in the simulations. The structure is modeled as described in
the text. (B) Schematic picture of the approach used to determine initial peptide positions with respect to the bilayer. After construction of the bilayer-water
system (see text), one peptide was placed in the middle of the water slabs at each monolayer. The system was relaxed for 0.25 ns. Then, one simulation was
continued without any bias (A0), while in another simulation, the separation along the membrane normal between the methyl carbon atoms of the ras lipids
[C16, R1(P1) and C16, R1(P2); and C16, R2(P1) and C16, R2(P2)] was decremented by 0.5 Å every 5 ps using a harmonic potential with a force constant of 100
kcal mol-1 Å-2. The constraint was removed after 0.25 ns (starting structure for A1), 0.35 ns (A2), and 0.42 ns (A3). Since P2 and P1 in trajectories A1 and
C1 have completely dissociated to solvent (see Results and Discussion), the last snapshots of these were used to start trajectories A1a and C1a, respectively.
This was done by “pulling-back-in” one chain of the dissociated peptide into the bilayer. Vertical and horizontal time axes indicate the length of the simulations
with and without a harmonic constraint, respectively. The five insets show the peptide positions and orientations used as starting structures for production
runs. Ras lipid chains are in blue; backbone and residue prolines are in red, while Leu and Met are in green. For clarity, only selected atoms of the DMPC
are shown: phosphorus and choline nitrogen atoms in dark yellow and blue, respectively, and the first methylene carbon of the lipid tails in cyan. A similar
approach was followed to obtain initial positions for simulations with a charged N-terminus.
Table 1. Performed Simulationsa
Acetylated
N-Terminus
Charged
N-Terminus
name A0 A1 A2 A3 A1a C0 C1 C2 C3 C1a
constrained dynamics (ns) 0.0 0.25 0.35 0.42 0.10b 0.0 0.35 0.40 0.45 0.10b
unconstrained dynamics (ns) 5.0 2.3 20.1 14.1 22.5 5.0 2.6 22.3 14.2 20.0
a See Figure 1B for details. b Simulations were continued from simulations A1 and C1, and the constraints were applied on a single lipid chain (see text).
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constraint at 0.25 ns, 0.35 ns, and 0.42 ns, we obtained three starting
configurations for simulations A1, A2, and A3. A similar procedure was
used to generate starting structures for another four trajectories
calculated with a charged N-terminus (C0-C3). Furthermore, two
trajectories, A1a and C1a, were started from the final conformation of
simulations A1 and C1, respectively (see legend of Figure 1B). In total,
10 simulations were run to investigate the insertion process (Table 1).
SimulationProtocol.TheCHARMMprogram49andtheCHARMM2747,48
parameters were used in all of the simulations and for part of the
analysis. The construction and setup of the simulation system were
based on the protocol of Woolf and Roux,50,51 adjusted to the
specificities of the present system. The liquid-crystalline phase of the
DMPC (at a temperature of 310 K, the temperature at which most of
the experiments were done14) was simulated at a constant number of
particles (N), normal pressure (PN), cross sectional area (A), and
temperature (T), the NPNAT ensemble.
To avoid strain of the bilayer due to the insertion of the two “foreign”
lipid chains of the ras peptide, the cross sectional area of each monolayer
was made slightly larger than that in a pure DMPC bilayer. Thus, the
total lateral area per leaflet was calculated for 27 lipids with an area
per lipid of 59.8 Å2 (ref 52) to be used for 26 lipids per leaflet in all
of the simulations involving peptide insertion. The peptide:DMPC ratio
was therefore 1:26 in the simulations, in contrast with the experimental
ratio of 1:10. Note that a more-dilute solution is preferable to make
sure that multimer formation is avoided, as was also mentioned by
Huster et al.. In the control simulation of a DMPC bilayer without the
peptides, 27 lipids per leaflet were used within the same cross-sectional
area.
The DMPC bilayer was constructed by randomly choosing structures
from the pre-equilibrated phospholipid structural libraries.53,54 To model
the bulk solvent, a water slab was constructed from a pre-equilibrated
TIP3 model and overlayed on the glycerol region of each leaflet. One
peptide was then inserted into each of the water slabs, and water
molecules closer than 2.6 Å to any peptide atom were deleted. The
size of the water box was chosen such that any atom of a peptide is at
least 10 Å away from the edge of the box, including the side parallel
to the lipid lateral surface. The dimension of the system was 43.6 ×
37.2 × 120.0 Å3, resulting in a total of ∼4350 water molecules, 2
peptides, and 52 DMPC lipids. In the case of the simulations with a
charged N-terminus, the system was neutralized by adding a chloride
ion in each water box. The simulation systems for the neutral and
charged peptides contained a total of 19 560 and 19 575 atoms,
respectively. Figure 2 (left and middle) shows representative snapshots
of the simulation setup.
(49) Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. T.; Swaminathan,
S.; Karplus, M. J. Comput. Chem. 1983, 4, 187-217.
(50) Woolf, T. B.; Roux, B. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11631-
11635.
(51) Woolf, T. B.; Roux, B. Proteins 1996, 24, 92-114.
(52) Petrache, H. I.; Dodd, S. W.; Brown, M. F. Biophys. J. 2000, 79, 3172-
3192.
(53) Venable, R. M.; Zhang, Y.; Hardy, B. J.; Pastor, R. W. Science 1993, 262,
223-226.
(54) de Loof, H. D.; Harvey, S. C.; Segrest, J. P.; Pastor, R. W. Biochemistry
1991, 30, 2099-2113.
Figure 2. Snapshots after 0.25 ns of relaxation (A0, left), after partial insertion promoted by a 0.35 ns constrained dynamics (A2, middle), and the final
snapshot (A2, right). Backbone and Pro are in red, ras lipid chains in blue, Leu and Met side chains in green, DMPC hydrocarbon tails in gray, headgroup
atoms in yellow, and water molecules in sticks (or ball-and-sticks). Part of the water molecules have been removed after partial insertion of the peptide.
Hydrogen atoms of the peptide and the DMPCs are omitted for clarity.
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Subsequent minimizations and a 200 ps equilibration with progres-
sively decreasing harmonic constraints on the peptide backbone, side
chains, lipid headgroups, and water oxygen atoms were similar to those
of previous reports.55 After equilibration, production simulations were
run in the NPNAT ensemble. Periodic boundary conditions in all three
spatial directions were used, with constant normal pressure (PN ) 1
atm) and constant A and T. Constant temperature was maintained using
the Hoover temperature control56 with a thermal piston mass of 3000
kcal mol-1 ps2. Truncation of electrostatic interactions has been shown
to have major effects on the bilayer properties.57 In this work, long-
range electrostatic interactions were treated by the particle mesh Ewald
(PME) method58 with a 12 Å cutoff for direct and reciprocal space
summations. A shift function at 10 Å for the Lennard-Jones interactions
and a heuristic update of the nonbonded list, with a cutoff at 12 Å,
were used. The integration time step was 2 fs, and all bonds involving
hydrogens were fixed using the SHAKE algorithm. Structures were
saved every 1 ps for analysis.
To speed up sampling, part of the water layer was removed after a
portion of the peptides had inserted into the bilayer, while keeping
sufficient waters to solvate both the peptides and the bilayer. This
resulted in a reduction of 40% in the total number of atoms (Figure 2,
right). In the early stages of the simulations, drift of the peptide along
the lateral spatial directions (i.e., perpendicular to the membrane normal)
was prevented by applying a cylindrical potential.50 This constraint was
removed after partial insertion to allow a spontaneous lateral reorga-
nization of the peptide in the bilayer.
Analysis. The bilayer thickness (DPP) is defined as the distance
between the geometric center of the phosphorus atoms at each
monolayer. The average chain length (LC) is defined as the average
distance along the bilayer normal between the first methylene carbon
and the terminal methyl carbon atoms of the lipid chains,59 calculated
from trajectories as
where x is 14 for the DMPC chains and 16 for the ras chains, and the
〈〉 denote time averages. Note that LC, defined here, is equivalent to
L*C in the literature,59 which does not include the distance from the
first methylene to the carbonyl carbon (∼0.55 Å) and the extra length
of the terminal methyl group (∼0.98 Å).59
The deuterium order parameter, SCD, was calculated as
where θn is the instantaneous angle between a vector along the
methylene/methyl hydrogens of the acyl carbon atoms and the bilayer
normal.
Graphical analysis of the simulations was made using the VMD
program.60
Results and Discussion
Control Simulations. To check the behavior and stability
of the DMPC bilayer and the peptide alone in water, simulations
with the same setup as that in the multicomponent simulations
were performed for each isolated component. Furthermore, the
effect on the insertion mechanism of the lipid tails was assessed
by simulating the peptide without lipid tails under the same
conditions as those for the lipid-modified peptide.
Peptide in Water. One factor that may affect the rate of
peptide insertion is its structural properties in water. To assess
the behavior of the peptide in water, a short simulation of 2 ns
was performed in a cubic box of TIP3 waters. As may be
expected for a system with no charged or polar side chains, the
peptide quickly adopted a collapsed conformation. It buried a
large part of its hydrophobic surface by “sequestering” the apolar
amino acids, Met and Leu, with the lipid hydrocarbon chains
(data not shown). The short simulation does not allow one to
describe the accessible conformational space.
DMPC in Water. A 6 ns trajectory of the DMPC bilayer
was run to investigate the bilayer behavior in the absence of
the peptides and to facilitate structural comparison with simula-
tions in the presence of the ras peptide. The trajectory was stable,
and the bilayer structural properties were generally the same as
in previous reports.55 The bilayer thickness (DPP) is a useful
parameter for estimating bilayer structural changes upon protein
insertion. The average DPP value calculated from the simulation
without peptides (37.0 Å, see Table 4) is in good agreement
with previous calculations using the same protocol (35.9 Å)55
and is close to the experimental thickness (i.e., the average
distance between lipid headgroups at each monolayer measured
by electron density profile method) of 36.0 Å.61 The deuterium
order parameters (SCD, eq 2), calculated from the simulation
(Figure 3), are typical of other DMPC simulations62 and in very
good agreement with experimentally measured values at 30 °C.52
Possible structural alterations after peptide insertions can
therefore be safely attributed to changes arising from the
insertion of the peptide.
Peptide without Lipid Tails. Three trajectories with the same
starting conditions as those in trajectories A2, A3, and A1a, but
lacking the palmitoyl and hexadecyl groups, were run for 2.5
ns each. Four of the six peptides fully dissociated into water.
For the remaining two peptides, most of the backbone and side
chains moved toward bulk water within 2.5 ns, with only the
N-terminus maintaining contact with the headgroup region of
the bilayer. This suggests that lipid modifications are essential
for membrane insertion.
Peptide Insertion. The location of the geometric center of
the peptides and the initial number of peptide-DMPC contacts
were used to monitor the insertion process and peptide-bilayer
interactions. Table 2 summarizes the initial and final peptide
locations, as well as the initial number of ras acyl carbon atoms
in contact with those of DMPC. Initial peptide positions varied
between 41 (completely in water) and 16 Å (partly inserted).
(55) Petrache, H. I.; Grossfield, A.; MacKenzie, K. R.; Engelman, D. M.; Woolf,
T. B. J. Mol. Biol. 2000, 302, 727-746.
(56) Hoover, W. G. Phys. ReV. A 1985, 31, 1695-1697.
(57) Patra, M.; Karttunen, M.; Hyvonen, M. T.; Falck, E.; Lindqvist, P.;
Vattulainen, I. Biophys. J. 2003, 84, 3636-3645.
(58) Darden, T.; York, D.; Pedersen, L. J. Chem. Phys. 1993, 98, 10089-10092.
(59) Petrache, H. I.; Tu, K.; Na¨gle, J. F. Biophys. J. 1999, 76, 2479-2487.
(60) Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graphics 1996, 14, 33-
38.
(61) Nagle, J. F.; Tristram-Nagle, S. Biochim. Biophys. Acta 2000, 1469, 159-
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Figure 3. Deuterium order parameters of hydrocarbon tails from the 6 ns
DMPC trajectory without peptides. The error bars are calculated by dividing
the last 4 ns of the trajectory in segments of 1 ns.
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Whenever the peptide was placed near the interface with an
average distance from the bilayer center of <25 Å (∼7 Å from
the average phosphorus atoms location), a subsequent insertion
was observed (shown in bold, Table 2).
Figure 4 shows the progress of peptide insertion during the
longest trajectory (A1a). The peptides slowly approach the bilayer
(at times even immersing in the hydrophobic region; heavy black
lines) and eventually stabilize, with the backbone occupying
the interfacial region. In agreement with Fourier transform
infrared experiments,14 the acyl chain lengths of the ras peptides
equilibrate at lengths equivalent to those of the DMPC lipids
tails, but the length fluctuations are much larger in the former.
As can be seen from the insets of Figure 4, the peptide-DMPC
hydrophobic contacts progressively increase along the trajec-
tories. The two peptides move independently of each other;
initially, they occupied similar locations in the middle of each
monolayer but then translated to opposite corners of the
monolayers’ cross sectional area (inset).
Furthermore, the calculated center of mass of the peptides
and the monolayers in the unconstrained simulations indicate
that while the motion of the two monolayers relative to each
other is negligible, there is a substantial lateral movement of
each peptide independently of the other (data not shown). All
of the simulations where insertions have been achieved show
similar behavior. These observations indicate that once the
peptides are inserted, the previous history (including the starting
position and orientation) is forgotten. The mobility of the peptide
at the membrane surface is qualitatively similar to that seen in
a recent MD study of a membrane-anchored single-lipidated
peptide.63,64 Furthermore, the values of the two-dimensional
diffusion constant on the membrane plane computed from the
trajectories,35 ∼10-30 × 10-8 cm2 s-1 for the DMPC and ∼6-
15 × 10-8 cm2 s-1 for the peptide, suggest that the peptide
moves slightly slower than individual lipids. The diffusion of
the DMPC lipids is within the range of excimer experiments.65
Comparison of the trajectories, based on the contact criteria,
may give a more-detailed picture of the insertion process.
Although insertion was not observed in the simulations where
no initial peptide-DMPC contacts were present (A0 and C0), a
minimum of roughly 5-7 inserted carbon atoms per acyl chain
is sufficient to spontaneously lead to full insertion. A smaller
number of ras acyl carbons contacting DMPC acyl carbons did
not result in insertion within the time scale of the simulations.
For example, while seven carbon-carbon contacts between ras
and the DMPC lipids resulted in insertion (e.g., P2 in A1a and
in C1a), three or four contacts could not stabilize the ras peptide
in the bilayer and led to desorption to water (P2 in A1 and P1 in
C1). Interestingly, even a chain with no or few initial contacts
subsequently inserts if the other chain is involved in a sufficient
number of initial contacts with the bilayer (e.g., P2 in A2 and in
C1). As an example in trajectory A2, the palmitic chain (R1) of
P2 was in water at the start and early stages of the simulation;
its insertion began at about 9.3 ns, and after fluctuating for about
2 ns, it made a stable association from 11 ns onwards (Figure
5). In total, five cases of single chain preinsertion were used to
investigate the behavior of the complex where only a single
chain of a peptide was initially in contact with the bilayer [A1a,
R1(P2) and R2(P1); A2, R1(P2); C1, R1(P2); C1a, R2(P1)]. It was
anticipated that the palmitoyl chain R1 (in trajectories A1a, A2,
and C1) and the hexadecyl chain R2 (in trajectories A1a and C1a)
would insert spontaneously. A total of three and one spontaneous
insertions of the palmitoyl and hexadecyl chains were observed,
respectively, whereas the hexadecyl group did not insert in the
20 ns simulation of C1a (Table 3). Despite the limited statistics,
it appears that there is no significant difference in the times
(63) Nagle, J. F. Biophys. J. 1993, 64, 1476-1481.
(64) Jensen, M. O.; Mouritsen, O. G.; Peters, G. H. Biophys. J. 2004, 86, 3556-
3575.
(65) Blume, A. Dynamic Properties. In Phospholipid Handbook; Cevc, G., Ed.;
Marcel Dekker: New York, 1993; pp 455-552.
Table 2. Initial and Final Peptide Positionsa
A0 A1 A2 A3 A1a C0 C1 C2 C3 C1a
Number of Ras Acyl Carbon Atoms in Contact with DMPC Acyl Carbons at the Startb
P1 R1 0 7 15 15 15 0 1 4 8 7
R2 0 3 10 12 0 0 2 7 11 0
P2 R1 0 0 0 6 0 0 1 8 11 15
R2 0 4 11 15 7 0 11 11 16 16
Distances between Peptide Geometric Centers and the Center of Bilayer (initialf final) (Å)c
P1 39f 39 26f 22 19f 10 17f 10 22f 13 41f 44 30f 38 24f 9 21f 9 24f 23
P2 34f 34 28f 33 23f 8 19f 12 23f 9 41f 52 22f 15 19f 10 16f 7 15f 11
a P1 and P2 represent peptides 1 and 2, respectively, whereas R1 and R2 represent the palmitoyl and hexadecyl lipid tails of the ras peptide, respectively.
b Contact is present if the ras acyl carbon is within 5 Å of at least one DMPC acyl carbon. The maximum possible number is 16 (i.e., the lengths of the
palmitoyl and hexadecyl chains). c Initial and final peptide positions are defined by the location of the peptide geometric center in the first and last snapshots
of the simulations [absolute values, as measured from the bilayer center (z ) 0), are indicated]. The initial contacts that led to insertion (i.e., to the maximum
possible number) and the corresponding locations are in bold.
Figure 4. Time series and snapshots show the movement of the peptide
toward the bilayer-water interface followed by insertion in trajectory A1a.
The cylindrical potential to prevent lateral motion of the peptide (see
Methods) was removed at 6.5 ns. The large apparent displacement of P1
between the snapshots at 13 and 17 ns is an effect of the periodic boundary
conditions. Lines above and below z ) 0 (the bilayer center) are for peptides
1 and 2, respectively. Thick lines: red, backbone geometric center; black,
all atom geometric center; green, peptide acyl chain length. Thin lines: blue,
DMPC acyl chain length; black, average phosphorus atom locations. The
insets show the peptide insertion levels at selected time points during the
simulations. Color codes are as in Figure 1B.
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needed for the Cys181 palmitoyl or Cys186 hexadecyl groups’
spontaneous insertion. Moreover, as mentioned above, a limited
preinsertion of one or both of the chains is sufficient to trigger
insertion and stabilization of the whole peptide.
Lipid Bilayer Structure. Lower order parameters were
observed for the 16:0 ras chains compared with the 14:0 DMPC
chains.14 The order parameters from the last 10 ns of some of
the simulations that resulted in peptide insertion are shown in
Figure 6. It is clear from the figure that the peptide lipid chains
are significantly less ordered compared with the DMPC chains,
which is in very good agreement with experiments.14 The
difference in the calculated average order parameters between
the DMPC chains and the ras chains is 0.060, compared with
the experimental value of 0.057. The effective length of saturated
hydrocarbon chains is proportional to the average order param-
eters.63 The results show that the longer 16:0 ras chains decrease
their order upon membrane insertion to match the length of the
shorter 14:0 DMPC lipids. In fact, the lengths of the ras and
DMPC chains become close to each other after the stabilization
of the peptide in the host lipids (Figure 4).
Table 4 compares the DPP values calculated for the free
DMPC simulation with those of the “insertion” simulations. In
all of the insertion simulations, the global thickness of the bilayer
has increased by about 1 Å: an average of 38.1 Å in the
presence of the peptide, compared with 37 Å for a pure DMPC
simulation. This is consistent with several 2H NMR and ESR
experiments which showed that hydrophobic peptides increase
bilayer thickness due to hydrophobic mismatch.66 Observed
globally, therefore, the structure of the bilayer is slightly
perturbed by the insertion of the peptide. However, the average
chain lengths (LC, eq 1) in simulations with and without peptides
are similar (Table 4).
Besides the average thickness, the local effect of the peptide
on the lipid bilayer is of special interest. The average distance,
DP, of the P atoms from the bilayer center (at z ) 0) was
calculated for those P atoms that are close to the peptide (a
cutoff of 8 Å) and compared with the average distance for the
rest of the P atoms. In all of the simulations with insertions,
the DP in the vicinity of the peptide is decreased with respect
to the average value (Table 4). In contrast, the rest of the bilayer
responds by increasing its DP. Petrache et al. observed that the
bilayer thickness around the monomeric form of glycophorine
A decreases, as in the ras peptide (Table 4), while an increase
was observed in the dimer.55 The change of the bilayer structure
due to the insertion of peptides is a complex process involving
both the length and the tilt of the peptide and the lipid.67 The
above observation therefore requires a further investigation
beyond the scope of this paper.
Peptide Structure. Structural analysis of the peptide back-
bone, in terms of its fluctuations, presence of hydrogen bonds,
and other observables, revealed that the peptide does not assume
a regular secondary structure before or after membrane insertion.
No backbone hydrogen bonds were observed in the simulations.
The root-mean-square fluctuations (RMSF) of the CR atoms after
complete insertion (0.5-1 Å for the last 2 ns of the simulations)
suggest that the peptide is rather rigid (see the thickness of the
tubes in Figure 7). The peptide backbone is extended, and
several conformations are observed. Furthermore, while the
overall backbone and side chain membrane localization of the
peptide is similar among the trajectories, cluster and principal
component analyses indicate that each trajectory samples a rather
different region of conformational space with few overlaps (data
not shown). Comparison of the peptide structures averaged over
the last 2 ns in terms of root-mean-square deviations (RMSD)
also shows the same behavior (Table 5). Although the simulation
times may be insufficient to allow conformational interconver-
sion, these results indicate that a unique peptide structure may
not be required for bilayer adsorption. The lack of a well-defined
three-dimensional structure may be biologically relevant since
it increases the likelihood of productive encounters between the
peptide/protein and plasma membrane.69,70 However, the ori-
entation of each side chain is important for the binding, and
the backbone conformation should accommodate this require-
ment. Figure 7 (bottom left) shows the conformational change
(66) de Planque, M. R.; Greathouse, D. V.; Koeppe, R. E., II.; Schafer, H.;
Marsh, D.; Killian, J. A. Biochemistry 1998, 37, 9333-9345.
(67) Petrache, H. I.; Killian, J. A.; Koeppe, R. E.; Woolf, T. B. Biophys. J.
2000, 78, 324A.
Figure 5. Peptide-DMPC hydrophobic interactions along trajectory A2.
Interactions are defined as the number of ras methylene/methyl carbons
and Leu and Met side chain heavy atoms, within 5 Å of DMPC methylene/
methyl carbons. For clarity, the data shown are only for peptide 2. The
insets represent the system before (left, at 2 ns) and after (right, at 20 ns)
complete insertion of peptide 2 (shown in the lower leaflet of the insets).
The hydrophobic groups of ras interacting with the DMPC hydrophobic
core are colored in blue and green; the DMPC lipid tails are in yellow, and
the headgroups are in “standard” atom colors.
Table 3. Approximate Insertion Times (in nanoseconds) of
Palmitoyl and Hexadecyl Groups of the Peptidea
chain (peptide) time trajectory
R1(P2) 2.4 (0.0) C1
R1(P2) 11.3 (9.3) A2
R1(P2) 7.0 (1.5) A1a
R2(P1) 12.3 (11.9) A1a
a Insertion times are measured for the insertion (distance of <5 Å from
any DMPC acyl carbon) of at least 8 of the 16 ras acyl carbons. Time
points where initial fluctuating contacts were made are shown in parentheses.
Figure 6. Deuterium order parameters of hydrocarbon tails for DMPC (solid
lines) and peptide lipids (dotted lines) after insertion of the ras peptide.
Circles, boxes, and triangles are for simulations C2, A2, and A3, respectively.
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of the backbone accompanying the rotation of the Leu side chain
from water-exposed to the interior of the bilayer. Similar
structural transitions are observed during the rotation and
insertion of the Met side chain (data not shown). Experimentally,
the amide bands in a Fourier transform infrared spectrum of
the peptides at two polarizations were different, which indicates
that the peptides in the sample adopt a nonrandom orientation.14
Peptide Environment Interactions. Differences in the
neutron scattering length density profiles between DMPC, with
and without the ras peptide, were used to determine the insertion
depth and distribution of the ras lipid chains as well as the
distribution of backbone and side chains.14 The ras lipid chains
were found to be located in the middle of the membrane,
approximately distributed within 10 Å of the bilayer center. The
backbone and side chains reside in the headgroup/glycerol/upper
chain region. The average number densities of the peptide lipid
chains, side chains, backbone, and water, calculated from our
simulations (Figure 8), strongly support these experimental
findings. While the peptide lipid chains populate the interior of
the bilayer and the side chains populate the upper chain region
(peak at 11 Å), the backbone resides in the membrane-water
interface (with a maximum at ∼13 Å) close to the DMPC
carbonyl oxygens. The side chains show large variations
populating the region beneath the DMPC carbonyl oxygens and
the upper hydrophobic region of the bilayer. The distribution
of the side chains populating the hydrocarbon region is similar
to that obtained by Tieleman and colleagues for a Trp residue
in their MD study of Arg/Lys containing interfacial pentapep-
tides partitioned in a solvated DOPC bilayer.37 In contrast, they
found that the charged Arg/Lys (as well as a Leu side chain)
populates the interfacial region.
The distributions are governed by specific atomic interactions
of the peptide with its environment. The carbon atoms of the
ras lipid chains are in contact with carbons of the DMPC host
matrix (Figures 4 and 5), contributing to stable association. In
addition to the ras lipid chains, the apolar residues, Met and
Leu, are involved in van der Waals interactions with the DMPC
lipid chains (Figure 5). From the radial distribution functions
(data not shown), polar interactions involving the amide and
(68) Koradi, R.; Billeter, M.; Wuthrich, K. J. Mol. Graphics 1996, 14, 29-32,
51-55.
(69) Wright, P.; Dyson, H. J. Mol. Biol. 1999, 293, 321-331.
(70) Caflisch, A. Trends Biotechnol. 2003, 21, 423-425.
Table 4. Structural Properties of the DMPC Bilayera
without peptides A2 A3 C2 C3
DPP 37.0 ( 0.4 38.0 ( 0.4 38.1 ( 0.3 38.1 ( 0.3 38.3 ( 0.3
LC 11.3 ( 0.2 11.4 ( 0.2 11.2 ( 0.2 11.5 ( 0.2 11.6 ( 0.2
DP (bound, leaflet 1) 18.2 ( 0.8 18.5 ( 0.7 17.6 ( 1.1 17.8 ( 0.8
DP (rest, leaflet 1) 19.3 ( 0.3 19.8 ( 0.3 19.6 ( 0.2 19.4 ( 0.3
DP (bound, leaflet 2) 17.5 ( 0.8 18.3 ( 1.0 17.9 ( 0.8 16.7 ( 0.7
DP (rest, leaflet 2) 19.4 ( 0.3 18.6 ( 0.3 18.9 ( 0.3 19.8 ( 0.3
a Data are averages over the last 4 ns of each trajectory ((, standard deviations). The bilayer thickness (DPP) is the distance of the average P atom
locations at each monolayer. DP is the distance of the average P atom location of a monolayer from the bilayer center, calculated for all of the P atoms, closer
by at least 8 Å to any peptide heavy atom (bound), and for the remaining P atoms (rest). The DP values are given for leaflets 1 and 2 since the level of
peptide insertion at each leaflet may differ. All values are given in angstroms.
Figure 7. Average backbone structures of the peptides during the last 10
ns of trajectories A1a (top), A2 (middle), and A3 (bottom); peptide 1 is shown
in the left-hand-side and peptide 2 in the right-hand-side. The thickness of
the tubes represents the root-mean-square fluctuations of the backbone. Also
shown are the side chains: from left to right, Met182, Leu184, and Pro185.
The bottom left structure shows the average structures before (gray) and
after (red for the backbone and black for side chains) the conformational
transition (see text for details). Figure made with MOLMOL.68
Table 5. CR RMSD Values of the Peptide Structures in Different
Insertion Simulations (angstroms)a
A2:P1 A2:P2 A3:P1 A3:P2 A1a:P1 A1a:P2
A2:P1 2.6 1.9 3.4 2.3 3.3
A2:P2 3.2 2.3 1.4 2.4
A3:P1 4.0 2.9 4.4
A3:P2 2.7 1.7
A1a:P1 2.5
a Data for the simulations with an acetylated N-terminus are shown. The
CR RMSD values were calculated for structures averaged over the last 2 ns
after complete peptide insertion.
Figure 8. Number density averaged over the last 2 ns of all of the
simulations that resulted in peptide insertion. Because of the different levels
of peptide insertion in the earlier stages of the simulations, the average
was taken in the trajectories with complete insertion and only for the last
2 ns.
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carbonyl groups of the peptide backbone and the phosphate and
choline groups of DMPC, respectively, anchor the peptide at
the lipid-water interface. Hydrogen-bond interactions, particu-
larly by the N-terminal side of the peptide (Figure 9), play a
significant role. The plots in Figure 10 indicate the interactions
of the different parts of the peptide with water in the last 10 ns
of the trajectories. As expected, the Met and Leu side chains
lose significant contact with water as they progressively
penetrate the lipid membrane. The backbone and Pro side chain,
however, remain in constant interaction with solvent. The
interactions of the ras peptide with the DMPC bilayer and water
are finely balanced. However, it is clear from the number of
ras and DMPC acyl carbon contacts that nonpolar interactions
provide the major driving force for association. The backbone
and the Pro ring help maintain the location of the peptide in
the interfacial region.
Peptide Stabilization in the Bilayer. Insertion of singly
myristoylated or palmitoylated peptides containing positive
charge clusters into bilayers with negatively charged interfaces
is assisted by attractive electrostatic interactions. However,
complete insertion of their lipid tails into the hydrophobic region
is prevented by unfavorable electrostatic desolvation penalty.71,72
In contrast, the completely hydrophobic polypeptide from the
C-terminus of the N-ras protein was shown previously,14 and
here, to insert deep into the DMPC bilayer. This leads to a larger
gain in hydrophobic stabilization compared with charged
peptides. Although the insertion of the ras lipid chain is driven
by hydrophobic interactions (the polar backbone-headgroup
interactions playing a passive role in the initial contact forma-
tion; see the section on peptide insertion), once inserted, the
backbone of the peptide contributes to the stability of the
complex by interacting with the DMPC headgroups (Figure 9).
Hydrogen-bonding interactions between the backbone amides
(mainly involving the N-terminal segment, particularly the
palmitoylated Cys181) and the phosphate oxygen atoms are
frequent. The hydrogen-bonding potential appears to be slightly
enhanced in the charged form of the peptide. In general,
however, there was no significant difference between the
charged and acetylated forms of the peptide in their interaction
with the bilayer, suggesting that the hydrophobic interactions
are the most crucial. This is further supported by the observed
interactions between the lipid tails of the ras peptide and the
DMPC. Note that the transfer from aqueous solution into a
nonpolar environment of each CH2 group of lipid-modified
proteins contributes about 0.8 kcal mol-1 of hydrophobic
stabilization,45,73 suggesting a large energetic contribution from
the lipid tail interactions. Further hydrophobic stabilizations due
to interactions between the apolar side chains and the DMPC
hydrocarbon tails ensure a strong association.
As seen in the previous section, Met and Leu side chains
orient toward the hydrocarbon core, while Pro and the backbone
preferentially populate the membrane-water interface. This
orientational scenario is in agreement with the experiment-based
hydrophobicity scales of Wimley and White (WW scales)
obtained from the partitioning of small peptides into lipid
vesicles74 and octanol.75 The former can be interpreted as the
free energy of transfer of whole peptides from water to
membrane interfaces (∆Gwfif) and the latter from water to the
hydrocarbon (HC) core (∆Gwfoct). The difference gives the
relative free energy of transfer from interface to HC (∆Giffoct).
When the lipid modifications are excluded, the total ∆Gwfif is
-0.8 kcal mol-1; so, the peptide would slightly favor binding
to the interface. The value of ∆Gwfoct is 0.48 kcal mol-1, and
consequently, the free energy of interface-to-HC transfer
(∆Giffoct) is 1.28 kcal mol-1, such that the insertion of the
nonlipid-modified peptide into the HC region would be unfavor-
able. The backbone is the major source of the unfavorable
peptide-HC interaction as its contribution (∆Giffoctbackbone) is 5.6
kcal mol-1 (note that ∆Gwfifbackbone and ∆Gwfoctbackbone are 1.2 and 2.0
kcal mol-1 per residue, respectively76). However, insertion into
the HC can be facilitated by side chain reorientations. When
∆Giffoct of the side chains is derived from the WW scales, Met
and Leu, with -1.24 and -1.49 kcal mol-1, respectively, favor
(71) Buser, C. A.; Sigal, C. T.; Resh, M. D.; McLaughlin, S. Biochemistry 1994,
33, 13093-13101.
(72) Pool, C. T.; Thompson, T. E. Biochemistry 1998, 37, 10246-10255.
(73) Peitzsch, R. M.; McLaughlin, S. Biochemistry 1993, 32, 10436-10443.
(74) Wimley, W.; White, S. Nat. Struct. Biol. 1996, 3, 842-848.
(75) Wimley, W. C.; Creamer, T. P.; White, S. H. Biochemistry 1996, 35, 5109-
5124.
(76) White, S. H. FEBS Lett. 2003, 555, 116-121.
Figure 9. Probability of the occurrence of backbone amide nitrogen-
phosphate oxygen hydrogen bonds in the last 10 ns of the simulations. A
distance cutoff of 3.5 Å between N and O atoms was used. Left panel
represents simulations with the acetylated N-terminus (A2 in red, A3 in black,
and A1a in blue). The right panel is for simulations with the charged
N-terminus (C2 in red, C3 in black, and C1a in blue). Circles are for peptide
1 and squares for peptide 2. The dotted lines are drawn only for clarity.
Figure 10. Number of ras atoms in contact with water during peptide
insertion normalized over the number of contacts in a fully solvated extended
conformation. A contact is defined as the number of ras heavy atoms within
5 Å of water oxygen atoms. The last 10 ns of A3, C3, A2, and C2 are shown
in black, red, green, and blue, respectively.
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the HC region, while the two glycines, with a ∆Giffoct value of
0.68 kcal mol-1, favorably interact with the interface. A Pro
side chain, with -1.11 kcal mol-1, would be expected to transfer
to the HC, but it remains in the interface due to the rigidity of
its backbone. The two Cys side chains are expected to point
into the HC with a free energy gain of -1.16 kcal mol-1. Any
lipid modification obviously increases this value. On the basis
of the WW scales, therefore, the insertion into the HC region
of the apolar amino acids, as well as the interfacial localization
of the backbone (as observed from the simulations), is thermo-
dynamically favored, as is the insertion of the ras lipid tails
into the HC core.
Furthermore, the insertion and stabilization of the peptide in
the phospholipid required only a limited number of ras acyl
carbon atoms in contact with those of DMPC (between five
and seven), and insertion of one chain leads to a fast spontaneous
insertion of the other. While the former confirms the hydro-
phobic origin of the driving force of the association, the latter
may relate to the fact that singly lipid-modified peptides
associate with plasma membranes with shorter half-life times.73,77
Conclusions
The C-terminal Cys181-palmitoyl and Cys186-farnesyl
chains play a fundamental role as membrane anchors of the
human N-ras protein. Recently, a battery of spectroscopic
techniques was used to investigate the membrane localization
of a heptapeptide with the amino acid sequence of residues 180-
186 containing the two lipid modifications.14 Here, MD simula-
tions were used for a detailed characterization of the late stages
of the insertion mechanism. The position and orientation of the
ras peptide and its components (backbone, side chains, and lipid
chains) during the MD runs are consistent with the spectroscopic
data.14 The agreement between simulations and experiments
allows the use of the former for an atomic level description of
the peptide-membrane association. The simulation results
highlight four aspects that go beyond the model obtained from
experiments. First, a partial insertion of both, or even only one
chain, is sufficient to trigger complete insertion and stabilization
of the peptide in the membrane within the time scale of the
MD simulations (10-20 ns). Second, the monolayer thickness
is slightly smaller for phospholipids in contact with the inserted
peptide and slightly larger far away from it. Because of the
simplified system used in the simulations, it is not possible to
speculate if this membrane deformation is relevant for signal
transduction. Third, over the 10 ns time scale of the MD
simulations, the peptide backbone is rather rigid and extended,
but backbone conformations differing by up to 4.0 Å are
observed in different MD trajectories. It is likely that multiple
peptide conformations are energetically accessible for rapid
binding of the human N-ras protein to the membrane. Finally,
although it is difficult to speculate on the details of the insertion
mechanism (because of the constrained MD used for the initial
peptide positioning), a coarse-grained sequence of events
consists of an initial contact between ras lipid tails and the
DMPC acyl chains, followed by complete lipid insertion, and
almost concomitant side chain reorientation and backbone
reorganization.
After our paper was submitted, an MD study of a synthetic,
cationic C14-N-acylated peptide (myristoyl-HWAHPGGHHA-
amide) inserted into a dipalmitoylphosphatidylcholine (DPPC)
lipid bilayer was published.64 The force field and simulated time
scale are the same as in the present work, whereas the simulation
protocol (constant surface tension and only one peptide per
bilayer) and phospholipids (DPPC vs DMPC) are slightly
different. Interestingly, the peptide mobility at the membrane
surface, as well as the multiple backbone conformations and
small structural fluctuations around them, is similar in the two
studies, despite the differences in peptide sequence, length, and
number of lipid tails.
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10 Conclusion and outlook
A variety of computational techniques were employed in this thesis to investigate dif-
ferent biophysical issues, emphasizing that methods must be adapted to the problem
under study. It was shown that computational approaches are powerful and versatile be-
cause they can describe systems at different levels of approximations. Although many
arguments were treated, a large part of this work was devoted to the investigation of amy-
loid fibril formation. This argument, deeply involved into medical research, witnesses
a tremendous interest of theoretical and computational research, and we believe that the
coarse-grained model introduced above can address many further questions.
First, it is proposed to investigate the effects of molecular crowding on amyloid for-
mation. It is not known whether intracellular deposition or extracellular accumulation
of β-amyloid peptide promotes the pathological process [94]. The excluded volume
induced by the molecular crowding of the cytoplasm influences the kinetics of fibrils
polymerization [95, 96], but it is not clear whether and which intermediates are stabi-
lized. Simulations of aggregation might be performed in the presence of spheres of dif-
ferent radii to approximate molecular crowding effects, and shed light on the influence
of molecular crowding on kinetics and pathways of fibril formation.
Second, the interactions of amyloid aggregates with membrane will be studied. Many
investigators have observed a lytic activity of amyloid oligomer on liposomes [97]. For-
mation of pore-like structures at the membrane surface seems a common feature of amy-
loid peptides [98]. For these reasons, the perturbation of cell membrane permeability
induced by amyloid aggregates might be the origin for cytotoxicity [99]. Simulations of
membrane and peptides can be helpful to depict which is the role of amyloid oligomers
for membrane instability and eventually shed light on the identity of the toxic species.
Finally, the mechanisms of inhibition of amyloid aggregation is the ultimate goal of
our research. Protecting the polypeptide from assembling into amyloid oligomers either
by using a small molecule [100, 101] or a peptide [102, 103], has been revealed as a
valid strategy against Alzheimer disease. Yet, the processes behind the fibril regression,
and monomer solubilization are not understood, and molecular dynamics simulations of
200
the type discussed in this thesis might reveal under which conditions fibrils and their
intermediates are depleted.
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